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3  Abbreviations 
 
 
2D two-dimensional 
3D three-dimensional 
APC antigen-presenting cell 
Arp2/3 actin-related protein 2/3 
BM basement membrane 
CalDAG Ca2+ and diacylglycerol-regulated 
guanine nucleotide exchange factor 
CCL CC-chemokine ligand 
CCR CC-chemokine receptor 
CD cluster of differentiation 
Cdc42 cell division cycle 42 
CLEVER-1 common lymphatic endothelial and 
vascular endothelial receptor 1 
CXCL CXC-chemokine ligand 
CXCR CXC-chemokine receptor 
DC dendritic cell 
dDC dermal dendritic cell 
ECM extracellular matrix 
ESAM endothelial cell-selective adhesion 
molecule 
FERM 4.1, ezrin, radixin, moesin 
FRC fibroblastic reticular cell 
GDP guanosine-5'-diphosphate 
GEF guanine nucleotide exchange factor 
GTP guanosine-5'-triphosphate 
GTPase guanine nucleoside triphosphatase 
HEV high endothelial venule 
ICAM-1 intercellular adhesion molecule 1 
IL-1β interleukin 1β 
JAM-A junctional adhesion molecule A 
LAD leukocyte adhesion deficiency 
LC Langerhans cell 
LEC lymphatic endothelial cell 
LFA-1   lymphocyte function-associated  
 antigen 1 
LN lymph node 
Mac-1 macrophage antigen 1 
MAdCAM-1 mucosal vascular addressin cell    
 adhesion molecule 1 
MHC major histocompatibility complex 
MMP matrix metalloproteinase 
MSP major sperm protein 
PECAM-1 platelet/endothelial cell adhesion 
molecule 1 
PGC primordial germ cell 
PI3K phosphoinositide-3 kinase 
PIP3 phosphoinositol-3,4,5-triphosphate 
PNAd peripheral lymph node addressin 
PPs Peyer’s patches 
PSGL-1 P-selectin glycoprotein ligand 1 
PTB phospho-tyrosine binding 
Rac ras-related C3 botulinum toxin 
substrate  
Rap1 Ras-associated protein 1 
RAPL regulator of cell polarization and 
adhesion enriched in lymphoid 
tissues 
Rho Ras-homologous 
ROCK Rho-associated kinase 
S1P sphingosine-1-phosphate 
SadA substrate adhesion-deficient A 
SLO secondary lymphoid organ 
VCAM-1 vascular cell adhesion molecule 1 
VE-cadherin vascular endothelial cadherin 
WASp Wiskott-Aldrich syndrome protein 
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4  Summary 
 
Both innate and adaptive immune responses rely on rapid leukocyte trafficking. Most 
leukocytes continuously scan the body and recirculate between blood, peripheral tissues and 
the lymphatic system. Physiological leukocyte movement can be subdivided into two-
dimensional (2D) and three-dimensional (3D) migratory events. The two migration modes  
likely differ mechanistically, although the precise differences were unknown and highly 
debated when I started my thesis work. During extravasation, leukocytes undergo a multistep 
adhesion cascade along the 2D surface of the blood endothelium. Here, selectin-mediated 
rolling along the endothelium promotes sensing of chemokines that are immobilized on the 
vascular lumen. This induces activation of integrin function which triggers leukocyte arrest 
and then crawling along the vessel wall. Integrin-mediated adhesion serves to couple the 
forces of actin polymerization and actomyosin contraction to 2D surfaces and thereby enables 
the cell to locomote. While integrin functions during extravasation have been studied in detail, 
it is controversial if integrin-mediated adhesion also contributes to 3D leukocyte movement in 
interstitial tissues (reviewed in Paper II). Although it is often equated with crawling of 
amoeboid-shaped cells on 2D surfaces where locomotion mechanics have been already 
assessed, leukocyte interstitial migration lacks a solid mechanical and molecular framework. 
Moreover, the generalization of findings in other amoeboid cells might cause problems, as the 
ambiguous definition of “amoeboid migration” comprises multiple locomotion modes, which 
range from contraction-based blebbing to entirely protrusive migration.  
This Ph.D. thesis sought to study the interplay between adhesive, contractile and protrusive 
forces in the physiological interstitial movement of leukocytes. Dendritic cells (DCs) served 
as a model system as their migration route from the skin via afferent lymphatic vessels to the 
draining lymph node leads through different interstitial environments (reviewed in Paper 
IV). As DCs express at least eight integrin heterodimers and the molecular composition of the 
tissue compartments might favour adhesive interactions (reviewed in Paper III and IV), we 
hypothesized that DCs employ integrins to generate adhesion-mediated traction for 3D 
locomotion. To investigate the role integrins play during leukocyte migration, we employed a 
combinatorial mouse genetics approach to delete four integrin key subunits and thus deplete 
all integrin heterodimers from the surface of leukocytes (Paper V). Surprisingly, migration 
speeds of DCs, granulocytes and B cells in 3D collagen gels and DCs in dermal skin and 
lymph nodes were unaltered. In contrast, adhesion to 2D in vitro surfaces and leukocyte 
extravasation in vivo was severely impaired in the absence of integrins. We obtained similar 
Summary 
V 
results when genetically deleting talin1, a major regulator of integrin activation (Paper V). 
Accordingly, after genetically deleting γ-parvin which contributes to a molecular complex 
linking integrins to the cytoskeleton, DC trafficking was also normal (Paper I). These 
experiments convincingly showed that for interstitial leukocyte migration integrin-mediated 
traction forces are dispensable. Pharmacological inhibition of actomyosin contraction and 
actin polymerisation revealed the major cellular forces that drive leukocyte migration through 
interstitial meshworks: The sole force of actin-network expansion at the leading edge is 
sufficient for 3D movement. Auxiliary myosin II-dependent contraction is only required on 
passage through narrow gaps, where a squeezing contraction of the trailing edge propels the 
rigid nucleus. Having established protrusive actin flow as a major driving force, we further 
addressed the question how coordination of actin flow influences 3D leukocyte migration 
(Paper VII). We therefore employed DCs lacking the small GTPase Cdc42. These cells still 
initiated actin flow and actomyosin contraction in response to chemotactic cues, but lacked 
temporal and spatial regulation of their protrusions. While migration on 2D surfaces was only 
mildly impaired, Cdc42 deficiency completely abrogated in vivo motility. This discrepancy 
was entirely caused by the geometrical complexity of the environment as multiple competing 
protrusions led to entanglement within 3D fibrillar scaffolds.  
In summary, my Ph.D. thesis shows that leukocytes migrate in the absence of specific 
adhesive interactions through interstitial tissues. This is in contrast to the general cell 
migration paradigm of integrin-mediated traction on 2D surfaces. Instead, actin-network 
expansion at the leading edge and auxiliary actomyosin contraction at the cell rear appear to 
directly transduce the intracellular force onto the 3D matrix. Therefore, we conclude that 
internal stabilization of polarity and coordinated cytoskeletal flow rather than transmembrane 
force coupling are decisive for 3D leukocyte migration. Adhesion-independent movement 
renders leukocytes autonomous from the tissue context and allows them to quickly and 
flexibly navigate through any organ without adaptations to alternating extracellular ligands. 
Moreover, substrate independency favours migration along paths of least resistance that does 
not necessitate proteolytic degradation of the interstitial matrix which we confirmed for 
granulocytes (Paper VI). 
The results of my Ph.D. thesis provide insights into basic questions of cell motility and 
cytoskeletal regulation which underlie leukocyte trafficking and thus immunological function. 
Furthermore, the results might have implications for dendritic cell-based tumor vaccination 
strategies. 
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5  Introduction 
5.1 Leukocyte migration in general 
5.1.1 Principle trafficking processes  
 
 
Figure 1: Leukocyte trafficking. (A) Leukocyte circulation through the body involves trafficking through different 
tissue compartments (scheme adapted from Alvarez et al. 1). (B) Leukocytes exit the blood by adhering to and 
transmigrating across an endothelial cell layer. Movement within tissues is characterized by crawling through 
interstitial matrix (scheme adapted from Sixt et al. 2). 
 
The innate and adaptive immune system protects the vertebrate’s body from foreign invaders. 
Specialized leukocyte subsets cooperate perfectly in time and space to become the cellular 
counterforce in a healthy organism. After their generation in the bone marrow or the thymus, 
they emigrate into the blood and circulate through the body. Leukocyte migration comprises 
three different processes: i) exit from the blood vessel into the tissue (extravasation), ii) 
migration within peripheral tissues and lymphoid organs (interstitial migration) and iii) entry 
into blood sinuses or lymphatic vessels (egress from tissues) (Fig. 1A). 
Extravasation from the blood allows entry into different organs (Fig. 1B). For instance, innate 
immune cells (neutrophils, monocytes) rapidly exit blood vessels at sites of acute 
inflammation. Naïve lymphocytes as part of the adaptive immune system recirculate 
constantly between blood, secondary lymphoid organs (SLOs) and lymph. To enter lymph 
nodes (LNs) and Peyer’s patches (PPs), they must actively traverse high endothelial venules 
(HEVs), whereas entry of the spleen occurs passively. Each leukocyte subtype carries 
characteristic sets of trafficking molecules (adhesion receptors and chemokine receptors) on 
its surfaces to specifically direct its recruitment to the correct anatomical site 3, 4.  
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During interstitial migration leukocytes scan the tissue for an infectious source in the body 
(Fig. 1B). At sites of acute injury, neutrophils rapidly release cytotoxic mediators to eliminate 
the invader. Monocytes differentiate to macrophages or dendritic cells (DCs) and establish a 
tissue-resident defence at peripheral sites. In contrast, naïve antigen-specific T lymphocytes 
search for antigen-presenting DCs in SLOs. After cellular encounter, T cells acquire 
activation signals and differentiate to effector T cells. As a consequence, they then change 
expression of trafficking molecules which enable LN exit and migration to peripheral sites. 
Trafficking molecules might not be as specific for leukocyte interstitial migration as for 
extravasation. While leukocyte-specific chemokine receptors were shown to determine 
directed migration, it is not clear if leukocytes require a characteristic set of adhesion 
receptors for navigating through interstitial tissues.  
Leukocyte exit organs either by entering blood sinuses (in bone marrow or spleen), lymphatic 
vessels (in peripheral tissues) or lymphatic sinuses (in LNs). As these processes have not been 
investigated in the course of this thesis, I will not further discuss them. 
 
5.1.2 Trafficking molecules 
 
 
Figure 2: Trafficking molecules. (A) Leukocyte-specific recruitment to peripheral tissues requires the concerted 
action of trafficking molecules (selectins, chemokines, integrins). (B) In the course of extravasation, trafficking 
molecules enable leukocytes to undergo a multistep adhesion cascade along the endothelium (schemes taken 
from Springer 5). 
 
Leukocyte migration has been mostly and extensively studied in the context of the 
extravasation process through the endothelial cell layer 6. To overcome both the high shear 
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force within the blood vessel and the tight seal of the endothelial cells, leukocytes undergo a 
sequence of distinct adhesive and signalling events which has been termed the multistep 
adhesion cascade (Fig. 2B). Traditionally, leukocyte emigration has been described as a three-
step model based on three molecular interactions: (i) selectin-mediated tethering and rolling 
along the inner vessel, followed by (ii) chemokine-induced leukocyte activation leading 
subsequently to (iii) integrin-dependent leukocyte firm arrest 5, 7. Therefore, selectins, 
integrins and chemokine receptors are also termed “trafficking molecules” as their 
combinatorial expression on the plasma membrane gives leukocytes a unique identity and 
ability to home to vascular beds with specific “area codes” 5 (Fig. 2A). This principle 
provides an enormous combinatorial diversity for leukocyte recruitment. It allows continuity 
for steady-state leukocyte homing, but also flexibility upon inflammation when leukocytes 
and endothelial cells activate or newly synthesize trafficking molecules. In the following, I 
will briefly outline the functional principles of selectins and chemokines and then introduce 
the family of integrin receptors and their functions on leukocytes in more detail.  
 
Selectins constitute a family of highly conserved C-type lectins, which bind sialyl-Lewis X-
like carbohydrate ligands that are presented by sialomucin-like surface molecules such as 
PSGL-1 6, 8. Ligand binding occurs with exceptionally high on- and off-rates and facilitates 
initial leukocyte capturing and rolling under heavy blood flow 5, 9, 10. Three members 
participate in the early extravasation steps: L-selectin is expressed on most circulating 
leukocytes and is especially important for transmigration across HEVs and peripheral 
inflamed vessels 11, 12. Upon inflammation, endothelial cells upregulate the expression of P- 
and E-selectin and determine recruitment of several immune cells by interacting with PSGL-1 
on the leukocyte surface 13. 
 
While rolling, leukocytes sense chemokines that are immobilized by heparan sulphate 
residues or silent chemokine receptors on the endothelial cells’ luminal side 14, 15. Chemokines 
bind to G-protein coupled chemokine receptors and initiate diverse signalling pathways 16, 17. 
Ligated chemokine receptors exchange GDP against GTP at the Gα subunit of heterotrimeric 
G proteins. Gα (with Gi as major regulator of chemokine signalling) and Gβγ subunits 
dissociate from each other, which triggers an intracellular calcium flux. The resulting 
activation of signalling molecules such as PI3K or small RhoGTPases induces several 
molecular pathways 18, 19. One outcome is integrin activation on the leukocyte surface. 
Circulating leukocytes carry integrins in a non-actived conformation that, upon chemokine 
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signalling, changes to an active state. The structural basis of this event and the key molecules 
involved in this process will be described in the next paragraph. 
 
5.2 Integrins on leukocytes 
5.2.1 Integrin structure and functions 
 
Figure 3: The integrin family. The various associations between α subunits and β subunits allow formation of at 
least 24 integrin heterodimers. The most intensively studied integrins on platelets and leukocytes are highlighted 
in red (scheme adapted from Kinashi20). 
 
In metazoans, integrins represent the major adhesion receptors binding both extracellular and 
cellular ligands 21. They are heterodimeric type I transmembrane glycoproteins that are 
composed of non-covalently associated α and β subunits. 18 α and 8 β chains can differently 
combine to form 24 integrin receptors 22. Each subunit is composed of a large extracellular 
domain (N-terminus of >700 residues), a single transmembrane domain (>20 residues) and a 
usually small cytoplasmic domain (C-terminus of 13-70 residues) 23. While the cytoplasmic 
domain is linked to the actin cytoskeleton, the extracellular domain binds to extracellular 
matrix molecules (ECM) and/or cellular counter-receptors. Several integrins can bind to the 
same extracellular ligand, but also several ligands are bound by the same integrin. The family 
of integrins can be subdivided into four major subfamilies according to key subunits that 
assemble multiple heterodimers 22 (Fig. 3). Analysis of expression patterns and studies of 
mice with homozygous null mutations revealed their physiological function and significance 
24, 25. The β1 subfamily is the largest family with 12 α chains that assemble with the β1 chain. 
Homozygous null mutations of the β1 gene in mice result in peri-implantation lethality at day 
E5.5 due to an inner cell mass failure 26, 27. The αv subfamily comprises five integrin 
heterodimers that all, together with the integrins α5β1 and αIIBβ3, recognize the tri-peptide 
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arginine-glycine-aspartic acid (RGD). The αv knockout mice survive until E12 and 
occasionally develop to birth. These mice show cleft palate and die from massive CNS or 
gastrointestinal hemorrhage 28. The four integrins that share the β2 subunit are exclusively 
expressed on leukocytes. Consequently, β2 null mice are viable and show most of the features 
of the human leukocyte adhesion deficiency type I (LAD-I) 29. LAD-I patients harbour 
inactivating mutations in the β2 chain and suffer from leukocytosis, and spontaneous and 
recurrent infections due to impaired emigration of neutrophils 30. Two other leukocyte-
restricted integrin dimers share the β7 chain and null mutations of the β7 gene result in viable 
mice with abnormal development of the PPs and reduced numbers of intraepithelial 
lymphocytes 31. In summary, integrins have been shown to play crucial roles in embryonic 
development, tissue maintenance and repair, host defence and hemostasis 32. 
Figure 4: A model of integrin conformation-function relationships. The three major conformational states that 
have been identified so far are shown (from left to right): bent form (inactive), extended with closed head-piece 
(primed) and extended with open head-piece and separated legs (ligand bound) (scheme adapted from Askari et 
al.33).  
 
Integrins signal bidirectionally across the plasma membrane, integrating signals from the 
extracellular ligands to the intracellular cytoskeleton and signalling adaptors 22. “Inside-out 
signalling” refers to the process by which cellular activation results in increase of the adhesive 
properties of the integrin, a process also called “integrin inside-out activation” 34. Studies on 
the integrins αIIBβ3, αvβ3 and αLβ2 (LFA-1) showed that integrins undergo conformational 
changes reflecting different stages of activation. There are three major integrin conformations 
that have been identified so far:  the bent form (low affinity), the extended form with a closed 
ligand-binding head (intermediate affinity) and the extended form with an open head-piece for 
ligand binding and separated legs (high affinity) 35 (Fig. 4). It is established that upon cellular 
activation, integrins undergo a conformational change that involves unbending and extension 
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of the receptor. However, a spectrum of conformations seems likely and accumulating 
evidence suggests that the degree of extension might be both specific for a particular integrin 
and for a specific activation stimulus 33. 
In particular reported for LFA-1, initial binding to multivalent ligands results in clustering of 
integrin receptors and stabilising an extended integrin, strengthening adhesion, and 
transmitting signals to the cell interior (“outside-in signalling”) 34, 36. The corresponding 
signals determine aspects of cell adherence, spreading, migration, but also differentiation, 
survival and leukocyte-specific processes such as degranulation and cytokine secretion. 
 
5.2.2 Integrin activation in leukocytes 
 
The short cytoplasmic domains of both α and β subunits harbour conserved amino acid 
sequences that contribute to the different conformational states of integrin activity. The 
α integrin cytoplasmic tails contain a GFFKR sequence that is believed to be critical for a salt 
bridge-mediated interaction with the β chain. This association is thought to prevent integrin 
activation by stabilizing the low-affinity state 23, 36. However, this issue is still under debate. 
The β chain cytoplasmic domain contains two NPXY (NPXF in the β2 chain) motifs that 
mediate talin and kindlin binding leading to separation of the α and β tails 36. This unclasping 
might be propagated across the plasma membrane by alterations in the interaction of the 
transmembrane segments and changes in the membrane insertions of the membrane-proximal 
domains of the cytoplasmic tails, but this has not yet been fully understood 23, 33. The ultimate 
consequence of inside-out signals is the change of the extracellular ectodomains to a high 
affinity conformation leading to integrin activation.  
 
Talin (~ 270 kDa) was the first protein shown to interact with integrin cytoplasmic tails 37, 38 
and constitutes an essential mediator of integrin activation 39. Two talin isoforms exist in 
vertebrates (talin-1 and talin-2) with talin-1 as the predominant isoform in hematopoietic cells 
40, 41. Talins consist of a globular N-terminal head region and a flexible rod domain. The talin 
head contains a FERM domain that is subdivided into F1, F2 and F3 domain. Upon 
intracellular activation, the auto-inhibited talin undergoes conformational change exposing the 
phosphotyrosin-binding (PTB) domain of the F3 domain 41. Binding of the PTB domain to the 
membrane-proximal NPXY motif is believed to disrupt the salt bridge between the α and β 
subunit and thus leads to separation of the cytoplasmic domains 42. However, additional 
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interactions with the β chain cytoplasmic domain are most likely required, as other PTB-
containing proteins can bind to the NPXY motif, but cannot activate the integrin 43. The 
physiological significance of talin-mediated integrin activation has been previously reported 
in two studies. Mice with a conditional deletion of the Tln1 gene showed spontaneous 
bleeding and lack of activation of the platelet integrins α2β1 and αIIBβ3 44, 45. For 
leukocytes, binding of talin to high affinity LFA-1 in T cells suggests a similar role in integrin 
activation 46, but this has not yet been confirmed in vivo.  
Recent data demonstrated that talin alone is not sufficient to activate integrins and requires 
kindlins for integrin activation 47. Kindlins are a novel family of FERM domain-containing 
proteins 48. They generally interact with the membrane-distal NPXY motif of the β chain 
cytoplasmic domain 47, 49-52. Their FERM domain shows high levels of sequence similarity to 
that of talin 53. In the absence of kindlins, integrin activation cannot occur 47, 50, 52, 54. It is 
meanwhile clear that both kindlins and talin are required for integrin activation. As they bind 
distinct regions of the integrin β cytoplasmic tail, they may cooperate to mediate integrin 
activation. The exact sequence of protein binding events remains further investigation. There 
are three kindlin family members in mammals with kindlin-3 exclusively expressed in cells of 
hematopoietic origin 55. Kindlin-3 has been shown to activate β1, β2 and β3 integrins on 
platelets and leukocytes 47, 54. Kindlin-3 null mice show severe bleedings and lack of platelet 
and neutrophil firm adhesion 47, 54. Recently, mutations in kindlin-3 were implicated with 
human LAD-III, which is associated with severe defects in leukocyte and platelet integrin 
activation 56-59. For years, the causes of LAD-III have been connected to another regulatory 
pathway of integrin activation. Some LAD-III patients had a mutation in CalDAG-GEF1, a 
guanine nucleotide exchange factor (GEF) for the small GTPase Rap1 60, 61. This was 
mirrored in mice with homozygous null mutations of CalDAG-GEF1 showing a LAD-III-like 
phenotype 62. However, recent in-depth analysis showed that Kindlin-3, but not CalDAG-
GEF1, restored the adhesive deficiencies in LAD-III cell lines and provided strong evidence 
that Kindlin-3 deficiency underlies LAD-III 56, 57.  
In hematopoietic cells Rap1 activates β1, β2 and β3 integrins 63. Several pathways of Rap1 
activation have been described in platelets and leukocytes. The activity of Rap1 is regulated 
by GDP-GTP exchange through GEFs 63. To exert its function, active Rap1 needs to be 
recruited to the plasma membrane and protein kinase C has been shown to induce a complex 
of protein kinase D1 and Rap1 with the surface-expressed integrin β1 chain 64. Active Rap1 
can modulate integrin affinity via two Rap1 effectors that act independently, but maybe also 
cooperatively 34. Rap1 induces the formation of a complex containing talin and the Rap1 
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effector RIAM that facilitates talin binding to the β2 cytoplasmic domain 65. RAPL, another 
Rap1 effector is most likely specific for the integrin LFA-1. RAPL associates with active 
Rap1 and binds to two lysine residues that are only found in the αL chain distal to the 
common GFFKR motif 66. Taken together, kindlin and talin binding to integrin β cytoplasmic 
tails represent essential steps in integrin activation. How protein recruitment to α cytoplasmic 
tails influences integrin activation requires further investigation. 
 
Another recently emerging concept has been observed for integrin α4β1 and suggests external 
force as an additional factor in integrin activation on leukocytes. It has been shown that 
moderately applied force on ligand-bound integrin α4β1 leads to nanosecond transitions to 
the high-affinity state 67, 68. Leukocytes might physiologically face low forces as shear flow of 
the blood stream. Hereby, it has been proposed that already extended integrins anchored to the 
inner cortical cytoskeleton undergo rapid ligand-induced integrin activation 9. Thus, force 
might strengthen integrin-ligand bonds and accelerate outside-in signals.  
 
5.2.3 Functions of integrins in leukocyte migration 
5.2.3.1  Extravasation 
 
Most knowledge about leukocyte integrins has been derived from studies of the extravasation 
process. Over the years and with the help of intravital microscopy, the classical three-step 
model has been refined by adding several separate events, including slow rolling, adhesion 
strengthening, intraluminal crawling, and paracellular and transcellular migration 6 (Fig. 5). In 
almost all steps, integrins have been proven or at least discussed to play major roles. In 
consideration of the vast amount of existing data, the following section will primarily focus 
on specific roles of distinct integrin heterodimers that have been observed in vivo. 
Extravasation of lymphocytes, neutrophils/monocytes and other blood cells will be discussed 
separately, as leukocyte subtypes differently employ integrin heterodimers. 
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Figure 5: The updated leukocyte adhesion cascade. The classical three steps are shown in bold letters. 
Additional steps that have been identified recently are shown in regular letters. The involvement of different 
integrin heterodimers at each step are indicated (VLA4: integrin α4β1) (scheme adapted from Ley et al.6). 
 
Integrins in the adhesion cascade 
Naїve lymphocytes activate integrins upon chemokine sensing at the HEV 69. Under 
homoestatic conditions, HEVs express VCAM-1 70 and ICAM-1 71, the ligands for α4β1 and 
LFA-1, respectively. HEVs in PPs, but not in peripheral LNs, express additionally MadCAM-
1, the ligand for the integrin α4β7 72 and results in different integrin employment during firm 
lymphocyte arrest. LFA-1 predominantly determines an abrupt arrest in peripheral LNs with a 
compensating role for integrin α4β1 70, 73, 74. In contrast, lymphocyte subsets expressing α4β7 
are preferentially recruited to PPs, where LFA-1-dependent adhesion plays only a minor role 
70, 72. Apart from firm arrest, integrins have also been implicated in earlier steps of 
lymphocyte extravasation. In HEVs of rat PPs, integrin α4β1 seems to facilitate both rolling 
and arrest 75. The integrin α4β1 is also part of a feedback loop that amplifies the homing 
process: Binding of α4β1 to autotaxin, a HEV-expressed lipase, generates lysophosphatic 
acid which in turn amplifies the chemokine receptor response 76. 
Neutrophils and monocytes differ from lymphocytes as they additionally express high 
amounts of the integrin αMβ2 (Mac-1) that binds several ligands including ICAM-1, ICAM-2 
and fibrinogen. In inflamed postcapillary venules, neutrophils and monocytes employ distinct 
integrins for extravasation. Whereas LFA-1 mediates neutrophil rolling and adhesion, Mac-1 
allows subsequent crawling along the endothelium to search for the optimal emigration site 77, 
78. By contrast, monocyte extravasation seems to depend largely on the integrin α4β1 79, 
which has also been suggested for T cells 80-82. An interesting phenomenon has been observed 
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in non-inflamed postcapillary venules. Here, monocytes perform long-range crawling along 
the resting endothelium which is 10 to 1000 times slower than rolling and independent of the 
blood midstream flow. This patrolling behaviour depends on LFA-1 and serves rapid tissue 
invasion in an early innate immune response 83. 
Integrin-dependent homing to other organs follows the general scheme of rolling, activation 
and arrest. Hereby, extravasation of common lymphoid progenitors in corticomedullary 
vessels of the thymus depends on α4β1 and LFA-1 84, while homing of stem cells and 
progenitor cells to the bone marrow requires only the α4β1-VCAM1 interaction 85-88. 
However, lymphocyte extravasation can also occur in the absence of rolling in a α4β1-
VCAM1-dependent manner in liver sinusoids 89 and in inflamed vessels of the central nervous 
system 90-93. 
 
Integrins during transmigration 
After the sequential adhesion cascade leukocytes cross the endothelial layer in a process 
termed transendothelial migration or transmigration or diapedesis (Fig. 5). Leukocytes can 
enter the tissue either via the paracellular (through endothelial cell junctions) 94 or the 
transcellular (through the endothelial cell itself) route 95. The percentage of transcellular 
migrating cells ranges from 10% to 90% among the different sudies. Therefore, it is not clear 
which conditions and vascular beds might favour one or the other route 96. For instance, 
neutrophils crawl laterally in a Mac-1-ICAM-1-dependent manner along the endothelium and 
before emigrating paracellularly 78, 97. When depleting Mac-1 on neutrophils, transmigration is 
delayed and occurs preferentially transcellularly 78.  
Integrins might be involved in the actual transmigration process, as integrin ligands are 
expressed on the apical side of the endothelium and laterally in the junction 98. During 
transcellular migration, both VCAM-1 and ICAM-1 are found on so-called docking structures 
or transmigratory cups on endothelial cells 99, 100. After contact with leukocytes, ligand 
clusters might form and trigger signalling events in the endothelial cells. These might then 
capture and guide the leukocyte through intercellular junctions or transcytose it directly 
through the endothelial cell body 101, 102. Podosomes on the leukocyte’s ventral side protrude 
into the underlying endothelium to test at which site to penetrate the endothelial layer 95.  
A role for ICAMs in the diapedesis step has been suggested, but is not entirely established 
yet. By contrast, other junctional proteins such as PECAM-1, CD99, JAM-A and VE-cadherin 
seem to collaborate in a sequential opening of the endothelial junction 94. However, 
paracellular transmigration might still influence integrin functions on extravasating 
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leukocytes. In a particular experimental setting (IL-1β-induced inflamed venule of the 
cremasteric muscle, peritonitis model), transient homophilic PECAM-1 interactions between 
leukocyte and endothelial cells upregulate the expression of integrin α6β1 on neutrophils 103. 
The α6β1 integrin, a major receptor for the basement membrane (BM) component laminin, 
has been shown to be important for BM passage 103. This interaction might be required when 
neutrophils face the BM before migrating through preformed openings (also called low 
expression sites as they show low levels of laminins and collagen IV) of the endothelial BM 
that correspond with gaps in the pericyte sheet without creating defects 104. However, this is 
not a general phenomenon as neutrophil migration in another setting does not require 
PECAM-1-induced integrin upregulation 105. 
 
5.2.3.2 Interstitial migration 
 
The subsequent steps after extravasation and passage of the endothelial BM have been poorly 
addressed and little is known about the adhesive interactions that mediate leukocyte migration 
in extravascular spaces. Migration outside blood vessels is commonly referred to as interstitial 
migration and ranges from movement through the loosely packed and fibrillar-collagen-
dominated connective tissue of the mesenchymal interstitium to trafficking within the cell-
rich environment of SLOs. Intravital microscopy data on this aspect of leukocyte migration 
are limited, as blocking integrin functions in most cases already interferes with leukocyte 
entry into tissues. The few existing studies propose integrin-independent lymphocyte 
migration in the LN (see also 5.4.2.4) 106, but also integrin-dependent neutrophil migration in 
the mesenteric interstitium 107. The latter conclusion derives from a series of studies that 
observed a partial inhibition (speed reduction of only 30%) of neutrophils by blocking 
antibodies against the collagen-binding β1 and α2 integrin chains 107, 108. Static observations 
in a series of studies employing blocking antibodies and genetic inactivation suggested that 
collagen receptors α2β1 and α1β1 play a role in integrin-mediated retention of T cells during 
cutaneous hypersensitivity, experimental arthritis, colitis and virus infection by localizing T 
cells within the interstitium 109-112.  
 
Artificial 3D gels consisting of ECM components, predominantly collagens I and III, have 
been extensively used to mimic the porous and fibrillar environment of the dermal 
interstitium (see also 5.4.2.2). They provide a defined migration scaffold to follow leukocyte 
migration by video microscopy. Employing this and related settings, several groups addressed 
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the question if adhesion contributes to migration within interstitial matrices. Leukocytes were 
shown to interact with extracellular matrix molecules in 2D settings 113 and chemotactic 
locomotion of T cells within 3D collagen gels depended on integrins of the β1 family 114. 
However, early reports already favoured a non-adhesive migration mode of neutrophils and 
lymphocytes through 3D matrices 115, 116. Along the same line, granulocytes of LAD-I patients 
and after blocking integrin β2 function only showed a motility reduction in 2D, but not in 3D 
settings 117, 118. When migrating in the spatially confined space between two closely adjacent 
glass surfaces, granulocytes can switch to biophysical mechanisms of translocation 
(squeezing or “chimneying”) that are independent of integrin binding. By contrast, on 2D 
surfaces granulocytes were completely dependent on integrins to generate traction forces 119. 
Ultimately, antibody blocking studies showed that random T cell migration in the gel can 
occur in the complete absence of integrin-mediated binding 120 and proteolytic activity 121.  
 
Leukocytes are often compared with migrating cells of an “amoeboid” shape. Some tumor 
cell lines show amoeboid morphology during 3D migration, but it is unclear if they engage 
integrins or not. While few reports claim amoeboid migration of single tumor cells to be 
integrin-independent 122, 123, others observe just reductions in tumor migration when blocking 
integrins 124-126.  
 
5.3 Amoeboid migration of leukocytes 
5.3.1  Amoeboid migration 
 
Leukocyte movement in interstitial environments is commonly referred to as amoeboid 
migration and owes its name from the protozoon Amoeba proteus (amoibè (αμοιβή) as the 
Greek word for “change”, and Proteus as the Greek god of change) 127, 128. The group of 
amoeboid migrating cells is heterogenous and comprises different unicellular eukaryotes 
which vary in size, compactness and their habitat, but all share the one morphological feature 
that defines them as “amoeboid”: During movement they undergo a constant shape change 
forming extensions (originally described as pseudopods or “false feet”) that rapidly protrude 
and retract. However, it is nowadays clear that different amoeboid cells employ various 
locomotion mechanisms resulting in variants of amoeboid phenotypes ranging from 
contraction-based blebbing to entirely protrusive migration. The term “amoeboid migration” 
often reflects and summarizes all kinds of “non-mesenchymal migration” modes (Fig. 6). 
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Mesenchymal cells such as fibroblasts, smooth muscle and endothelial cells have an 
elongated morphology with slow migration rates. Tight coupling to the environment through 
long-lasting, highly adhesive focalized contact sites (focal contacts, focal and fibrillar 
adhesions) aligns the cell along the substrate. As a consequence of substrate-dependent 
migration, mesenchymal cells cannot circumvent matrix-dense regions. To overcome these 
barriers in fibrillar tissues, they proteolytically degrade the environment and move forward 
129, 130. Amoeboid cells by contrast show only weak adhesion to substrates and lack prominent 
adhesion sites. Thus, only low adhesive forces counteract the inherent cortical contractility 
explaining the roundish amoeboid morphology. The transient interactions with the 
environment allow substrate-independent, highly dynamic migration with high speeds and 
extreme deformability. This enables the cells to move along paths of least external resistance 
without proteolysis 121, 131.  
 
 
Figure 6: The phenotypic hallmarks of amoeboid 
and mesenchymal migration (see also text) 
(scheme adapted from Friedl and Weigelin 132 and 
Friedl 129).  
 
 
 
 
As described above, leukocyte migration in the context of extravasation requires integrin-
mediated adhesion, whereas locomotion in confined and 3D environments might depend less 
on adhesion. Therefore, leukocytes might differently generate internal forces for migration. In 
the following section, I will introduce the basic force-generating principles (contraction and 
protrusion) and discuss their interrelation and dependence on adhesion for cell movement. I 
will further compare leukocytes with other amoeboid cells and highlight similarities and 
differences in their crawling behaviour. 
 
5.3.2 Cellular forces in amoeboid migration 
 
Once cell polarity is established, protrusive forces at the cell front and contractile forces 
behind the leading edge orchestrate cell migration 133, 134. Protrusive forces can be driven by 
polymer-network expansion or internal hydrostatic pressure and both principles serve to 
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“push” the plasma membrane outward (Fig. 7). Polymerizing actin moves beads, bacteria and 
virus intracellularly 135. When acting at the cell front, polymerization and elongation of actin 
filaments extend the plasma membrane 136. This results in protrusive structures with sheet-like 
lamellipodia and needle-like filopodia 137, 138 (Fig. 7A).  
 
Figure 7: Formation of cellular protrusions. (A) Actin polymerization “pushes” the membrane at the leading 
edge and forms lamellipodia and filopodia (scheme adapted from Ladwein and Rottner 139). (B) Alternatively, 
internal hydrostatic pressure leads to detachment of the membrane from the actin cortex (left) or ruptures in the 
actin cortex (right). (C) The resulting cytoplasm-filled, actin-devoid blebs have been suggested to mediate 
migration (schemes taken from Charras and Paluch 140). 
 
“Pseudopodia” termed historically all cellular protrusions, but is nowadays only referred to 
finger-like projections of Dyctiostelium and leukocytes 141. Alternatively, internal hydrostatic 
pressure generates cytosol-filled blebs. In contrast to polymer network expansion, bleb 
formation requires contractile forces. Myosin II produces tension in actin networks by pulling 
actin filaments past one another. This causes a rise in pressure leading either to ruptures in the 
cortical actin with plasma membrane anchored actin-binding proteins 142 or local detachment 
of the plasma membrane from the cortical cytoskeleton 143, 144 (Fig. 7B). In both cases, a flow 
of cytosol generates a growing bulge that displaces the membrane. After cytosol inflation 
slows down, the sequential recruitment of actin, actin-binding proteins and myosin II leads to 
bleb retraction 145. Contractile forces behind the leading edge can only produce traction on the 
surface, when the cell front is fixed in some way (Fig. 8). Whereas actin-devoid blebs are 
likely not coupled extracellularly, actin-rich protrusions adhere to the environment. Then, 
actomyosin contraction in front of the nucleus generates “pulling” forces to translocate the 
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cell body. To allow retraction and detachment on high adhesive surfaces, cells must 
additionally contract their actin cortex at the back 146 (Fig. 8). In general, tight coordination of 
protrusive, contractile and adhesive forces determines cell migration and altering their 
individual strength results in differently shaped cells with individual migration strategies. 
 
5.3.2.1  Balancing adhesion and contraction  
 
For some amoeboid cells the nature of adhesion structure is still not known (Amoeba proteus, 
nematode sperm). In Dictyostelium, SadA was identified as putative membrane receptor that 
mediates firm adhesion 147, but it is unclear if it contributes to eupodia and actin foci, two 
described actin-containing structures that mechanically link the cells to the substratum 148, 149. 
Leukocytes carry adhesion receptors such as integrins diffusely distributed on their plasma 
membrane 120. While some leukocytes (naïve lymphocytes, unstimulated neutrophils, mature 
dendritic cells) already detach from 2D surfaces by the flux of culture medium, others 
(activated lymphocytes, monocytes and neutrophils) crawl integrin-dependently against high 
shear forces along blood vessels (as described above) 78, 83, 150. Adhesive structures initially 
confine amoeboid cells to surfaces, a function that is not necessarily correlated to the 
generation of traction. Studies on human T lymphocytes suggest a dual role for adhesions: A 
highly adhesive mid-cell region, the so-called focal zone, confines T cell migration along 
endothelial and lipid bilayers 46. To allow migration, weaker adhesions at the T cells’ leading 
edges might act in concert with contractile forces and mediate horizontal movement on the 
substrate 151. 
Figure 8: Contractile and protrusive forces during cell migration on 2D surfaces. Contractile forces behind the 
leading edge generate traction forces on the underlying surface. On high adhesive surfaces, contraction at the 
back is required to detach the cell (scheme adapted from Lauffenburger and Horwitz 146). 
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Amoeboid cell movement requires adhesion-mediated traction to transduce internal 
contractile forces onto the 2D substratum (Fig. 8). The third Newton’s law of motion predicts 
that contractile forces of the cell body will always result in rearward traction forces at the 
adhesive cell front. Traction force measurements revealed high stresses at the trailing edge of 
Dictyostelium 152-154 and the uropod of neutrophils 155. Rearward traction forces at the leading 
edge have been demonstrated in aggregation-prone Dictyostelium cells 152, but could rarely be 
detected in vegetative Dictyostelium cells 153 and neutrophils 155. Thus, lacking prominent 
adhesion sites at the leading edge favours a distributed pattern of single very small rearward 
forces at the leading edge that each might fall under the limit of detection. 
High traction stresses at the cell rear are myosin II-dependent 152, 154. Inhibiting myosin II 
activity during migration on “high” adhesive surfaces leads to reduced velocities in 
Dictyostelium 156 and an elongated morphology of neutrophils 157 and T lymphocytes 158, 159. 
Hence, actomyosin contraction at the posterior part of the cell facilitates detachment and 
retraction.  
When migrating on “low” adhesive surfaces, amoeboid crawling is independent of myosin II-
based contraction as has been demonstrated for Dictyostelium cells 160, neutrophils 157 and T 
lymphocytes 161. Despite the lack of myosin II activity, Dictyostelium cells still displayed 
unchanged rearward traction forces at the leading edge 152, suggesting actin polymerization as 
the only force-generating principle. Myosin II-independent locomotion is reminiscent of the 
migration of nematode (Ascaris suum) sperm that lack kinesins such as myosin II and crawl 
by the sole force of an expanding polymer network. Instead of actin, they utilize major sperm 
protein (MSP) as filament-forming polymer. Nematode protrusions result from pH-dependent 
polymerization and bundling of MSP filaments pushing against the membrane and a volume 
expansion caused by a decreased density of filament packing 162, 163. How can these cells 
retract their cell body in the absence of contraction? While the polymer network at the leading 
edge assembles and branches, the ongoing rearrangement and disassembly of the network at 
the posterior part is sufficient to rupture adhesion points and cause retraction 164, 165. Similar 
principles are likely to account for the expansion of actin networks 162, although this has not 
been proven. Instead, protrusion at the leading edge might create membrane tension pulling 
the back of the cell forward without the need for contraction. 
As described in section 5.2.3.2, leukocyte migration within confined and 3D environments 
might not depend on adhesive forces, but relies predominantly on contractile forces and 
polymer network expansion. Early observations of constriction rings 166, 167 and lateral 
pseudopods that insert into matrix footholds 168, 169 were all morphological expressions of 
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dynamic cytoskeletal changes (Fig. 6). Although 3D leukocyte movement has often been 
termed “biophysical migration”, this ambiguous definition lacks any mechanistical 
framework. Only little is known about the interplay of contractile forces and polymer network 
expansion in leukocytes. Therefore, I will summarize current data that has been obtained in 
other amoeboid migrating cells. 
 
5.3.2.2 Balancing contraction and polymer network expansion  
 
Cellular protrusions might result from contraction-based internal pressure (blebs) or polymer 
network expansion (lamellipodia, filopodia). While truly polymerization-driven lamellipodia 
were observed in myosin II-independent migration of Dictyostelium, neutrophils and T 
lymphocytes 157, 160, 161, 170 or nematode sperm 162, it is unknown how and if bleb formation 
alone transduces migratory force to a substrate (Fig. 7C). Protrusive bleb formation occurs 
during migration of Dictyostelium 170, 171, but blocking myosin II ceases blebbing and results 
in actin-rich filopodia-lamellipodia at the leading edge 170. This clearly showed that both 
forces can act at the same time and questions if retracting blebs or residual adhesive actin-rich 
protrusions generate traction. Similar to Dictyostelium on 2D, zebrafish primordial germ cells 
(PGCs) in vivo also show a biased formation of protrusive blebs at the leading edge. 
Chemokine receptor signalling increases free calcium and activation of myosin II at the cell 
front, which favours a blebbing model of focalized contraction and local pressure increase 143, 
172.  
Some tumor cell lines (e.g. A375m melanoma, LS174T colon carcinoma) also show inherent 
amoeboid appearance 124, while some mesenchymal-type cell lines (e.g. HT-1080 
fibrosarcoma, MDA-MB-231 mammary carcinoma) switch to amoeboid morphology after 
protease inhibition 124, 126, 131. As formation of blebs often coincides with the amoeboid 
phenotype and enhanced invasion or migration, blebbing movement has been widely 
promoted as a tumor cell migration strategy 140, 173. However, unlike PGCs, most amoeboid 
tumor cells are not polarized and form cellular blebs in an uncontrolled fashion in all 
directions. As they appear stationary in most 3D assay, it is unknown if blebbing contributes 
to tumor cell migration at all. Together with the missing knowledge about the role of 
adhesion, it cannot be ruled out that amoeboid-shaped tumor cells might still move by traction 
through residual adhesive protrusions. In recent years, tremendous progress has been achieved 
in understanding the molecular switch from mesenchymal to amoeboid morphology 129. While 
the mesenchymal-type mode is promoted by signals that activate the small GTPase Rac and 
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thus formation of F-actin-rich protrusions, the amoeboid mode results from enhanced 
contraction. Hereby, activation of the small GTPase RhoA leads to ROCK-dependent myosin 
light chain phosphorylation and myosin II activation 124. Thus, Rac and RhoA signalling have 
opposing effects and reciprocally regulate each other 125. Inhibiting one pathway will 
automatically activate the other signalling module and consequently change the mode of 
movement.  
How leukocytes generate force during interstitial migration has not been well investigated. 
Interpretations and conclusions of available data were not fully convincing due to technical 
drawbacks (antibody blocking of integrins, artificial in vitro assays, leukocyte cell lines). DCs 
were only rarely employed, although they serve as a perfect model to study leukocyte 
mechanics during physiological interstitial migration. In the last part, I will briefly introduce 
DCs and describe in detail the migratory environment and chemotactic cues that guide DCs 
from the skin to the lymph node. I will further depict molecular players (adhesion receptors, 
cytoskeletal regulators) that have been suggested to facilitate DC migration.   
 
5.4   Dendritic cell migration 
5.4.1 Dendritic cells in general 
 
DCs are the most potent antigen-presenting cells (APCs) that induce adaptive immune 
responses to pathogens, but also maintain self-tolerance of T cells 174. They act as sentinels by 
continuously sampling the tissue for foreign particles. Once an antigen is taken up, it is 
proteolytically processed and peptide fragments presented on the APC surface in the context 
of major histocompatility complex (MHC) molecules. Hereby, presentation via MHC class I 
and MHC class II (MHC-II) molecules induce the activation, proliferation and differentiation 
of naïve CD8+ T cells (cross-presentation) and CD4+ T cells, respectively 175. Several DC 
subsets have meanwhile been defined by differential expression of surface molecules with 
conventional DCs (CD11chigh, MHC-II+) and type I interferon-producing plasmacytoid DCs 
(CD11clow MHC-IIlow) as the two most prominent subtypes 176.  
Almost present in all organs, DCs are enriched at peripheral sites of microbial entry (such as 
skin and mucosal tissue) and in SLOs where they initiate T cell priming. Most studies have 
focussed thereby on the function of skin DCs and their trafficking from the skin via lymphatic 
vessels to the draining cutaneous LNs 1, 177. 
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5.4.2 Dendritic cell trafficking from the skin to the lymph node 
5.4.2.1 Mobilization and principle guidance cues 
 
Two populations of resident DCs exist in the skin: the Langerhans cells (LCs) of the 
epidermis and the dermal DCs (dDCs) residing within the interstitium 178, 179. As immature 
DCs they constantly scan the skin for internal (damage) and external (microbes) danger 
signals (Fig. 9A). Upon inflammatory stimuli, DCs first undergo a brief period of immobility 
and increased antigen uptake followed by so-called maturation 180. This includes the 
upregulated expression of: (i) co-stimulatory molecules (MHC-II, CD40, CD80, CD86) to 
initiate T cell priming, and (ii) the CC-chemokine receptor 7 (CCR7) to follow chemotactic 
cues to the draining lymph nodes (Fig. 9). Even under non-inflammatory conditions, a small 
number of DCs traffics to the LN (steady-state migration) 181, 182.  
 
 
 
Figure 9: Dendritic cell trafficking. (A) Dendritic cells migrate from the skin (epidermis and dermis) into 
lymphatic vessels. The molecular processes and sequence of migration events are highlighted (described in 
detail in the text) (scheme taken from Alvarez et al. 1). (B) Expression of chemoattractant guidance cues along 
the route from the lymphatic vessel to the lymph node (scheme adapted from Randolph et al. 177). 
 
DC migration from the skin to the LN is predominantly guided by CCR7-binding chemokines 
183. During in vitro maturation CCR7 is highly upregulated on DCs, while other chemokine 
receptors are downregulated 184, 185. The ligands for CCR7 were detected along the migration 
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route (Fig. 9B): (i) Lymphatic endothelial cells (LECs) of the afferent lymph vessels 
constitutively produce CCL21-Leu and CCL21-Ser, the two existing isoforms of CCL21, and 
upregulate their expression during inflammation 186, 187. (ii) Stroma cells in the LN paracortex 
express both CCL19 and CCL21-Ser 187. In several studies, steady-state and inflammatory 
DCs lacking CCR7 did not enter afferent lymphatics and were thus absent in the LN 183, 186, 
188. This was in line with findings in plt/plt mice (paucity of lymph node T cells) that have a 
naturally occurring deletion of CCL21-Ser and CCL19 189. DCs still entered lymphatics, but 
did not traverse into the LNs 189, 190. Expression of CCR7 alone might not be sufficient to 
induce DC migration, as additional signals such as lipid mediators were shown to sensitize 
CCR7 for its ligands 191, 192. DC migration might also be influenced by other chemotactic 
molecules in a CCR7-independent fashion. Upon inflammation, enhanced expression of 
CXCR4 on DCs and its ligand CXCL12 on inflamed vessels was reported 193. Moreover, DCs 
express all five known sphingosine-1-phosphate (S1P) receptors and might also be attracted 
by high amounts of S1P in the lymph fluid 194-196. Indeed, small molecule antagonists against 
S1P receptors interfered with DC migration to the LN 195, 197. 
While the chemotactic guidance cues are well-defined, it is unclear by which mechanisms 
DCs (i) migrate through the interstitium of the dermis and the lymph node or (ii) overcome 
potential anatomical barriers.  
 
5.4.2.2   Dendritic cell trafficking in the skin 
 
Skin architecture 
The skin consists of the epidermis and the underlying dermis joined and maintained together 
by a basement membrane 198. In the epidermis, multiple layers of keratinocytes at distinct 
stages of differentiation form a thin layer of stratified squamous epithelium. They rest on the 
epidermal BM, a dense sheet of tightly interconnected molecules such as laminins, collagen 
IV, nidogens and heparan sulphate proteoglycans 199, 200. The mesenchymally derived dermis 
is composed of scattered fibroblasts and their deposited ECM. The dense ECM scaffold can 
be functionally divided into the fibrillar fraction (fibrillar collagen bundles, elastic fibers, and 
microfibrils) and the non-fibrillar fraction (mainly glycosaminoglycans and proteoglycans). 
While the fibrillar fraction is mechanically stable and counteracts the tension produced by 
contracting fibroblasts 201, the non-fibrillar fraction fills the volume between the fibers and 
behaves like a viscous fluid 202.  
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Migration within the skin 
Under non-inflammatory conditions, LCs in the epidermis appear as branched immobile cells 
with dendrites that intermingle with neighbouring keratinocytes and occasionally show 
repetitive movement 203-205. They owe their sessile phenotype to homophilic E-cadherin 
contacts with keratinocytes 206. After antigenic stimulation, LCs disrupt these junctions and 
detach which already leads to DC maturation 207, 208. During exit from the epidermis, LCs face 
the structural dense epidermal BM which requires specialized mechanisms for transmigration 
209. Studies on ear explants indicated matrix metalloproteinase (MMP) 2- and 9-mediated 
proteolytic degradation 210 and integrin α6-dependent adhesion to be involved in this process 
211. In a psoriasis model, integrin α1-deficient T cells were unable to traverse the epidermal 
BM which further implicated a role of integrins 212. Besides integrins, the hyaluronat receptor 
CD44 has been suggested to participate in LC migration 213. In this scenario, enhanced 
expression of osteopontin in the inflamed skin fosters chemotactic migration via CD44 and 
αv integrins 214. However, another study confirmed impaired migration of CD44-deficient 
DCs to the LN, but LC migration was not affected 215.  
 
Once LCs have overcome the epidermal BM, they migrate similar to dDCs in the 
mesenchymal interstitium. As described above (see section 5.2.3.2), 3D collagen gels 
simulate fibrillar scaffolds of the dermis and have also been used for the study of DC 
migration and DC-T cell interaction 120, 121, 216. Thereby, it has been noted that DCs migrate 
with a speed of 5 µm/min up to 50-times faster than mesenchymal cells such as fibroblasts 
(0.1-0.5 µm/min) 217. Only recently, employing intravital multiphoton microscopy on ear 
dermis of CD11c-YFP reporter mice, dDC interstitial migration was observed for the first 
time in vivo 204. In healthy mice, immature dDCs were actively crawling at a mean velocity of 
4 µm/min. Moreover, translocation through the interstitial space was pertussis toxin sensitive 
suggesting a role for chemokines. Up to 4 h after LPS challenge, dDC migration speed 
significantly decreased, but increased again after 6 to 8 h. The mechanisms behind this 
phenomenon are unclear, but insights may come from in vitro studies. Immature DCs are 
highly adhesive on 2D substrata and form invasive, integrin-containing adhesive structures, 
called podosomes 218, 219. While immature DCs rely on integrin α5β1-mediated adhesion, 
maturing DCs disassemble podosomes and become highly migratory 220, 221. If interstitial 
migration depends on proteolytic activity remains still controversial. In contrast to the 
meanwhile accepted dogma of non-proteolytic amoeboid leukocyte migration 121, MMP9-
deficient DCs showed impaired migration in vivo and in dermal explants 210, 222. However, this 
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defect might also result from alterations in the dermal chemokine milieu, as MMPs are known 
to process chemokines 223. 
 
5.4.2.3 Dendritic cell trafficking into the lymphatic vessel 
 
Lymphatic vessel architecture 
 
 
Figure 10: Lymphatic vessel architecture. 
Initial lymphatics form discontinuous button-
like junctions, collecting lymphatics form 
continuous zipper-like junctions between 
lymphatic endothelial cells. The detailed view 
shows oak-leaf-shaped lymphatic endothelial 
cells (dashed line) with lateral buttons (red) 
(scheme taken from Baluk et al. 226). 
 
 
 
Lymphatic vessels openly communicate with the interstitium and actively pump interstitial 
fluid unidirectional out of the tissue towards the LN 177. The distal blind endings of initial 
lymphatics pass into the proximal part, the lymphatic collector vessels (Fig. 10). Initials are 
composed of oak-leaf-shaped LECs which form overlapping flap valves to allow entry, but 
prevent exit of interstitial fluid 224, 225. LECs are anchored laterally by discontinuous button-
like junctions forming 3 µm-sized openings in the initials 226 (Fig. 10). The thin BM 
surrounding the initials is also discontinuous and does not restrict solute movement 227, 228. 
Lymphatic collector vessels form continuous, zipper-like endothelial cell-cell junctions 
similar to blood vessels. As they harbour semilunar valves and a surrounding smooth muscle 
layer that periodically contracts, they consequently push fluid toward the draining lymph 
node. Furthermore, elastic fibers connect the abluminal side of the lymph vessels to the 
fibrillar matrix of the dermal interstitium. When the interstitial pressure increases and as such 
the interstitial ECM enlarges during edema, the elastic fibers pull the lumen of the lymphatics 
open and allow more fluid to pass 224. 
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Migration into lymphatic vessels 
Several adhesive ligands are expressed on the lymphatic BM or LECs and might facilitate 
entry into the lymphatic vessels. Upon inflammation, VCAM-1 and ICAM-1 are highly 
expressed on LECs. Systemic administration of blocking antibodies against VCAM-1 or 
ICAM-1 suggested a role for the integrins LFA-1 and α4β1 on DCs 229. Accordingly, DC 
migration in ICAM-1-deficient mice 230 and in mice deficient for RAPL was impaired 231. 
RAPL is required for activation of the integrins α4β1 and LFA-1 by the small GTPase Rap1 
66. In contrast, integrin β2-deficient mice showed normal DC migration 232. Hence, if integrins 
contribute to lymphatic is still an open question.  Interestingly, the button-like junctions of 
lymphatic initials contain VE-cadherin and tight junction proteins including occludins, 
claudins, zonula occludens-1, ESAM and JAM-A 226. Similar proteins are found in blood 
vessel endothelial junctions and have been implicated in leukocyte diapedesis. Of note, JAM-
A-deficient DCs display increased migration to lymph nodes suggesting a role for JAM-A as 
gatekeeper for DC entry into the afferent lymphatics 233. It is unclear how DCs traverse the 
lymphatic endothelium. Transient gap opening and lateral interaction with molecules of the 
button-like junctions might allow paracellular passage, but also transcellular migration is 
possible 234. In addition, LECs highly express other surface molecules which might support 
DC entry: mannose receptor (ligand for L-selectin) 235, CLEVER-1 236 and podoplanin 237. 
Podoplanin is of particular interest as its tissue expression is associated with CCL21 
expression 238, 239. As lymphatic vessels express high levels of CCL21 186, 240, podoplanin 
might influence CCL21 presentation and as such chemotactic migration. Alternatively, a 
model termed ‘autologous chemotaxis’ was suggested for tumor cell guidance into lymph 
vessels 241. Some tumor cell lines, similar to DCs, co-express CCR7 and its ligand CCL19, 
which seems paradox at first sight. However, within the interstitium, the unidirectional flow 
convection toward the lymph vessel might drag the secreted chemokine and thereby create a 
gradient that could then be followed by the same cell. Although this concept appears 
appealing, the individual contributions of CCL19 and CCL21 remain to be challenged in vivo. 
Transport of DCs within the lymphatic vessels is most likely the same than for solutes. 
Thereby, a passive flowing with the stream of interstitial fluid is powered by the periodic 
contractions of the lymphatic vessels 242. DCs and fluid are then pumped directly into the 
subcapsular sinus of the LN 243.  
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5.4.2.4  Dendritic cell trafficking within the lymph node 
 
Lymph node architecture 
Lymph vessels from different peripheral drainage areas often congregate at one LN. The LN 
is composed of (i) the outer subcapsular sinus (entry side for afferent lymphatic vessels), (ii) 
the B cell follicles (zone of B cell activation beneath the sinus), (iii) the inner T cell 
paracortex (zone of T cell activation), and (iiii) the medullary sinus (exit site for leukocytes) 
244 (Fig. 11).  
Figure 11: Lymph node architecture. Lymph fluid and dendritic cells arrive via afferent lymphatic vessels. 
Dendritic cells pass the sinus and area between B cell follicles (B) before entering the T cell cortex (T). Arrows 
indicate the route of soluble antigen along fibroblastic reticular cell (FRC) conduits. The detailed view indicates 
FRC conduits bridging the sinus with the HEV (scheme taken from von Andrian and Mempel 69). 
 
The subcapsular sinus is populated by different resident cell types. Stromal retothelial cells 
build a 3D sponge-like structure resting on a floor consisting of sinus-lining cells and a 
discontinuous BM. Subcapsular macrophages settle between the retothelial cells and 
contribute to the extremely cell-rich composition of the sinus encasing the LN parenchyma 
245. 
Both follicles and paracortex comprise immune cell types that reside in a stromal cell 
network. While follicles bear B cells in the follicular dendritic cell network, the paracortex is 
densely packed with T cells and few DCs in the sponge-like scaffold of fibroblastic reticular 
cells (FRCs) 246. FRCs reside on and continuously enwrap highly ordered ECM tubes termed 
conduits, according to their function in channelling small molecules through the cortex (Fig. 
11). The conduit, varying in diameter from 200 nm to 3 µm, consists of an inner core of 
parallel collagen (type I and III) bundles intermingled with microfibrils and an outer core of 
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fibronectin and typical BM membrane proteins such as laminins, collagen IV and nidogens 
247, 248. Although more than 95% of the conduit is covered with FRCs, gaps remain that are 
covered by hematopoietic cells 249, 250. Mainly resident DCs localize close to FRCs enabling 
them to rapidly uptake (within minutes) subcutaneously injected small molecules that 
percolate exclusively in the LN conduits 248. The FRC fiber network is qualitatively 
homogenous throughout the T cell paracortex, but is described as more densely packed in a 
zone called “cortical ridge”. Here, in close vicinity to the B cell follicles, a high density of 
HEVs ensures entry of leukocytes from the blood stream into the LN 251. Of note, FRC 
networks and conduits are not exclusive to the LN T cell paracortex, but are found in almost 
similar composition in the splenic white pulp and the thymic medulla 252, 253. 
 
Migration into and within the lymph node 
The mechanisms of DC migration through the cell-rich subcapsular sinus have not been 
investigated so far. Locomotion kinetics obtained from intravital microscopy studies 
suggested that the sinus might not represent a major anatomical barrier for DCs 254. This is in 
line with observations on T cells that effortlessly glide into the subcapsular sinus, when 
exposed to an artificial chemokine gradient 255.  
Unlike in the sinus, FRCs of the T cell paracortex abundantly express CCL19 and CCL21 
suggesting a chemokine gradient along the sinus-cortex border. When both chemokines are 
absent in the cortex (as observed in plt/plt mice), DCs do not enter the LN parenchyma, 
arguing for a dominant role of CCR7 in LN entry 189, 190. Our knowledge about paracortical 
DC migration is mainly based on multiphoton microscopy studies and is still descriptive. 
Bone-marrow derived DCs entered the T cell paracortex and congregated close to HEVs 18 to 
20 h after subcutaneous injection, before at later time points DCs were more evenly 
distributed 256, 257. One day after injection, DCs showed remarkable motility with average 
speeds of 6-7 µm/min 257, 258, before velocities decreased again and DCs integrated into a 
dense network of sessile DCs 259. Interestingly, endogenous dDCs also travelled close to 
HEVs 24 h after ear inflammation, while epidermal LCs required 72 h to localize to deeper 
cortex areas 203. The underlying mechanisms of this phenomenon are not clear, but differential 
expression of chemokine receptors such as CXCR5 might play a role 260. 
 
How DC motility in the lymph node is sustained and how DCs generate traction for 
locomotion are open questions, but studies on T cell migration revealed some intriguing 
principles that might also hold true for DCs. Early intravital microscopy work suggested that 
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T cells perform a dynamic random walk in the LN and encounters with DCs were regarded as 
random collisions 69, 261. However, when simultaneously visualising the stromal FRC network, 
T cell paths led preferentially along the reticular fiber network and turned out to be 
deterministic and not random 262, 263. Similar to DCs, naïve T cells express CCR7 and it 
appeared appealing that its ligands CCL19 and CCL21 are expressed along FRCs and might 
contribute to deterministic T cell migration 106, 240. Indeed, interference with CCR7 signalling 
on T cells decreased the basal motility almost by half 255, 264, 265. Hence, FRCs appear to be a 
chemokinetic and adhesive surface. Surprisingly, simultaneous functional blockade of the 
major integrins α4β1, α4β7 and LFA-1 on T cells did not influence T cell motility 106. This 
contrasts with studies on NK cells, another leukocyte subset, which required integrin α2β1-
mediated close contact to FRCs for effective migration in the LN 266.  
In summary, T cell motility in the paracortex requires signalling through CCR7 ligands 
expressed on FRCs. Although T cells migrate along the FRC network, current data argues 
against adhesion-mediated traction as force-generating principle for T cell movement in the 
LN. However, it is unknown how an alternative migration mode might mechanistically work 
and if adhesion-independent migration is general for all leukocytes. 
 
5.4.3 Cytoskeletal regulation of dendritic cell migration 
 
As outlined in section 5.2.3.2, 3D leukocyte migration is non-proteolytic and might not 
require strong adhesive interactions with the environment 119-121. Hence, the constant shape 
change of locomoting leukocytes relies largely on internal cytoskeletal forces (contraction, 
polymer network expansion). The small GTPases Rac, Rho and Cdc42 represent key switches 
for determining cytoskeletal dynamics 267. In tumor cells, they regulate the switch from 
mesenchymal to amoeboid shape (see section 5.3.2.2) 124, 268. How Rho GTPases influence 
leukocyte interstitial migration has not been investigated in detail. Most data rely on 
migration studies on 2D surfaces that do not reflect the complexity of 3D or in vivo 
environments 269. Only few studies addressed cytoskeletal dynamics during physiological DC 
migration. Rac1/Rac2-double deficient DCs showed completely abrogated actin 
polymerization which resulted in cell rounding and concomitant immobility of the cells. Thus, 
DC migration from the skin to the LN was severely impaired 270. Although RhoA’s function 
in regulating actomyosin rear end contraction is established in leukocytes 271, its relevance for 
migration in 3D environments has not been tested yet. 
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Cdc42 stabilizes and maintains spatial and temporal asymmetries in many cell types 269, 272 
and polarity also determines directional movement of leukocytes. Accordingly, loss of 
chemotactic path finding was observed upon intervention with Cdc42 in neutrophils 271, 273, 
macrophages 274, hematopoietic stem cells 275 and Drosophila melanogaster hemocytes 276. 
Although Cdc42 has not been deleted in DCs until to date, studies using dominant-negative 
versions of the molecule revealed defects in the endocytotic pathway 277, antigen presentation 
278, podosome formation 279 and dendrite formation 280 of immature DCs. The impact of 
Cdc42 on DC cytoskeletal dynamics and migration in 3D interstitial environments is 
unknown, but work on upstream activators and downstream effectors provided indirect hints. 
PI3Kγ is a lipid kinase mainly expressed in leukocytes and involved in the production of PIP3. 
This second messenger is recruited to the plasma membrane and activates primarily protein 
kinases with a pleckstrin homology motif, but mediates also assembly of GTPase regulators 
281. In neutrophils, inhibition of PIP3 accumulation prevents the activation of Cdc42 and 
reduces Rac activity leading to the formation of unstable pseudopods 271. Interestingly, 
PI3Kγ-deficient DCs showed impaired migration from the periphery to draining LNs 282. 
However, this defect might not be entirely caused by cytoskeletal disorganization. As PI3Kγ 
gets directly activated from βγ subunits of activated G protein coupled receptors, it might also 
influence chemokine sensing 281. A key Cdc42 effector is WASp that activates the Arp2/3 
complex and thus contributes to organized actin polymerization 283. WASp-depleted DCs 
showed several cytoskeletal abnormalities including impaired membrane projections and 
podosomes 279. Moreover, migration of injected bone marrow-derived DCs and LCs to the LN 
was compromised 284, 285. However, it is unclear if Cdc42-mediated WASp function accounted 
for these defects, as WASp can also be regulated independent of Cdc42. In summary, 
regulation of cytoskeletal dynamics seems to determine DC migration. Future studies will 
now have to address the underlying cell biological events fostering interstitial movement and 
the physiological level where this regulation might be relevant. 
 
 
 
Introduction 
28 
6  Aim of the thesis 
 
Leukocyte migration has been studied in detail in the context of extravasation. Interstitial 
migration, however, remains poorly investigated and might fundamentally differ in its 
molecular mechanisms (reviewed in Paper II). It is still an open question if physiological 
interstitial migration requires transmembrane adhesion receptors. Moreover, the amoeboid 
shape change of leukocytes still lacks a mechanical and molecular framework. Therefore, this 
Ph.D. thesis sought to study the interplay between adhesive, contractile and protrusive forces 
during interstitial leukocyte chemotaxis in vivo and in vitro. In the course of the thesis, the 
following questions were experimentally targeted: 
 
i) Does leukocyte migration require integrins and adhesion-mediated traction? (Paper 
I and V) 
ii) How do actomyosin contraction and actin network expansion regulate interstitial 
migration? (Paper V) 
iii) Which role does the coordination of leading edge protrusions play? (Paper VII) 
iv) Does lack of two specific serine proteases impair granulocyte extravasation and 
interstitial migration? (Paper VI) 
 
To monitor leukocyte interstitial migration by time-lapse video microscopy, in vitro (2D and 
3D) chemotaxis and ex vivo skin explant assays were established that allowed reproducible 
and manipulable experimental settings. As primary model system, bone-marrow derived 
dendritic cells (DCs) were employed. The bone marrow was derived from different mouse 
strains: γ-parvin-deficient mice (Paper I), proteinase 3/neutrophil elastase-double-deficient 
mice (Paper VI) and mice that were genetically depleted in the hematopoietic system for all 
integrins (Paper V), talin (Paper V) and Cdc42 (Paper VII). Dendritic cell movement from the 
dermis of the skin via lymphatics to the lymph node (reviewed in Paper IV) was further tested 
and migratory dynamics visualized by two-photon microscopy of the lymph node (Paper V). 
To generalize findings, results obtained with dendritic cells were confirmed with granulocytes 
and B lymphoblasts (Paper V and VI). Chemical inhibitors were employed to interfere with 
actomyosin contraction and actin polymerization (Paper V).   
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7  Brief summaries of the publications 
7.1  Summary Paper I 
Chu, H. et al. (2006). γ-Parvin is dispensable for hematopoiesis, leukocyte trafficking, and T-
cell-dependent antibody response. Mol. Cell Biol. 26, 1817-25. 
 
Parvins consist of three members (α-, β-, γ-parvin) which are components of a multiprotein 
complex that assembles at the cytoplasmic domain of integrin receptors at sites of cell 
adhesion. Together with integrin-linked kinase (ILK) and PINCH, parvins form a functional 
complex that links integrins to the cytoskeleton. While α- and β-parvins are widely expressed, 
γ-parvin has been reported to be restricted to hematopoietic cells. In this study, the expression 
pattern of the parvins in hematopoietic cells and the phenotype of γ-parvin-deficient mice 
were analyzed. Mice lacking γ-parvin were viable and fertile. Surprisingly, loss of γ-parvin 
expression had no effect on blood cell differentiation, proliferation, and survival and no 
consequence for the T-cell-dependent antibody response and for the migration of lymphocytes 
and dendritic cells. These data indicate that despite high expression of γ-parvin in 
hematopoietic cells it must play a more subtle role for blood cell homeostasis. 
I contributed to this study by assisting in leukocyte homing assays and flow cytometry 
analysis of apoptosis. 
 
7.2 Summary Paper II (Review) 
Sixt, M. et al. (2006). β1 integrins: zip codes and signaling relay for blood cells. Curr. Opin. 
Cell Biol. 18, 882-90. 
 
β1 integrins comprise the largest integrin receptor family. At least eight of the twelve known 
heterodimers of the β1 integrin family are expressed on hematopoietic cells. Among these, the 
VCAM-1 receptor α4β1 has been studied most thoroughly during the process of blood cell 
extravasation. In this review, we summarize and discuss the confirmed and speculative roles 
of β1 integrins in leukocyte extravasation, transmigration, movement and retention in 
interstitial tissues and cell-cell interactions between immune cells. We further give a short 
overview how targeting integrin interactions might be beneficial in anti-inflammatory 
therapies.   
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7.3  Summary Paper III (Review) 
Lokmic, Z.*, Lämmermann, T.* et al. (2006). The extracellular matrix of the spleen as a 
potential organizer of immune cell compartments. Sem. in Immunol. 20, 4-13.  
* equally contributing first authors. 
 
Blood cells and blood-derived pathogens constantly pass through the open vascular system of 
the spleen. To exert its dual role as secondary lymphoid organ and site of erythrocyte 
removal, the spleen is highly organized into different compartments (white pulp, red pulp and 
marginal zone). While their immune cell composition has been studied in detail over the 
years, the fibroblastic reticular cell network has only gained little attention. This stromal 
backbone consists of reticular fibroblasts and extracellular matrix (ECM). In this review, we 
summarize how distinctly expressed ECM molecules define splenic compartments and 
speculate about their impact on immune cell localization and structural support. In particular, 
we highlight the unique molecular structure of the reticular fiber network in the white pulp 
that, as in the T cell cortex of the lymph node, serves as a conduit for fluid and small particle 
transport. 
 
7.4 Summary Paper IV (Review) 
Lämmermann, T. and Sixt, M. (2008). The microanatomy of T-cell responses. Immunol. Rev. 
221, 26-43.  
 
Soluble and cell-bound antigens are delivered from the periphery through lymphatic vessels 
into the lymph node where they initiate adaptive immune responses. In this review, we 
describe the non-hematopoietic infrastructure of the lymphatic system with a focus on antigen 
transport from the skin to the draining lymph node. Dendritic cells (DCs) are the major 
antigen-presenting cells in the periphery. After antigen uptake, they migrate in the dermis, 
enter the lymphatic vessels and pass the subcapsular sinus of the lymph node. In the cortex, 
they meet T cells that move along the fibroblastic reticular cell (FRC) network, the stromal 
backbone of secondary lymphoid organs. Here, we describe the functional anatomy of these 
compartments and the molecular requirements for DC migration. In contrast to cell-bound 
antigen, soluble antigen is rapidly transported by dermal fluid to the lymph node where it is 
directly drained into the inner core of the FRC network serving as conduit system. We discuss 
the molecular similarities between the conduit system and the dermis and suggest that the 
conduits can be viewed as a compacted peripheral interstitium. 
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7.5  Summary Paper V 
Lämmermann, T. et al. (2008). Rapid leukocyte migration by integrin-independent flowing 
and squeezing. Nature. 453, 51-55.  
 
According to the general cell migration paradigm, locomoting cells generate traction by 
coupling contractile forces and actin polymerization to an adhesive surface. In agreement with 
this principle, rapidly migrating leukocytes use integrin-mediated adhesion when moving over 
two-dimensional surfaces or along blood vessels. By contrast, the contribution of integrins 
during three-dimensional (3D) movement of leukocytes within tissues has remained 
controversial. While blocking integrin function with antibodies might have produced 
unspecific side effects, single genetic depletion of integrin subunits could not rule out a 
compensating role for other integrin heterodimers. In this study, we genetically ablated all 
integrin heterodimers from murine leukocytes and show that functional integrins do not 
contribute to migration in 3D in vitro networks. By studying dendritic cell migration in the 
dermis, entry into the lymphatics and movement within the lymph node, we show that 
leukocyte migration in vivo is dispensable of integrins. Instead, leukocytes can migrate by the 
sole force of actin-network expansion, which promotes protrusive flowing of the leading 
edge. Myosin II-dependent contraction is only required upon passage through narrow gaps, 
where a squeezing contraction of the trailing edge propels the rigid nucleus. We conclude that 
non-adhesive migration renders leukocytes autonomous from the tissue context and allows 
them to quickly and flexibly navigate through any organ without adaptations to alternating 
extracellular ligands. 
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7.6 Summary Paper VI 
Kessenbrock, K. et al. (2008). Proteinase 3 and neutrophil elastase enhance inflammation by 
inactivating anti-inflammatory progranulin. J. Clin. Invest.. 118, 2438-47.  
 
Neutrophils represent the first line of defense during infectious inflammation, but also 
contribute to non-infectious chronic inflammation. In this study, mice that were depleted of 
two very similar neutrophil serine proteases, proteinase 3 (PR3) and neutrophil elastase (NE), 
showed reduced neutrophil infiltration in a model of subcutaneous formation of antigen-
antibody immune complexes (Arthus reaction). This was not a generalized defect in 
neutrophil extravasation or migration, as neutrophil infiltration in response to application of 
phorbol esters to the skin and migration in a fibrillar interstitium was not impaired. Instead, 
NE and PR3 cleaved the anti-inflammatory molecule progranulin (PGRN) and administrating 
PGRN to wild-type mice inhibited neutrophil influx in the course of the Arthus reaction. In 
conclusion, NE and PR3 mediate local pro-inflammatory effects by degrading PGRN.  
My contribution to this study was design and analysis of the phorbol ester-mediated 
inflammation model and analysis of neutrophil chemotaxis in 3D collagen gels. 
 
 
7.7 Summary Paper VII 
Lämmermann, T. et al. (2009). Cdc42-dependent leading edge coordination is essential for 
interstitial dendritic cell migration. Blood. Prepublished online February 3, 2009. 
 
Interstitial leukocyte migration is independent of adhesive forces and pericellular proteolysis. 
Instead, the protrusive flow of the actin cytoskeleton directly drives a basal mode of 
locomotion that is occasionally supported by actomyosin contractions at the trailing edge to 
propel the cell’s rigid nucleus. In this study, we address the question how coordination of 
actin flow influences leukocyte migration in a three-dimensional (3D) environment. We 
employed DCs lacking the small GTPase Cdc42 that still initiated actin flow and actomyosin 
contraction in response to chemotactic cues, but failed to temporally and spatially regulate 
their protrusions. While this defect still allowed the cells to move on two-dimensional 
surfaces, their in vivo motility was completely abrogated. This difference was entirely caused 
by the geometrical complexity of the environment as multiple competing protrusions led to 
instantaneous entanglement within 3D matrix scaffolds. We conclude that the decisive factor 
for migrating DCs is internal stabilization of polarity and adequate coordination of 
cytoskeletal flow. 
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Integrins regulate cell behavior through the assembly of multiprotein complexes at the site of cell adhesion.
Parvins are components of such a multiprotein complex. They consist of three members (-, -, and -parvin),
form a functional complex with integrin-linked kinase (ILK) and PINCH, and link integrins to the actin
cytoskeleton. Whereas - and -parvins are widely expressed, -parvin has been reported to be expressed in
hematopoietic organs. In the present study, we report the expression pattern of the parvins in hematopoietic
cells and the phenotypic analysis of -parvin-deficient mice. Whereas -parvin is not expressed in hemato-
poietic cells, -parvin is only found in myeloid cells and -parvin is present in both cells of the myeloid and
lymphoid lineages, where it binds ILK. Surprisingly, loss of -parvin expression had no effect on blood cell
differentiation, proliferation, and survival and no consequence for the T-cell-dependent antibody response and
lymphocyte and dendritic cell migration. These data indicate that despite the high expression of -parvin in
hematopoietic cells it must play a more subtle role for blood cell homeostasis.
Cell extracellular matrix (ECM) adhesions are crucial for
various biological processes, including cell migration, prolifer-
ation, and cell survival (12, 15, 17). Integrins connect the ECM
to the actin cytoskeleton at cellular attachment plaques that
contain focal adhesion (FA)-associated proteins (8). A family
of proteins consisting of actopaxin/CH-ILKBP/-parvin, af-
fixin/-parvin, and -parvin, collectively called the parvins, has
been recently identified in humans and mice (22, 23, 31, 34). In
lower organisms such as Caenorhabditis elegans and Drosophila
melanogaster, there is only a single parvin protein (19, 23).
Parvins are composed of an N-terminal polypeptide stretch,
followed by a single actin-binding domain, which consists of
two in tandem arranged calponin homology domains. - and
-parvin share a high homology (23), and both bind to inte-
grin-linked kinase (ILK), paxillin, and F-actin at FAs (1, 9, 22,
23, 31, 34). In addition, -parvin also binds -PIX, a guanine
exchange factor for Rac and Cdc42 (21, 25), and -actinin (35).
Both - and -parvin associate with ILK and PINCH to form
the ILK-PINCH-parvin complexes (37, 39, 40). Disruption of
the complex in mammalian cells alters cell shape and impairs
cell motility and survival (7, 36, 38, 39). In C. elegans disruption
of the complex causes muscle detachment and a PAT (para-
lyzed at the four-cell stage) phenotype (19).
-Parvin consists of 331 amino acids and shares the same
protein structure as - and -parvin. The mouse -parvin only
shows 40% identity and 60% similarity to the - or -parvin at
the amino acid level. No -parvin binding partners have been
identified thus far. In contrast to the wide expression pattern of
- and -parvin, -parvin mRNA is predominantly found in
hematopoietic and lymphoid tissues (16, 22, 23, 34). These
features of the -parvin raise the question of whether -parvin
mediates integrin signaling via association with ILK and
thereby regulates events, including cell differentiation, migra-
tion, and positioning in the hematopoietic system. In the
present study, we described the expression pattern of the par-
vin protein family in hematopoietic organs and hematopoietic
cells. To directly test the function of -parvin in vivo, we
generated -parvin-deficient mice. Our study shows that -par-
vin is highly expressed in myeloid and lymphoid cells and that
neither hematopoiesis nor T-cell-dependent antibody re-
sponse, nor lymphocyte or dendritic cell (DC) migration is
abnormal in the absence of -parvin.
MATERIALS AND METHODS
Antibodies. Rabbit anti-PINCH1 and PINCH2 polyclonal antibodies were
described (18). Monoclonal anti-ILK antibody was from BD Transduction Lab-
oratory, rabbit anti--actin and mouse antitalin antibodies were from Sigma
Aldrich, rat anti-B220 (RA3-6B2), rat anti-Thy1.2, anti-rabbit or -mouse immu-
noglobulin G (IgG) (HL)–horseradish peroxidase, anti-IgM (R6-60.2), rat
anti-IgD (11-26c.2a), rat anti-CD19 (1D3), anti-CD4 (H129.19), anti-CD8 (53-
6.2), rat anti-CD3 (17A2), anti-Gr-1 (RB6-8C5), anti-Mac-1 (M1-70), anti-Ter-
119, hamster anti-CD11c (HL3), CD86 (GL1), and major histocompatibility
complex (MHC) II (M5/114.15.2) were from BD Pharmingen (San Jose, CA).
Alexa 488 phalloidin was from Molecular Probes (Leiden, The Netherlands).
Antibodies were conjugated with fluorescein isothiocyanate (FITC), phyco-
erythrin (PE), or biotin and used at a 1:200 dilution. FITC-conjugated goat
anti-rat or -mouse IgGs and streptavidin Cy-5 were from Jackson Immunore-
search (West Grove, PA). Rabbit pan-laminin antibody was described in Sorokin
et al. (28). Annexin V-FITC was a gift from Ernst Po¨schl (University of Erlan-
gen-Nu¨rnberg, Erlangen-Nu¨rnberg, Germany) and was used at a 1:1,000 dilution.
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Generation of parvin peptide antibodies. To generate specific antibodies,
N-terminal peptides corresponding to -parvin amino acid residues 5 to 19
(PQKSPLVPKSPTPKS), -parvin residues 3 to 16 (SAPPRSPTPRAPKM), and
-parvin residues 2 to 17 (ELEFLYDLLQLPKEVA) were synthesized, coupled
to the carrier protein KLH (Imject Maleimide Activated mc KLH; Pierce), and
used to immunize rabbits. The antisera were further purified by using the
SulfoLink kit (Pierce) and tested on in vitro translated -, -, and -parvin
proteins, respectively (Fig. 1A).
Generation of -parvin-deficient mice. A -parvin cDNA fragment derived
from EST clone AA981356 was used to screen a 129/Sv mouse P1-derived artificial
chromosome library (27). P1-derived artificial chromosome 656L16 (from the Hu-
man Genome Mapping Project Center, Cambridge, United Kingdom) was used to
generate the targeting vector. A 5.5-kb fragment was used as 5 flanking arm and
a 2.3-kb fragment as a 3 flanking arm (Fig. 2A). An internal ribosome entry
site-lacZ reporter cassette, followed by a PKG-driven neo gene (27), was inserted
between the two arms. The targeting vector was electroporated into passage 15
R1 embryonic stem (ES) cells and selected with G418 (3). Southern blots from
360 EcoRV-digested ES cell clones were hybridized with an external 700-bp
SphI-HindIII fragment derived from intron 10 (Fig. 2A). Nine recombinant ES
clones were identified by detection of a 4.9-kb recombinant band, in addition to
the 5.7-kb wild-type band. Three targeted ES clones were injected into blasto-
cysts to generate germ line chimeras, which were then mated with C57BL/6
females. Genotyping of -parvin mutant mice was performed by Southern blot or
by PCR using a wild-type allele primer pair (forward, GTTTGAAGAACTGCA
GAAGG; reverse, GTTGATCCATTCCATCAGCA) and a recombinant allele-
specific primer pair derived from the lacZ gene (forward, CTGGGTAATAAG
CGTTGGCAAT; reverse, CCAACTGGTAATGGTAGCGAC).
In vitro translation. -, -, and -parvin cDNAs (16) were amplified with Vent
DNA polymerase (New England Biolabs, United Kingdom) and cloned into a
modified pCS2 mammalian SP6 promoter driven expression vector. In vitro
translation reactions were performed with TNT Coupled Transcription/Transla-
tion Systems (Promega, Mannheim, Germany) using rabbit reticulocyte lysate
and subsequently analyzed by Western assay.
Western analysis and immunoprecipitation. Cells were lysed in 150 mM
NaCl–5 mM EDTA–1% Triton X-100 (pH 7.4) in the presence of protease
inhibitors (Roche, Mannheim, Germany). Alternatively, tissues were homoge-
nized in radioimmunoprecipitation assay buffer (150 mM NaCl, 50 mM Tris-HCl
[pH 7.4], 5 mM EDTA, 0.1% sodium dodecyl sulfate, 1% sodium deoxycholate,
1% Triton X-100) containing protease inhibitors. For Western analysis, 30 to 50
g of protein were gel separated, blotted, and probed with the primary and the
secondary horseradish peroxidase-conjugated antibodies.
For immunoprecipitation, cells were lysed in ice-cold buffer (150 mM NaCl, 1
mM EGTA, 1% Triton X-100, 100 mM NaF, 10% glycerol, 50 mM HEPES [pH
7.5], 10 mM Na4P2O7) supplemented with protease inhibitors. Then, 500 g of
protein was incubated with 0.8 mg of protein A (Sigma) in 50 l of lysis buffer
and with 1 g of purified -parvin antibody or 1 g of preimmune serum as a
negative control at 4°C overnight. The protein-antibody-containing pellet was
washed with lysis buffer and subjected to immunoblotting.
Northern blot assay, reverse transcription-PCR (RT-PCR), and immuno-
staining. Preparation, gel separation, blotting, and hybridization of total RNA
from spleen and thymus was performed as previously described (3). -Parvin
cDNA (nucleotides 269 to 865) was used as probes.
For RT-PCR, total RNA was reverse-transcribed with iScript cDNA Synthesis
Kit (Bio-Rad, Germany) and amplified with a -parvin forward primer located in
exon 5 (GGAAGCCGTGCAAGACCTGC) and a reverse primer located in
exon 6 (CCCTGAAGTGCATGGCCAGG). An HPRT1 primer pair was used as
a control (forward, TCAGTCAACGGGGGACATAAA; reverse, GGGGCT
GTACTGCTTAACCAG).
FIG. 1. Expression of parvins in the hematopoietic system (A) Peptide antisera were generated against -parvin, the long isoform of - and -parvin.
Spleen lysate and in vitro-translated -, -, and -parvin proteins were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and probed
with the antisera. (B) Thymus, spleen, lymph nodes (LN), Peyer’s (PP), and bone marrow (BM) were isolated, lysed, and immunoblotted with anti--,
-, and -parvin and anti-ILK antibodies. (C) B220-, CD4-, and CD8-positive cells were sorted from adult mouse splenic single cell suspensions and
analyzed by Western blotting with antiparvin, anti-ILK, and anti-PINCH1 antibodies. (D) BM-derived macrophages (Mac) and dendritic cells (DCs) were
lysed and immunoblotted with antiparvin, -ILK, and -PINCH1 antibodies. (E) BM-derived DC lysate was immunoprecipitated with anti--parvin
antibody and with control preimmune serum. The immunoprecipitates were immunoblotted with -parvin, ILK and PINCH1 antibodies, respectively.
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Immunofluorescence studies of tissue sections and cells were performed as
described previously (3).
Flow cytometry analysis (FACS) and magnetic cell sorting. Single-cell suspen-
sions were prepared by gently pushing the dissected organs through 70-mm cell
strainers (BD). Fluorescence-activated cell sorting (FACS) analysis was per-
formed as described previously (24). For magnetic cell sorting, 107 spleen cells
were mixed with FITC-conjugated anti-B220, CD4, CD8, or CD3 antibodies (BD
Biosciences), respectively; incubated with anti-FITC microbeads; and sorted out
according to the instructions of the manufacturer (Miltenyi Biotech, Inc.). Sorted
cells were analyzed by FACS to test purities and analyzed by Western blotting or
RT-PCR.
Generation of bone marrow (BM)-derived DC and macrophages were carried
out as described previously (20, 26). Cells were immunostained (DCs for CD11c
and Gr-1, macrophages for Mac-1) and analyzed by FACS.
For apoptosis assay, macrophages were harvested on day 8, stained with
annexin V-FITC, and analyzed by FACS to determine the percentage of the
apoptotic cells.
DC migration in vivo. On days 8 to 10 of DC culture, the medium was
supplemented with 200 ng of lipopolysaccharide (LPS; Sigma)/ml to induce
maturation. For fluorescence labeling, cells in phosphate-buffered saline were
incubated for 10 min with 3 mM CFSE or 10 M TAMRA (Molecular Probes)
at room temperature. A 1:1 mixture of each 106 CFSE- and TAMRA-labeled DC
was injected into the hind footpad of recipient mice in a volume of 30 ml of
phosphate-buffered saline. After 48 h, the popliteal lymph nodes (LN) were
dissected and immunostained with pan-laminin antibody, or single-cell suspen-
sions were prepared and analyzed by flow cytometry.
Lymphocyte homing in vivo. Spleen single-cell suspensions of knockout and
control animals were prepared and erythrocytes were lysed. For fluorescence
labeling, cells were incubated for 10 min with 1 mM CFSE or 20 M TAMRA
(Molecular Probes) at room temperature. A 1:1 mixture of each 2  107 CFSE-
and TAMRA-labeled cells was injected intravenously. After 90 min and 24 h,
lymphocytes were isolated from spleen and peripheral LN (inguinal, axial), and
the ratio of control to mutant cells in these organs was determined by FACS
using simultaneous staining with antibodies to B220 or CD3.
Immunization. Mice were immunized via the intraperitoneal route with 100 g
of alum-precipitated NP23-CG) and boosted with 10 mg/mouse 6 weeks after the
first immunization. A total of 50 l of blood was collected from each mouse at
the indicated time points. Enzyme-linked immunosorbent assays (ELISAs) were
carried out as described previously (10).
Statistics. The statistical analyzes of FACS and ELISA data were performed
by using the Student t test. The P value for significance was set at 0.05.
RESULTS
Expression of the parvin family members in the hematopoi-
etic system. To determine the expression of the individual
parvin family members, we generated peptide antisera that
exclusively recognized the corresponding in vitro translated
protein (Fig. 1A). The -parvin mRNA can generate three
isoforms depending on which translation initiation codon is
used for protein translation (34). The peptide we used to
generate our anti--parvin antibody is not present in the two
shorter isoforms called -parvin(s) and -parvin(ss). Hence,
the anti--parvin antibody exclusively recognizes the long
-parvin(l) isoform.
Western blot analysis of lysates derived from thymus, spleen,
LN and Peyer’s patch (PP) revealed that -parvin, -parvin,
and -parvin are expressed at the expected molecular masses
(around 42 kDa for - and -parvin and 37 kDa for -parvin)
(Fig. 1B). BM lysates showed high expression levels of -par-
FIG. 2. Generation of -parvin-deficient mice. (A) An internal ribosome entry site (IRES)-LacZ neomycin cassette was inserted into the
-parvin gene by replacing a 5.4-kb genomic fragment spanning exon 3 to intron 7, including both ATG-containing exons. The arrow indicates ATG
triplets. (B) Homozygous mice were genotyped by Southern blot. (C) Loss of -parvin mRNA was shown by Northern blot in mouse thymus and
spleen tissues. GAPDH cDNA probe was used to control mRNA loading. (D) Loss of -parvin expression was determined by Western blotting.
The blots were reprobed with antiactin as loading control. Single cells, spleen single-cell suspension; WT, wild type; Rec, recombinant.
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vin, low levels of -parvin and no detectable -parvin (Fig. 1B).
In addition to the BM, we detected the -parvin protein in
thymus, spleen, LN, and PP on Western blot (Fig. 1B). In
addition to these hematopoietic organs, we found very weak
-parvin signal in lung and hardly detectable signal in testis
lysates (data not shown). To further determine the cell-type-
specific expression of the parvin family members, we sorted B
cells and CD4- and CD8-positive T cells from adult mouse
spleen by using magnetic microbeads. The purities of the
sorted cells ranged between 92 and 99% as analyzed with
cell-type-specific antibodies by FACS (data not shown). -Par-
vin was expressed at similar levels in all three cell populations
(Fig. 1C). - and -parvin(l) were absent from B and T cells
(Fig. 1C). Lysates from a splenic single-cell suspension showed
- and -parvin(l) expression but no detectable -parvin. BM-
derived macrophages and DCs expressed - and -parvin but
no detectable -parvin protein (Fig. 1D).
- and -parvin can bind ILK and together with PINCH1
form an ILK-PINCH-parvin complex (39, 40). To test whether
-parvin has similar properties, lysates from DCs were immu-
noprecipitated with anti--parvin antibody or preimmune se-
rum. Subsequent Western blotting detected ILK, PINCH1,
and -parvin in the anti--parvin immunoprecipitates but not
in the preimmune serum control (Fig. 1E), indicating that
-parvin can also bind ILK and form a ternary complex with
ILK and PINCH1.
Mice lacking -parvin expression are viable and fertile. To
directly analyze -parvin in vivo, we introduced a constitutive
null mutation into the -parvin gene of mice (Fig. 2A). South-
ern blot or PCR based genotyping of tail biopsies from 159
3-month-old mice revealed the presence of homozygous mice
at the expected Mendelian ratio (Fig. 2B and data not shown).
Northern and Western blot analysis confirmed the absence of
-parvin in homozygous mutant mice (Fig. 2C and D). Both
heterozygous and homozygous -parvin mutant mice were in-
distinguishable from their wild-type littermate controls. They
were fertile and had a normal life span.
Normal hematopoiesis in -parvin-deficient mice. - and
-parvin have been shown to modulate cell migration and cell
survival (6, 31, 34, 40). To test whether -parvin has a similar
function in vivo, we first determined the cellularity and the
population sizes of different cell lineages in BM, thymus,
spleen, LN, and PP of 5-month-old control and -parvin-null
mice. The average cell numbers were similar between control
and -parvin-deficient BM, thymus, and spleen. They were
(29.8  8.1)  106 in control BM and (35.1  11.1)  106 in
-parvin-null BM, (37.1  10.6)  106 in control thymus and
(40.2  12.1)  106 in -parvin-null thymus and (104.0 
33.5)  106 in control spleen and (107.6  30.8)  106 in
-parvin-null spleen.
To determine the population sizes of different cell lineages we
prepared single cell suspensions from lymphoid organs, immuno-
stained them with different lineage markers (B-cell markers B220,
IgM, IgD, and CD19; T-cell markers CD4, CD8, and CD3; eryth-
rocyte marker Ter119; granulocyte marker Gr-1; macrophage
marker Mac-1; natural killer cell markers Dx5 and NK1.1) and
analyzed them by FACS. The relative numbers of the different
cell types were similar in BM, thymus, spleen, LN, and PP be-
tween control and -parvin-null mice of 4, 8, and 20 weeks of age
(Fig. 3A to C and data not shown).
To test whether -parvin-null hematopoietic organs have a
normal architecture and distribution of the different cell pop-
ulations, we performed histochemistry and immunostainings of
tissue sections derived from hematopoietic organs. Hematox-
FIG. 3. Composition and architecture of lymphoid organs in -par-
vin-deficient mice. (A to C) Single-cell suspensions derived from pri-
mary and secondary lymphoid tissues (BM [A], thymus [B], spleen [C])
were immunostained with different hematopoietic lineage makers and
analyzed by FACS. The relative cell numbers are shown (n 	 5/5,
5-month-old mice). (D to G) Immunostaining of spleen (D and E) and
LN (F and G) with anti-B220 (FITC) and anti-Thy1.2 (Cy3) antibodies
showed normal distribution of B and T cells. F, B-cell follicle; PALS,
periarteriolar lymphoid sheath. Magnification, 200.
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ylin-eosin staining revealed a normal architecture of thymus,
spleen, LN, and PP derived from -parvin-null mice (data not
shown). Immunostaining of spleen, LN, and PP with the B-cell
marker B220 and the T-cell marker Thy1.2 showed normal T-
and B-cell distribution in the mutant tissues (Fig. 3D and data
not shown).
Normal lymphocyte homing and T-cell-dependent antibody
response in -parvin-deficient mice. The association of -par-
vin with integrins and the actin cytoskeleton in hematopoietic
cells suggested a potential role of -parvin in leukocyte traf-
ficking. We therefore tested whether short and long-term hom-
ing of B and T cells was altered in the absence of -parvin.
Single cell suspensions of spleens from knockout and control
mice were labeled with different fluorescent dyes and a 1:1
mixture of both genotypes was injected intravenously into wild-
type recipients. After 90 min and 24 h the ratio of fluorescent
cells that homed into spleen and peripheral lymph nodes was
determined for B220 positive B cells and CD3 positive T cells,
respectively. No significant difference in homing frequency
could be observed between mutant and control cells (Fig. 4A).
To more generally test for a role of -parvin in adaptive
immune responses, we first measured the levels of total immu-
noglobulins (IgM, IgA, IgG1, IgG2a, IgG2b, and IgG3) and
found that they were similar between -parvin-null and control
animals (data not shown). Next, we investigated whether the
T-cell-dependent antibody response differs between control
and -parvin-null mice. Mice were immunized with the T-cell-
specific antigen NP-CG and the anti-NP antibody heavy chain
isotypes (IgM and IgG1), as well as light-chain isotypes (Ig

and Ig) were measured 1, 2, 3, and 4 weeks later by ELISA.
No significant differences were found in any of these anti-NP
isotypes between -parvin-null and control mice (Fig. 4B and
C; see Fig. S1 in the supplemental material). Moreover, when
mice were boosted with NP-CG antigens 6 weeks after the
immunization, -parvin-null mice showed a similar memory
antibody response as control mice (Fig. 4C and Fig. S1 in the
supplemental material; data for IgG2a and IgG3 are not
shown).
Differentiation of macrophages and maturation and migra-
tion of DCs are normal in -parvin-deficient mice. To test for
a possible role of -parvin in the myeloid lineage, we differ-
entiated DCs from BM precursors in vitro and induced matu-
ration by adding LPS to the culture medium. Efficiency of DC
generation was identical in -parvin-deficient and control cul-
tures (Fig. 5A). Morphology as determined by bright-field mi-
croscopy was unchanged in this cell type (data not shown). To
more specifically address possible cytoskeletal alterations, we
performed immunostaining of adherent immature DC for F-
actin and the integrin-associated proteins talin (Fig. 5B) and
vinculin (not shown). Independent of the genotype, we found
the typical podosome structure containing an actin core sur-
rounded by a ring of talin and vinculin.
FIG. 4. Lymphocyte homing and T-cell-dependent antibody responses in -parvin-deficient mice. (A and B) Spleen single cell suspensions of
-parvin-deficient and control mice were labeled with TAMRA and CFSE, mixed 1:1, and injected intravenously into wild-type mice. Half of the
experiments were performed with inverted labeling. The ratio of knockout to control B and T cells in LN and spleen was determined by FACS.
Values are the means of three independent experiments with three to six animals  the standard error of the mean. (B and C) Mice were
immunized with the T-cell-dependent antigen NP-CG, and the anti-NP IgM (B) and IgG1 (C) responses were measured by ELISA. (n 	 7).
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After maturation, -parvin-deficient DCs upregulated MHC
II and the costimulatory molecules CD86 and CD40 to a sim-
ilar extent as control DCs (Fig. 5C and data not shown). In
vivo, these mature DCs actively migrate via the afferent lym-
phatics into the draining LNs where they encounter and acti-
vate naive T cells. To test migration and positioning of DC in
vivo, we performed competitive migration experiments. In
vitro generated -parvin-deficient, and control DCs were la-
FIG. 5. Differentiation, maturation, and migration of BM-derived DCs. (A) -Parvin control and null BM-derived DCs were analyzed by FACS
with CD11c and Gr-1 antibodies. Quantification shows mean values of three independent experiments. (B) Immature DC were plated on
coverslips, fixed, and immunostained. (C) FACS analysis of MHCII and CD86 on the BM-derived DCs (upper panel) and mature DCs stimulated
with LPS overnight (lower panel). The quantification shows mean values of three independent experiments  the SD. (D) BM-derived DCs from
both control and -parvin-deficient mice were stimulated with LPS overnight, labeled with TAMRA and CFSE, respectively, mixed in a 1:1 ratio,
and subsequently injected into the hind footpad of mice. After 48 h, the popliteal LNs were dissected and immunostained with pan-laminin
antibody. F, B-cell follicle. Magnification, 200. Quantitative data were obtained by FACS analysis of popliteal lymph nodes. Values are means
of five independent experiments with three to six mice each  the standard error of the mean. (E) BM-derived macrophages were harvested
(including the cells in suspension) on day 8 and stained with FITC-conjugated annexin V. Data for control cells are shown in black line; those for
-parvin-null cells are shown in red.
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beled with different fluorescent dyes, mixed at a 1:1 ratio, and
injected into the footpads of wild-type mice. Histological ex-
amination of the draining LNs 24 and 48 h after injection
revealed that both -parvin-null and control DCs migrated into
the T-cell cortex where they located in the same areas (Fig. 5D
and data not shown). For quantification, LN suspensions were
analyzed by flow cytometry revealing no significant differences
between knockout and control cells. These data indicate that
myelopoiesis, terminal maturation, and migration of DCs are
unaltered in the absence of -parvin.
It has been shown that deletion of ILK in a macrophage
cell line resulted in increased apoptosis due to decreased
levels of PKB/Akt phosphorylation (29). To test whether
this effect could be due to the absence of the ILK-PINCH-
-parvin complex, we differentiated primary macrophages
from BM precursor cells in vitro and stained for annexin V
to determine the percentage of apoptotic cells in the cul-
tures. Our data showed that -parvin-null BM precursors
could differentiate into macrophages, as well as heterozy-
gous control cells, and both purities were more than 98%
(FACS data not shown). No difference in apoptosis could be
observed between -parvin-null and heterozygous control
cells (data not shown and Fig. 5E).
Loss of -parvin is not compensated by an upregulation of
- or -parvin expression. It is possible that the lack of an
obvious phenotype in the hematopoietic organs and in T and B
cells, and DCs of mutant mice is due to compensation by other
parvin family members. To test this hypothesis, we determined
the expression of all parvins in hematopoietic organs and
myeloid and lymphoid lineages. The level of the -parvin(l)
isoform (that is detected by our antibody) was unchanged in
the -parvin-deficient BM, thymus, spleen, and LN (Fig. 6A),
as well as in macrophages and DCs (Fig. 6B). To exclude
expression of the shorter isoforms in T and B cells, we per-
formed RT-PCR and found that -parvin mRNA was not
detectable in both control and -parvin-deficient cells (Fig.
6C), indicating that also the smaller isoforms are not compen-
sating for the loss of -parvin. The level of -parvin protein
was neither increased in lysates from mutant thymus nor mu-
tant LN nor spleen (Fig. 6A), and undetectable in -parvin-
deficient, as well as wild-type BM, DCs, and macrophages
(Fig. 6B).
FIG. 6. Levels of - or -parvin in -parvin-deficient mice. (A) The lysates derived from spleen, thymus, BM, and LN from both control and
-parvin-deficient mice were immunoblotted with anti-parvin, ILK, and PINCH1 antibodies. (B) BM-derived macrophages and DCs from both
control and -parvin-deficient mice were immunoblotted with antiparvin, anti-ILK, and anti-PINCH1 antibodies. (C) B220-, CD4-, and CD8-
positive cells were sorted from adult splenic single cells and analyzed by RT-PCR for -parvin mRNA. HPRT1 was used as a control. (D) B220-
and CD3-positive cells were sorted from adult splenic single cells and analyzed by Western blotting with anti--parvin, -ILK, and -PINCH1
antibodies. BM, bone marrow; LN, lymph nodes; Mac, macrophages; DC, dendritic cells.
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Next we tested whether the absence of -parvin had an
impact on the ternary protein complex with ILK and PINCH1.
Western blot analyzes showed that ILK and PINCH1 proteins
were reduced in the -parvin-deficient BM, thymus, spleen,
and LN (Fig. 6A), as well as in -parvin-deficient macrophages
and DCs (Fig. 6B). In B and T lymphocytes, ILK protein was
also reduced, while PINCH1 was undetectable in B and T cells
in the absence of -parvin (Fig. 6D).
DISCUSSION
In the present study we report the hematopoietic expression
pattern of the parvin family members, show that -parvin can
form a ternary complex with ILK and PINCH1, and describe
the first analysis of -parvin-deficient mice.
To determine the expression of the individual parvin mem-
bers in hematopoietic organs and cells, we used peptides to
generate highly specific antibodies against -, -, and -parvin.
Western analysis with these antibodies showed that -parvin
was the only parvin family member that was expressed in all
hematopoietic organs and cells tested. -Parvin is highly ex-
pressed in B and T lymphocytes, DCs, and, to a lesser extent,
in macrophages. -Parvin was expressed in all hematopoietic
organs, in myeloid cells but not in lymphocytes. Finally, our
Western blot studies showed that -parvin was present in
whole organ lysates derived from spleen, thymus and LN but
absent in splenic single cells, BM-derived cells, and myeloid
(DCs and macrophages) and lymphoid cells (T and B lympho-
cytes). These findings suggest that -parvin is likely expressed
in stromal and/or endothelial cells of hematopoietic organs
and may have, if at all, a rather indirect role on the develop-
ment and function of hematopoietic cells.
It has been shown in several studies that - and -parvins
localize to focal adhesion sites and tensin-rich fibrillar adhe-
sions (11, 23, 31, 34). A central player for recruiting - and
-parvin to focal adhesions is ILK, which binds with its kinase
domain to the second calponin homology domain of the - or
-parvins and with its N-terminal ankyrin repeat to the LIM
only protein PINCH (30, 31, 34). The ternary protein complex
of ILK, PINCH, and - or -parvin forms prior to cell adhe-
sion and is anchored through ILK to the cytoplasmic domain of
the 1 integrin upon adhesion (33, 34, 39, 40). -Parvin shares
approximately 40% identity and 60% similarity with the
paralogous - and -parvins, and it was not known whether
-parvin is also capable of binding ILK and forming a complex
with PINCH. To resolve this question, we performed coimmu-
noprecipitation experiments with lysates from DCs, which ex-
press high levels of ILK, PINCH1, and -parvin. The results
revealed that immunoprecipitation of -parvin efficiently
pulled down ILK and PINCH1, indicating that -parvin can,
like the other parvins, form and stabilize a ternary complex
with ILK and PINCH1.
The specific expression of -parvin in hematopoietic cells
suggests a potential role in hematopoiesis and/or the immune
response. Furthermore, the ability to associate with ILK and
PINCH1 makes -parvin and the entire ternary protein com-
plex a candidate for transducing 1 and 3 integrin functions
in hematopoietic cells. 1 integrins are expressed on almost all
hematopoietic cells and perform functions during the embry-
onic and adult hematopoiesis. During embryogenesis 1 inte-
grins control trafficking of embryonic and extra-embryonic he-
matopoietic stem cells into the fetal liver (13, 24) and induce
the formation of PPs by enabling the interaction of a unique
subset of hematopoietic cells that is expressing CD4 and lack-
ing CD3 with stromal cells in the gut (4). Postnatally, 1
integrins are essential for the homing of adult hematopoietic
stem cells into the BM and the regulation of the T-cell-depen-
dent antibody response (1, 2, 24). 3 integrins have an essential
role for platelet aggregation (14) and play a more subtle role
during monocyte migration (32). The role of ILK and PINCH1
in blood cells is less well studied. In one report it has been
demonstrated that ILK plays an important role for monocyte/
macrophage survival by regulating the activation of PKB/Akt
(29), and another study suggested that ILK may regulate trans-
endothelial migration of monocytes (5). To test whether -par-
vin contributes, at least in part, to the transduction of the 1
and/or 3 integrin function(s) in the hematopoietic system, we
disrupted the -parvin gene in mice. Surprisingly, the -parvin-
deficient mice were born at the expected Mendelian distribu-
tion, were fertile, and displayed no obvious phenotype. More-
over, the cell numbers and the proportion of different myeloid
and lymphoid cells in BM, thymus, spleen, LN, and PP were
normal in mice lacking -parvin expression. Similarly, differ-
entiation of BM precursors to macrophages occurred normally
and without signs of increased apoptosis. This indicates that
-parvin has no rate-limiting function for the homing of he-
matopoietic stem cells during development, as well as for their
potential to give rise to the different blood cell lineages. Fur-
thermore, the recirculation through lymphatic organs is also
normal in the absence of -parvin. Finally, functional assays
such as T-cell-dependent antibody response and the in vivo
migration of BM-derived DCs to LN are also independent of
the expression of -parvin.
An explanation for the lack of phenotype in -parvin-defi-
cient mice is compensation or redundancy by other parvin
family members. Although this could explain the normal mi-
gration of DCs and the absence of apoptosis in macrophages,
which both express in addition to -parvin significant levels of
-parvin, it does not explain the normal T-cell-dependent an-
tibody response, since both T and B cells express -parvin only
and neither upregulate - nor -parvin expression in the ab-
sence of -parvin. In line with previous studies on the stability
of the ILK/PINCH/parvin complex, the loss of -parvin expres-
sion reduced the levels of ILK and PINCH in T cells (33).
Interestingly, the reduction of ILK and PINCH1 in -parvin-
deficient T and B cells suggests that the ILK/PINCH1/-parvin
complex plays most likely a more subtle role for regulating the
T-cell-dependent antibody response and that 1 integrins use
another signaling complex to fulfill this task. Such functions
can be tested by deleting individual members of the ILK/
PINCH/parvin complex specifically in T cells using the Cre/
loxP system.
In summary, our study shows that mouse development and
postnatal aging can proceed normally when the -parvin gene
is disrupted. Although the -parvin gene seems to be dispens-
able in vivo, we cannot rule out that -parvin serves specific
tasks that we have not been investigated here. It is also possible
that there is a certain degree of compensation between -par-
vin and -parvin. This possibility will be difficult to analyze,
since the -parvin and -parvin genes are separated by only
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around 12 kb and the generation of compound mutant mice is
only possible by targeting both genes in the same ES cell line.
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b1 integrins: zip codes and signaling relay for blood cells
Michael Sixt, Martina Bauer, Tim La¨mmermann and Reinhard Fa¨sslerAt least eight of the twelve known members of the b1 integrin
family are expressed on hematopoietic cells. Among these, the
VCAM-1 receptor a4b1 has received most attention as a main
factor mediating firm adhesion to the endothelium during blood
cell extravasation. Therapeutic trials are ongoing into the use of
antibodies and small molecule inhibitors to target this
interaction and hence obtain anti-inflammatory effects.
However, extravasation is only one possible process that is
mediated by b1 integrins and there is evidence that they also
mediate leukocyte retention and positioning in the tissue,
lymphocyte activation and possibly migration within the
interstitium. Genetic mouse models where integrins are
selectively deleted on blood cells have been used to investigate
these functions and further studies will be invaluable to critically
evaluate therapeutic trials.
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Introduction
To fulfill their surveillance function immune cells con-
tinuously patrol the organism, shuttling back and forth
between the blood stream, the lymphatic fluid, secondary
lymphatic organs and peripheral tissues [1]. This mobile
life style requires flexible switching between passive
transport and various cell-to-cell and cell-to-extracellular
matrix (ECM) interactions to arrest, migrate and become
activated.
The current paradigm of cell locomotion within tissues
and along cell surfaces involves integrin-mediated adhe-
sion to ECM or cellular counter-receptors, which gener-
ates traction forces necessary for translocation of the cell
body [2]. Integrins are perfectly suited to this task since
they link the cytoskeleton with the extracellular environ-
ment. Integrins are heterodimeric cell surface receptors
made up of a and b subunits. The combination of 18
known a and 8 b subunits in mammals can give rise to 24Current Opinion in Cell Biology 2006, 18:482–490different receptors [3]. Antibody blocking studies, gene
targeting approaches in mice and investigation of human
diseases have unambiguously revealed that integrins are
essential for intact hematopoietic development, home-
ostasis and inflammation. However, integrin ligand bind-
ing can affect several cellular events in addition to
adhesion and migration, including cell differentiation,
polarization, activation and survival [3]. A drawback of
most studies manipulating integrin functions on blood
cells in vivo is that the cell-biological process affected by
the manipulation is not exactly defined. This is especially
evident when complex inflammatory models (for example
for autoimmune diseases) are studied and clinical symp-
toms or histological parameters are used as readout. A
further critical issue is that within recent years an increas-
ing number of mouse knockout studies have been pub-
lished that address the in vivo function of cytoplasmic
proteins involved in integrin signaling without explicitly
investigating which integrins are affected.
In this review we focus on the largest integrin family
which contains the b1 chain. The blood-cell-specific b2
integrin subfamily has been extensively reviewed by
others [4]. We will try to dissect the different cell-biolo-
gical functions that b1 integrins mediate when leukocytes
emerge from the blood vessels, locate within tissues,
become activated and re-enter the blood circulation.
Extravasation from the blood circulation
One of the best-established concepts in leukocyte biology
is the extravasation paradigm. When hematopoietic cells
leave the blood stream they go through a sequential
adhesion cascade to overcome both the high shear forces
within the blood vessel and the tight seal of the endothe-
lial cells (see Figure 1). Transient selectin–carbohydrate
interactions cause hematopoietic cells to begin to roll
along an activated endothelium. While rolling, the cells
sense chemokines that are immobilized on heparan sul-
fate residues on the luminal side of the endothelial cells.
The ligated chemokine receptors then transmit signals
into the leukocyte that lead to the rapid activation of
integrins (inside-out signaling — see Box 1), which
results in the integrins adhering firmly to their counter
receptors on the endothelial cell. Although adhesion
during extravasation is an essential step during leukocyte
trafficking, it has little in common with cell migration in
the true sense. It is rather a cell adhesion event of the
hematopoietic cell to the two-dimensional surface of the
endothelial lumen.
The crucial b1 integrin family member involved in extra-
vasation is a4b1, which binds to the endothelial Igwww.sciencedirect.com
b1 integrins: zip codes and signaling relay for blood cells Sixt et al. 483
Box 1 Regulation of b1 integrin activation
On circulating leukocytes, integrins are locked in the low-affinity
state. Only upon ‘inside out’ signaling (triggered, for example, by
chemokines, growth factors or T cell receptor activation) integrins
adopt a high-affinity conformation (termed integrin activation)
facilitating ligand binding and subsequent cell adhesion. Ligand
binding in turn induces integrin ‘outside in’ signaling that (among
many other effects) further consolidates cell binding by clustering
the integrins and thereby increasing binding avidity. Cytoplasmic
key players mediating ‘inside-out’ signaling are the small GTPases
of the Rap family and talin.
Rap1: Several recent in vitro studies have proven that Rap1, the
best-characterized member of the five Rap proteins, is essential for
b1 integrin activation on leukocytes. Studies with cell lines revealed
that activated Rap1 increases b1 integrin-mediated adhesion and
migration on VCAM-1 via a4b1 and on fibronectin via a4b1 and
a5b1 [57,58]. The same was shown for primary thymocytes of
transgenic mice expressing the constitutively active Rap1-mutant
Rap1V12 [59], whereas T and B cells derived from Rap1-deficient
mice show impaired adhesion on fibronectin [60]. Rap1 is recruited
to the plasma membrane by PKD1, where it is activated upon
integration into a complex containing the b1 integrin cytoplasmic tail
[61,62]. For Rap1-mediated inside-out signaling, the two Rap1
binding effectors RIAM and RAPL are essential. Accordingly, T cells
and dendritic cells from RAPL-deficient mice show impaired
adhesion to b1 integrin ligands and reduced transmigration through
endothelial monolayers [63]. Overexpression of RIAM enhances
Rap1-mediated T cell adhesion to fibronectin. Through its interac-
tion with profilin and ENA/Vasp proteins, RIAM probably links
Rap1–GTP to the actin cytoskeleton [64].
Talin: Talin is a large rod-like molecule that binds via its globular
head domain to the membrane proximal NPXY motif of b integrins
in a phosphorylation-regulated manner. Talin acts as a physical
link between integrins and the actin cytoskeleton and its binding to
integrin b chains is regarded as the final common step in integrin
activation [65]. Two recent studies assessed the in vivo role of the
b1 integrin NPXY motifs by employing mouse genetic models.
They revealed that the intact conformation of the NPXY motifs are
essential, as substitution of the tyrosines by alanine abolishes b1
integrin function and leads to a b1 integrin-null phenotype [66,67].
Accordingly, chimeric mice with alanine substitutions, similar to a
b1 integrin-null chimera, fail to develop hematopoietic cells,
probably as a result of impaired talin binding [67]. Both studies,
however, challenged the former view that tyrosine phosphorylation
is essential for affinity regulation of b1 integrins, as replacement of
both cytoplasmic tyrosines with phenylalanine did not result in an
obvious phenotype, indicating that tyrosine phosphorylation is
dispensable for the physiological b1 integrin function in vivo.superfamily cell surface receptor VCAM-1 (vascular cell
adhesion molecule 1). This interaction is conserved in
many different physiological settings where extravasation
occurs. In the steady state, lymphocyte recirculation via
high endothelial venules [5], T cell precursor entry into
the thymus [6] and T cell and stem cell homing into the
bone marrow [7–9] are regulated via this pathway. During
inflammation, lymphocytes and monocytes use a4b1 to
immigrate into the skin, lung, peritoneum and liver
[10,11,12]. For several cell types it has also been shown
that VCAM-1-a4b1 binding can mediate not only firm
adhesion but also rolling along the endothelium [12]. In a
somewhat controversial deviation from the paradigm,www.sciencedirect.comthere is evidence that extravasation of lymphocytes into
the central nervous system during autoimmune inflam-
mation is possible in the absence of previous rolling
[13,14]. Here the cells can be rather abruptly captured
by VCAM-1 exposed on the endothelial lumen.
In most cases the function of a4b1 is partially redundant
with that of b2 integrins and a4b7, which bind the
endothelial counter-receptors intercellular adhesion
molecule (ICAM-1) and mucosal addressin cell adhesion
molecule-1 (MAdCAM-1), respectively. An impressive
example of this redundancy is lymphocyte recirculation
into lymph nodes, which is only partially affected by b2
and b7 elimination [5] and unimpaired in the absence of
b1 integrin [15]. Combined blockade, however, results in
almost 100% reduction of lymphocyte recirculation [5].
Many details concerning the overlapping functions of
these integrins remain to be clarified using genetic mod-
els in which the separate families are targeted
simultaneously.
Important exceptions to this redundancy are T cell traf-
ficking into the CNS, which is largely inhibitable by a4b1
blockade [16], stem cell homing into the bone marrow,
which is completely defective in the absence of b1
integrin [7], and the migration of hematopoietic progeni-
tor cells from the fetal blood into the fetal liver during
early development. In early hematopoietic development,
we could show that genetic deletion of the b1 integrin
gene in progenitor cells leads to their accumulation in the
fetal blood and hence the inability to populate hemato-
poietic tissues [7,17]. Although it is likely that a4 is of
major importance in this setting, other a chains may be
involved. A possible candidate is the largely neglected
integrin a9b1, which is highly expressed on granulocytes
and binds to VCAM-1 and the ECM proteins tenascin,
osteopontin and fibronectin. a9b1 has been shown to
mediate transendothelial migration in vitro via interaction
with VCAM-1 [18]. Interestingly, a4 and a9 chain are
closely related and together form a sub-family that binds
to the cytoplasmic adaptor paxillin [19].
Migration through the endothelium
Tight adhesion to the endothelium is followed by a
cascade of migration events that probably successively
trigger each other. First the cells have to pass through the
endothelial monolayer. There is no in vivo evidence that
this process — called ‘diapedesis’ — is directly depen-
dent on b1 integrins. It is rather mediated by cell adhe-
sion molecules of the JAM family, CD99 and PECAM-1
[1]. Nevertheless, ligation of endothelial VCAM-1 via
a4b1 seems to be a prerequisite for diapedesis, as it
triggers a signal within the endothelial cell that is trans-
mitted via the cytoplasmic tail of VCAM [20]. The
endothelial cell then reacts by actively extending protru-
sions to capture and guide the extravasating cell through
intercellular junctions or by transcytosing it directlyCurrent Opinion in Cell Biology 2006, 18:482–490
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Figure 1
Roles of b1 integrins during extravasation, interstitial migration and lymphocyte activation. (a) During selectin-mediated rolling, the extravasating
cell senses chemokines that are immobilized on the surface of the endothelium, leading to the inside-out activation of integrin a4b1. (b) The
a4b1–VCAM-1 interaction mediates firm adhesion and triggers a reverse signal via VCAM-1 that induces the extension of endothelial protrusions,
Current Opinion in Cell Biology 2006, 18:482–490 www.sciencedirect.com
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[20,21].
Transmigration through the basement
membrane
All the events following diapedesis are far less character-
ized, which is mainly due to their experimental inacces-
sibility and the lack of established in vitromodels to study
molecular interactions. Directly after passing through the
endothelium, the transmigrating cells face a seemingly
impermeable barrier of ECM: the endothelial basement
membrane (BM). BMs are tightly interconnected and
thin (50–100 nm) sheets of specialized ECM compo-
nents of the laminin and collagen IV family [22]. It is
possible that b1 integrins play an active role during this
passage and in vitro studies have demonstrated that
leukocytes can actively bind BM components [23]. If
BM transmigration is selectively blocked in vivo one
would expect that extravasating leukocytes become
trapped between the endothelial cell layer and the under-
lying BM. Indeed this phenomenon was observed when
extravasation of granulocytes triggered by interleukin
(IL)-1 was studied in mice in which platelet endothelial
cell adhesion molecule-1 (PECAM-1) was functionally
inactivated by blocking antibodies or genetic deletion
[24]. The homophilic interaction between PECAM-1 on
granulocyte and endothelium induced the up-regulation
of the laminin binding a6b1 integrin on the granulocyte
surface, which in turn was necessary for BM transmigra-
tion [25]. Although this sequence of events was well
demonstrated in this specific experimental setting, it is
not a general phenomenon, as granulocyte extravasation
in response to tumor necrosis factor (TNF)a occurred
independently of PECAM-1 and a6b1 [26]. Another
recently reported example of the possible involvement
of a BM binding integrin during extravasation is the
reduced homing of hematopoietic stem cells into the
bone marrow after antibody blockade of a6b1 [27].
A physiologically distinct situation where leukocytes
cross a BM occurs during the emigration of Langerhans
cells from the epidermis. Their penetration through the
epidermal BM (which is biochemically distinct from
blood vessel BMs [28]) can also be inhibited by antibody
blockade of a6 integrin [29]. Although in this case it
remains to be shown which b chain (b1 or b4) pairs with
a6, laminin is the likely ligand.
Apart from these fragmentary data about molecular
players, the progression of physiological events that leads
to BM transmigration is completely enigmatic.(Figure Legend 1 continued) establishing a ‘docking structure’. (c) Diaped
(not shown). Signals from the endothelium induce surface expression of a6b
laminin-binding integrin a6b1 and cell surface proteases mediate passage o
follicular dendritic cells and B cells and dendritic cells and T cells where it p
chemotactic gradients is possibly mediated by the collagen-binding a2b1 in
www.sciencedirect.comProteolytic digestion via proteases, especially by the
matrix metalloproteinase (MMP) family, has been sug-
gested in several ex vivo models [30,31]. In this context it
is interesting that ligation of integrins can lead to the
induction of MMPs on leukocytes [31,32]. It remains to
be shown if integrins merely signal the presence of a BM
to induce proteolytic cascades or other events leading to
the BM’s local disassembly, or if integrin-mediated adhe-
sion is also a physical requirement for the translocation of
the cell body through the BM.
Migration through the interstitium
The diverse extracellular environments that leukocytes
face upon passaging through the BM range from the
loosely packed and fibrillar-collagen-dominated connec-
tive tissue of the mesenchymal interstitium to the
cell-rich environment of secondary lymphatic organs.
At this stage, true directed migration takes over and it
is assumed that leukocytes navigate along gradients of
chemotactic agents towards their destinations. Despite
numerous in vitro studies using artificial settings such as
transwell filters coated with ECM components, it is still
controversial if this directed migration depends on integ-
rins at all in vivo. The most direct experimental evidence
for integrin involvement is provided by a series of intra-
vital microscopy studies revealing that migration of gran-
ulocytes through the mesenteric interstitium can be
partially inhibited by blocking antibodies against the
collagen-binding b1 and a2 integrin chains [33–35].
However, measured reductions in speed of only 30%
raise the question of whether the remaining migratory
activity is mediated by compensating (b2 or av) integrins
or whether it is completely integrin-independent. In vitro
experimental approaches using three-dimensional gels of
the fibrillar collagens I and III, which mimic the inter-
stitial ECM, can be utilized as migration matrices and
studied by video microscopy. Even in this artificial and
very defined setting, the results obtained with integrin-
blocking antibodies are controversial. By combined anti-
body blockade of av, b2 and b1 integrins, it was shown
that random T cell migration in the gel can occur in an
‘ameboid’ fashion in the complete absence of integrin-
mediated binding [36] and proteolytic activity [37]. How-
ever, others demonstrated that in the presence of che-
motactic agents, T cells utilize b1 (a1, a2, a6) integrins
for locomotion within collagen gels [38]. Although the
issue of interstitial migration remains to be clarified using
genetic approaches in combination with intravital micro-
scopy, it is evident that it is essential to define not only the
nature of the ECM ligand but also the spatial configura-
tion of the extracellular environment in order to establishesis is mediated via PECAM-1, JAMs, CD99 and b2 integrins
1 and proteases on the transmigrating cell. (d,e) In some cases the
f the basement membrane. (f) a4b1 localizes to synapses between
romotes lymphocyte activation. (g) Interstitial migration along
tegrin.
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[39] showed that in the spatially constrained environment
of a narrow space between two closely adjacent glass
surfaces, granulocytes can switch to biophysical mechan-
isms of translocation (squeezing or ‘chimneying’) that are
independent of integrin binding. By contrast, on two
dimensional surfaces granulocytes are completely depen-
dent on integrins to generate traction forces [39]. These
findings impressively demonstrate the importance of
using 3-dimensional model systems to study interstitial
blood cell migration.
In the light of these diverse and partially controversial
data, it seems possible that within the 3-dimensional
environment of the interstitium the quickly migrating
blood cells employ adhesive mechanisms that are funda-
mentally different from the integrin-dependent migra-
tion strategies used by mesenchymal cells.
Retention and positioning within the tissue
While it still remains to be clarified to what extent
integrins are involved in interstitial leukocyte migration,
there is solid evidence that integrin-mediated binding can
define the position of hematopoietic cells by immobiliz-
ing and retaining them in their niches. Owing to the poor
knowledge about the spatial configuration and molecular
composition of these niches, it is not known if retention
simply reflects integrin-mediated cell binding or if more
complex processes are triggered via integrin signaling that
ultimately lead to retention. Two prominent examples of
integrin-mediated retention are illustrated by studies
involving marginal zone B cells and hematopoietic pro-
genitor cells.
Several studies revealed that different precursors can be
released from the bone marrow by antibody blockade or
genetic inactivation of the a4 integrin [40,41]. Similar
results were obtained with mice lacking the a4b1 ligand
VCAM-1 [42]. It has been proposed that in the bone
marrow the stroma-derived chemokine CXCL12 triggers
a sustained signal that keeps the integrin in the active
state and therefore immobilizes the cells to VCAM-1 and
fibronectin on stroma cells [43].
Marginal zone B cells are part of the first line defense
system against circulating soluble antigens. As such, they
are located in a defined ring area around the white pulp
follicles of the spleen, where they capture blood-borne
antigens. Only upon activation by microbial stimuli or
antigen do they downregulate integrin avidity, detach
from the marginal zone and follow a chemotactic gradient
of the chemokine CXCL13 that guides them into the
follicle, where they produce immunoglobulins. The
retention of marginal zone B cells is redundantly
mediated by a4b1 and aLb2 integrin, and blockade or
genetic ablation of these integrins causes the cells to
dislocate from the marginal zone [44]. In marginal zoneCurrent Opinion in Cell Biology 2006, 18:482–490B cells, integrin affinity was shown to be regulated via the
GTPase RhoA and the exchange factor lsc, as in the
absence of lsc these cells are unable to leave their niche
following stimulation owing to an insufficient down-mod-
ulation of integrin avidity [45].
An interesting series of studies that suggests a role for
integrin-mediated retention during pathological pro-
cesses has been performed by de Fougerolles and
co-workers. Using antibody blockade and genetic inactiva-
tion, they demonstrated that the collagen receptors a1b1
and a2b1 are critically involved in the course of cutaneous
hypersensitivity, experimental arthritis and colitis by
localizing T cells within the interstitium [46–48]. Further-
more, in twomodels of murine virus infection, the number
of virus-specific CD8 memory T cells in the lung of
infected animals could be reduced by anti-a1b1 adminis-
trationwithout affectingT cell recruitment during primary
infection [49,50]. Therefore it is likely that a1b1
is needed for the long term retention of CD8 memory
T cells in the lung.
Cell–cell interactions and activation of
lymphocytes
The initiating step in all T-cell-dependent immune
responses is the formation of an immunological synapse
— the contact between an antigen-presenting cell (B
cell or dendritic cell) and a T cell. A main functional
constituent of the synapse is a sealing zone (the periph-
eral supramolecular activation cluster or pSMAC), which
is defined and maintained by the interaction of LFA1
on the T cell with ICAM 1 on the antigen presenting
cell.
Although early in vitro studies already suggested that b1
integrins have potent co-stimulatory functions, condi-
tional knockout mice lacking b1 integrins on hemato-
poietic cells showed a relatively weak immunological
phenotype: T-cell-dependent immune responses were
grossly unaffected with the surprising exception that
IgM production was severely decreased [15]. However,
recent data suggest that members of the b1 integrin
family might play a more subtle regulatory role during
immune synapse formation. Mittelbrunn et al. showed
that a4b1, like aLb2, localizes within the pSMAC of
synapses between T cells and dendritic cells/B cells.
Furthermore, they could demonstrate that this interaction
is important for shifting of the T cells towards a Th1-type
cellular immune response [51]. Another recent study
showed that B cells utilize a4b1 to bind VCAM-1 co-
expressed with antigen on the surface of fibroblasts in
vitro, which might reflect B cell interaction with follicular
dendritic cells in the lymph node [52,53]. Moreover, it
could be shown that this interaction synergizes with the B
cell receptor signal and triggers B cell activation. It will be
important to test if integrins assist T/B cell receptor
signaling only indirectly, by establishing and maintainingwww.sciencedirect.com
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the signaling pathways triggered by both receptors.
Members of the b1 integrin subfamily as
anti-inflammatory drug targets
Pharmacological interference with leukocyte extravasa-
tion is an attractive strategy for anti-inflammatory thera-
pies that was sparked off by the discovery of the
extravasation paradigm in the late 1980s. Table 1 lists
some selected diseases where blockade of b1 integrins
showed beneficial effects, together with a proposed
mechanism of action. Although the intended therapeutic
effect ofmost of these therapeutic approaches involves the
inhibition of firm adhesion to the endothelium, it is not
clear whether other processes, for example lymphocyte
activation, could be affected as well. A prominent example
of this uncertainty is autoimmune inflammation of the
central nervous system. It is well established that the
binding of lymphocytes to inflamed brain blood vessels
during experimental autoimmune encephalomyelitis in
rodents is inhibited by antibodies against a4b1 and that
these antibodies prevent the development of the disease
[16]. This therapeutic principle was used in a clinical trial
to treat patients suffering from the equivalent human
disease, multiple sclerosis [54]. Despite very promising
results, approximately one out of thousand patients
acquired a deadly opportunistic viral infection of theTable 1
Model system Involved integrin dimer and
mode of inhibition
Effects of integrin i
EAE, multiple sclerosis
(Lewis rat, mouse,
human)
a4b1 Reduced clinical si
reduced inflammatAnti-a4 mAb
Morbus Crohn
(human)
a4 integrins Reduced clinical si
C-reactive proteinHumanized anti-a4 mAb
Arthritis
(mouse)
a4b1 Reduced clinical si
inflammatory infiltra
bacterial clearance
S18407: synthetic a4b1
inhibitor
Hepatitis
(mouse)
a1b1, a2b1 Reduced clinical si
inflammatory infiltraAnti-a1/a2 mAb, a1
deficiency
a4b1 Reduced clinical si
Anti-a4 mAb, anti-VCAM-1
mAb
Peritonitis (mouse) a4 integrins Defective recruitme
and monocytes toY991A mutation in a4,
blocks paxillin binding
Influenza
(mouse)
a1b1 No inhibition of the
lung during primary
number of memory
tissue and compro
immunity
a1 deficiency; anti-a1 mAb
Colitis
(mouse)
a1b1 Reduced clinical sy
nflammatory infiltra
and TNF-a product
a1 deficiency; anti-a1 mAb
CNS, central nervous system; EAE, experimental autoimmune encephalom
www.sciencedirect.comCNS during chronic treatment [55]. These could have
been caused either by impaired trafficking of non-patho-
genic lymphocytes that are essential for normal CNS
immunosurveillance or by a more general immunosup-
pression. Indeed it has been shown in rodent EAE that an
anti-a4 antibody which does not inhibit lymphocyte hom-
ing in vivo still ameliorates EAE [56]. This argues in favor
of an additional role for a4b1 apart from mediating extra-
vasation. In this context the recent data suggesting a role
for a4b1 in T cell activation are of special interest.
Conclusions
Advances in the field of intravital imaging make it now
possible to track the dynamic behavior of cells in most
tissues of living animals. In combination with genetic
models where integrins are specifically deleted on
defined blood cell lineages, this approach will allow the
pinpointing of many of the cell biological roles of b1
integrins on hematopoietic cells. This knowledge will be
decisive to predict side effects when pharmacological
approaches are developed in which integrins are targeted
in a non-cell-type-specific manner. Investigating cyto-
plasmic players involved in the activation of the b1
integrins will further teach us to what extent the signaling
pathways are cell-type- and a-chain-specific and will
eventually reveal new drug targets to inhibit extravasation
in a more cell- and tissue-type-specific manner.nhibition Proposed mode of action References
gns of disease,
ory infiltrate
Blockade of firm adhesion to
endothelium and thereby
extravasation
[16,54,56]
gns and lowered
levels
Not addressed, probably
extravasation blockade
[68]
gns, reduced
te and mediators;
not affected.
Interference with neutrophil
activation, cellular trafficking
not severely affected
[69]
gns, reduced
te
Unclear; either migration in
tissue or activation of cells
[46]
gns of disease Interference with a4b- mediated
rolling, adhesion in sinusoids
[12]
nt of lymphocytes
the peritoneum
Probably extravasation blockade [70]
recruitment to the
infection; reduced
CD8+ T cells in the
mised secondary
Inhibition of long term retention
of CD8 memory T cells in the
lung
[50]
mptoms, reduced i
te, decreased IFN-g
ion
Reduced extravasation, migration
or retention of monocytes;
reduced cytokine production
[48]
yelitis; TNBS, 2, 4, 6-trinitrobenzene sulfonic acid.
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The extracellular matrix of the spleen as a potential organizer
of immune cell compartments
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bstract
Until recently little information was available on the molecular details of the extracellular matrix (ECM) of secondary lymphoid tissues. There
s now growing evidence that these ECMs are unique structures, combining characteristics of basement membranes and interstitial or fibrillaratrices, resulting in scaffolds that are strong and highly flexible and, in certain secondary lymphoid compartments, also forming conduit networks
or rapid fluid transport. This review will address the structural characteristics of the ECM of the murine spleen and its potential role as an organizer
f immune cell compartments, with reference to the lymph node where relevant.
2007 Elsevier Ltd. All rights reserved.
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. Introduction
Cellular compartmentalisation within secondary lymphoid
rgans is essential for normal immune function. Over the past
ears, the complex relationship between cell–cell adhesion
olecules, cytokines and chemotactic factors involved in the
aintenance of immune cell compartments within lymph nodes
nd the spleen has started to be elucidated [1–3]. Only recently,
owever, has attention turned to stromal cells, the cellular part
f the non-hematopoietic scaffold, and their impact on estab-
ishing the milieu in which immune reactions take place. Even
hough the acellular component of this scaffold, the reticular
bre network, has long been recognised to form the backbone
f secondary lymphoid organs, relatively little is know of this
cellular compartment and whether it does more than support
he fibroblastic reticular cells of secondary lymphoid organs.
Abbreviations: BM, basement membrane; ECM, extracellular matrix;
EVs, high endothelial venule; MZ, marginal zone; PALS, periarterial lymphoid
heath; WP, white pulp; RP, red pulp.
∗ Corresponding author. Tel.: +49 251 83 55581; fax: +49 251 83 55596.
E-mail address: sorokin@uni-muenster.de (L. Sorokin).
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oi:10.1016/j.smim.2007.12.009Historically, electron microscopic studies have been
mployed to decipher the nature of the extracellular matrix
ECM) of secondary lymphoid tissues, revealing the reticular
bre network or “reticulum” [4], but details on molecular com-
osition remained sparse not only due to the strong focus on
mmunology and cellular composition of secondary lymphoid
issues, but also due to the absence of specific tools for the
etection of defined ECM molecules. Several isolated studies on
he spleen demonstrated the presence of both interstitial matrix
olecules (collagen types I, II and III, fibronectin, tenascin-
) and basement membrane components (laminins, collagen
ype IV, heparan sulfate proteoglycans, nidogen) (summarised
n Table 1). However, the generic nature of these studies together
ith the species differences observed in spleen architecture
5,6] has made it difficult to draw conclusions apart from the
resence or absence of defined molecules in certain sites. It
s only recently, as a consequence of systematic analyses of
he localisation of defined basement membrane versus intersti-
ial matrix molecules with respect to immune cell populations,
hat the existence of distinct matrices associated with differ-
nt immune cell compartments has become apparent [7]. This
eview gives an overview on how the differential expression
f ECM molecules defines lymphoid compartments, with focus
n the spleen, and will provide a framework for future studies
Z. Lokmic et al. / Seminars in Immunology 20 (2008) 4–13 5
Table 1
Summary of studies performed on extracellular matrix molecules expressed in the spleen
ECM type ECM molecule Mouse Rat Human Guinea fowl
Interstitial matrix Collagen I [38] [33] [77]
Collagen II [78]
Collagen III [33,79] [77]
Fibronectin [50] [33] [77]
Tenascin [46,51] [79] [77]
Vitronectin [33]
Basement membrane Laminins [42,48,80] [80] [7,33,79] [77]
Collagen IV [7,33,60,79]
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Heparan sulfates [49]
Hyaluronan
lucidating the influence of the non-immunological scaffold on
mmune cell function.
. Extracellular matrices
Two structurally and functionally distinct extracellular matri-
es can be distinguished in most tissues, the loose connective
issue of the interstitial matrix and the thin sheet-like structure
f the basement membrane. The interstitial matrix represents
network that loosely connects mesenchymal cells or fibrob-
asts and is typically composed of the fibrillar-forming collagens
such as collagen types I, II, III, V and XI), which convey
reat flexibility and tensile strength to these matrices, plus
on-collagenous glycoproteins (such as tenascin, fibronectin,
itronectin, chondroitin-, dermatan-, keratan-sulfate proteo-
lycans), which are highly charged molecules with a high
apacity for intermolecular interactions not only with other ECM
olecules but also with growth factors and cytokines [8–11].
pecialised interstitial matrix molecules associated with highly
lastic tissues include the microfibrillar proteins, such as fibrillin
and 2, and elastin. In contrast, basement membranes are highly
nterconnected glycoprotein networks that act principally to sep-
rate tissue compartments. They consist of a scaffold of collagen
ype IV that is interconnected to a laminin network via molecules
uch as the heparan sulfate proteoglycan, perlecan, and the nido-
ens. Apart from these four main components, molecules such
s agrin, fibulin-1 and -2, BM-40/osteonectin/SPARC, colla-
en types VII, VIII, XV and XVIII are minor components of
ome basement membranes, which nevertheless have distinct
unctional roles [12].
Laminins, heterotrimeric glycoproteins composed of , ,
nd  chains, are considered to represent the biologically active
omponent of basement membranes, with the  chains carry-
ng distinct cell binding sites that signal specific information
o different cell types that controls their growth, migration and
ifferentiation. To date 5, 4 and 3 laminin chains have been
dentified that may combine to form at least 16 different isoforms
13] that are named according to their  chain composition.
or example, laminin 111 is composed of laminin 1, 1 and 1
hains [14]. The major receptors for the laminins include 1 and
3 integrins, and-dystroglycan of the dystrophin-glycoprotein
omplex (as reviewed by [15]), all of which interact only with
i
w
g
m[81]
[49]
[82]
aminin  chains. Apart from direct signalling to cells via such
eceptors, laminins and other basement membrane components,
n particular the highly charged heparan sulfate proteoglycans,
erlecan and agrin, can also function as storage sites for growth
actors and cytokines as described for the interstitial matrix
lycoproteins above.
Reticular fibres have long been known as argyrophilic struc-
ures that are highlighted by silver staining and commonly found
n parenchymal tissues such as the liver, bone marrow, lung and
idney, typically underlying epithelia or covering the surface of
uscle, adipose and Schwann cells [4,16,17]. Ultrastructurally,
hese fibres consist of both basement membrane and interstitial
atrix components [4,18,19]. Particularly prominent reticular
bres occur in secondary lymphoid organs where, because of
heir fluid draining function (described below), they have also
een termed “conduits”. Conduits in this context are, therefore,
eticular fibres with an unusually large diameter (1–2m), char-
cterised by an outer basement membrane layer, and a central
brillar collagen core as a defined substructure. In the following
aragraph, we describe the ECM of the spleen, which is par-
icular due to the heterogenity of molecularly distinct reticular
bres that define different lymphoid compartments.
. Types of ECM in the spleen
The main splenic structures that contain ECM components
re the capsule, trabecules, vascular walls and reticular fibres.
dense connective tissue layer of fibrillar collagen, a typical
nterstitial matrix, and elastic fibres surround the spleen and
ncapsulate trabecules and incoming arteries. The functional
ompartments of the spleen are the white pulp and red pulp
hich are connected by the marginal zone. Endothelial cell base-
ent membranes are found in the vascular walls of the central
rtery and branching capillaries of the white pulp, as well as in
he venous sinuses of the red pulp. In addition, the endothelial
ell basement membrane of the marginal sinus, underlying the
arginal zone, shows unique characteristics that are discussed
elow. Apart from their identification by the immune cells resid-
ng in these niches, each of the three splenic compartments –
hite pulp, red pulp and marginal zone – can also be distin-
uished by the organization and composition of the basement
embrane of the reticular fibre network. This becomes appar-
6 Z. Lokmic et al. / Seminars in Immunology 20 (2008) 4–13
Fig. 1. Pan-laminin immunofluorescence (Pan LM) staining of adult murine spleen in combination with markers of specific immune cell compartments, including
B220 for B cells, T cell receptor  (TCR) for T cells, IgM/IgD to distinguish MZ B cells (IgMhigh/IgDlow) from follicular B cells (IgMlow/IgDhigh), VCAM-1 and
ICAM-1 as markers of stromal cell compartments, MOMA-1 as a marker of the metallophilic sinus-lining macrophages, and ERTR-9 as a marker of marginal zone
macrophages. The sinus-lining basement membrane appears as quasi-continuous pan-laminin staining surrounding the white pulp. MZ is marginal zone; WP is white
pulp; RP is red pulp; S is venous sinus, T is trabeculae.
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Fig. 2. Schematic representation of the typical structure of a reticular fibre found in the lymph node. Table lists significant differences between reticular fibre networks
found in lymph nodes and at different sites in the spleen. In addition to the molecules listed, in all tissues the microfibrillar layer also contains collagen type VI
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xamples of molecular differences in reticular fibre networks in the spleen. PAL
nt by staining of adult murine spleen sections with antibodies
pecific for one of the major basement membrane components,
uch as pan-laminin antibody. Even at low magnifications, the
plenic compartmentalisation is evident: The white pulp, delin-
ated by the quasi-continuous marginal sinus-lining basement
embrane, contains a network of larger diameter reticular fibres
hat show wider spacing compared to the filigran, dense retic-
lar fibre network of the marginal zone and red pulp (Fig. 1).
o-staining for basement membranes and markers of B- and
-lymphocytes, and/or macrophage populations specific for the
arginal zone and marginal sinus demonstrates a correlation
etween localisation of immune cells and distinct ECM com-
artments (Fig. 1), which are explained in detail below.
.1. White pulp reticular networks (conduits)The reticular fibres of the T cell area of the splenic white pulp,
he periarteriolar lymphoid sheath (PALS), closely resemble the
ell-described reticular fibres of the T cell cortex of lymph node
Fig. 2). The basement membrane layer of these reticular fibres
c
l
e
lIV, perlecan and nidogens 1 and/or 2. Immunofluorescence images illustrate
eriarterial lymphoid sheath; MZ is marginal zone.
s characterised by the presence of laminin isoforms 511, 411
nd 332, the heparan sulfate proteoglycan, perlecan, collagen
ype IV and nidogen 1, while the fibrillar core typically contains
ollagen types I [20–22] and III [23,24]. These two distinct ECM
ayers are interconnected by a microfibrillar layer [19,25] char-
cterised by fibrillin 1 and/or fibrillin 2, collagen type VI and,
he yet to be defined, ER-TR7 antigen [20,23] (Fig. 2). The entire
CM core is largely ensheathed by reticular fibroblasts that may
nterdigitate with other cells types, such as dendritic cells as has
een shown in the lymph node [20], but also remains naked in
ertain regions [26].
Although the overall multilayered structure is similar, the
eticular fibres of the lymphoid follicle (B cell area) of the white
ulp have several unique characteristics that distinguish them
rom reticular fibres of lymph nodes and PALS. Most notably
hey show little or no ERTR-7 antigen expression and they lack
ollagen type III in their core; apart from the characteristic
aminins 511 and 411 in the basement membrane layer they also
xpress laminin 211 and not laminin 332 found in the PALS and
ymph nodes (Fig. 2) (manuscript in preparation).
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The differential expression of collagen types I and III in the
eticular fibre core is likely to control fibre diameter, and strength
nd flexibility of the network. While collagen type I fibrils can
orm long-range, highly stable structures, the inclusion of col-
agen type III into these fibrils confers increased elasticity and
s associated with reduced fibril diameter [16,17,27]. Collagen
ype VI, found in the microfibrillar mantle, is a short-chained
ollagen that forms filamentous networks commonly found in
lastic tissues [28,29]. Collagen type VI and the fibrillins have
een postulated to interact with both basement membrane and
nterstitial matrix components and thereby probably form an
lastic link between the collagen core and the outer basement
embrane of the reticular fibre [30].
The outer basement membrane is most likely to act as
n adhesive substrate for the ensheathing fibroblastic reticular
ells. Why different laminin isoforms occur in this basement
embrane in different reticular fibres is not clear, but sev-
ral possibilities exist. Laminins 511, 211, 411 and 332 are
ot only biochemically distinct molecules but are also struc-
urally distinct, as shown by rotary shadowing [15]. This results
n large variations in their abilities to form interactions both
ithin a laminin network and with other basement membrane
omponents [15,31], which may influence the tightness of the
arrier formed by the basement membrane and thereby influ-
nce the conduit function of reticular fibre networks. In addition,
hese different laminin isoforms impart different cellular sig-
als via several receptors, many of which have been identified
n fibroblastic reticular cells [32,33], that control cell growth,
ifferentiation and migration [13,31]. The laminin composition
f the basement membrane underlying the fibroblastic reticular
ells may, therefore, influence their differentiation state and/or
he expression of defined marker molecules, contributing to the
bserved heterogeneity of this cell population (reviewed in Allen
nd Cyster, this volume; [34–36].
Basement membranes normally restrict the movement of
arge (>70 kDa) and positively charged molecules. This selective
arrier to soluble molecules both into and out of the reticu-
ar fibre contributes to the fluid-conduction or so-called conduit
unction that has been demonstrated for reticular fibres of lymph
odes [20–22,37]. Tracer injection experiments in mice [38]
ave revealed that low molecular weight tracers accumulate in
he core of reticular fibres of the B cell area of the splenic white
ulp in a similar manner as has been described for the lymph
ode [20,37], suggesting that it may also provide a fluid trans-
ort mechanism. In the lymph node this conduit system has been
hown to be connected to the afferent lymphatics and to transport
oth chemokines (CCL21, CCL19) and small molecular weight
ntigens [21,22,37] from peripheral sites of inflammation to the
igh endothelial cell venules (HEVs). Resident dendritic cells
hich interdigitate with the reticular fibroblasts within T cell
reas of lymph nodes are capable of taking up antigen from the
ore of the conduit, presumably for the presentation to local T
ells although this has not yet been conclusively demonstrated
20]. Unlike the lymph node, the splenic conduit system is not
onnected to an afferent lymphatic system. Rather, there is most
ikely a tight connection between the vascular system and the
onduit system. The central collagen core of the white pulp retic-
n
Bmunology 20 (2008) 4–13
lar fibre emerges from the interstitial matrix of the trabecular
rteries (unpublished observation). Time course tracer experi-
ents have shown that small molecular weight tracers (<70 kDa)
rriving in the bloodstream are deposited in the marginal zone
nd move rapidly to the red pulp. A small proportion of the
ncoming tracer, however, moves from the marginal zone in
he direction of the center of the follicle within the reticular
bre, where it colocalises with chemokines such as CXCL13
in the B cell area) and CCL21 (in the PALS) in the conduit
ore [38]. The white pulp reticular fibre network may, therefore,
rovide a means of transport of blood borne factors from the
lood stream which may influence immune interactions in the
ymphoid follicles.
Apart from the conduit function, the reticular fibre network
f the lymph node has recently been shown to provide a scaf-
old which supports the migration of naive T cells and B cells
etween the afferent lymphatics and HEVs and border of the B
ell areas [39]. It is unlikely that the ECM of the reticular fibre
etwork plays a role in this migration process, rather that lym-
hocytes migrate on the fibroblastic reticular cell layer, which
n turn is anchored to the ECM scaffold. The reticular fibrob-
asts that enfold the splenic conduit fibres have been suggested
o bind and present chemokines in the PALS (CCL21) and in
he lymphoid follicles (CXCL13) [38], consistent with a role in
igration of lymphocytes. As the white pulp reticular fibre net-
ork interconnects the marginal sinus with the white pulp and
ALS, and the outer sheath of the central artery [18,38] it is pos-
ible that, as in lymph node, it provides a route for lymphocytes
oving either into or out of the white pulp.
.2. Red pulp reticular networks
Within the spleen, the reticular fibre network of the red pulp
iffers from that of the white pulp in several ways: reticular
bres of the red pulp have a considerably smaller diameter
30–50 nm) than those of the white pulp (1–2m) [4,40] and
hey lack the characteristic pronounced fibrillar collagen core
Fig. 2). Rather, the red pulp reticular fibre network consists of
typical basement membrane component (containing collagen
ype IV, perlecan, nidogen 1 and an as yet undefined laminin iso-
orm), plus an extensive microfibrillar layer containing ERTR-7
ntigen, collagen type VI and fibrillin 2 (Fig. 2) (manuscript in
reparation). The spatial organization of these two ECM layers
o each other and to the stromal cells of red pulp is not clear,
ue to the absence of appropriate electron microscopic studies.
part from its function in the retention of aging erythrocytes, the
ense red pulp fibre network may provide the stable backbone
or red pulp macrophages and other red pulp stromal cells. Its
mpact on proliferation and differentiation of these cells as well
s its direct influence on recirculating lymphocytes remains to
e elucidated.
.3. Marginal sinus and marginal zone reticular
etworks
The marginal zone is described as a layer surrounding the
cell follicles, with the marginal sinus facing to the WP
Z. Lokmic et al. / Seminars in Im
Fig. 3. Immunofluorescence staining for pan-laminin and the endothelial cell
marker, MECA-32, showing the sinus-lining basement membrane delineating
the border to the white pulp and an outer basement membrane underlying the
MECA-32+ endothelial cells of the marginal sinus (marked with arrows). Black
and white images illustrate laminin 5 immunofluorescence staining which
occurs predominantly in the reticular fibre network of the white pulp and in
a diffuse manner in the surrounding marginal zone. The higher magnification
image shows the staining of laminin 5 in the marginal zone but not red pulp
stroma. Basement membranes of the venous sinus in the red pulp also contain
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one is the outer basement membrane of the marginal sinus vessels as also seen
n the uppermost panel.efining its innermost border and the RP its outermost bor-
er and is the only B cell-dependent area in the body where
lymphocytes are not organized in a follicular structure
Figs. 1 and 3).
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.4. Marginal sinus
In the spleen all incoming cells arrive via the central artery.
he capillaries of splenic follicles are branches of the central
rtery in the white pulp that anastomose to form a vascular net
overing the white pulp and terminate in the marginal sinus.
he contents of the marginal sinus pass into the marginal zone,
hile the flat sinus-lining reticular fibroblasts characterised by
xpression of the mucosal addressin cell adhesion molecule
MAdCAM) [41] and the Ig superfamily adhesion molecule
ember, L1 [42], are located at the inner border of the marginal
inus and separate the white pulp from the marginal zone. A
inus-lining basement membrane occurs at this site containing
ll components that are typically present in basement mem-
ranes, including: laminins (isoforms laminin 511, 521 and some
aminin 411 and 421), collagen type IV, perlecan and nidogens
and 2 (Fig. 3).
The basement membrane at this site in rats and humans
as been described to have a double layered structure, with
ne basement membrane underlying the endothelial cells of the
ncoming blood vessels, separating the marginal sinus from the
arginal zone, while the other forms the inner border between
arginal sinus and white pulp and underlies the MAdCAM pos-
tive sinus-lining reticular cells [43–46]. Electron microscopy
as identified discontinuities in the two basement membranes:
ores sufficiently large to allow the passage of cells occur in the
asement membrane layer bordering the marginal zone which
orrespond to gaps between adjacent endothelial cells, thereby,
ermitting the free passage of blood borne leukocytes. In con-
rast, smaller discontinuities, which would not permit the easy
assage of cells, occur both in the basement membrane layer
nd the sinus-lining reticular cells on the inner border to the
hite pulp [43–46]. The marginal sinus is discontinuous and
aries in width. In the regions where there are discontinuities
n the marginal sinus, the white pulp is separated from the
arginal zone by the sinus-lining basement membrane alone.
t has been speculated that these sites of direct connection also
epresent sites of lymphocyte migration from the marginal zone
nto the lymphoid follicle. Pan-basement membrane staining
Fig. 3) suggests a close association between the sinus-lining
asement membrane and subjacent white pulp reticular fibre
etwork [43,44], potentially forming a route for lymphocyte
igration from the marginal zone into the follicle as described
bove.
.5. Marginal zone reticular networks
The marginal zone is described as a region surrounding the
cell follicles, with the marginal sinus defining its innermost
order and the red pulp its outermost border and is the only B
ell-dependent area in the body where B lymphocytes are not
rganized in a follicular structure (Figs. 1 and 3). The inner bor-
er can be clearly defined by MAdCAM expressing sinus-lining
eticular cells and the underlying basement membrane, while the
uter border is defined by the distribution of IgMhigh/IgDlow
cells. The reticular fibre network of the marginal zone is
haracteristically much denser than that in the red pulp or the
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hite pulp [47] (Fig. 3) and has a unique expression of laminin
21 [7] and heparan sulfate proteoglycan, agrin (manuscript in
reparation), plus a dense expression of other basement mem-
rane molecules including collagen type IV, nidogen 1 [48] and
erlecan [49]. Some interstitial matrix molecules occur here,
ncluding fibronectin [50,51] and the ERTR-7 antigen, but not
brillar collagens or the typical microfibrillar molecules (fib-
illin 1 and 2), indicating an important structural difference
o the matrices of the white pulp and red pulp [7,46,52,53].
npublished confocal microscopy data suggests that the ECM
f the marginal zone does not share the conduit-like structure of
hite pulp reticular fibre network but rather more closely resem-
les a classical basement membrane structure, which encases
ndividual cells or groups of cells, resulting in a basket-like
tructure (Fig. 3). Electron microscopic studies have suggested
hat there is frequent contact between the reticular fibres of
he marginal zone and lymphocytes [46], further substantiat-
ng the concept that the reticular fibre network is distinct at
his site.
The function of the specialised ECM in the marginal zone is
nclear, as is the precise spatial relationship between the ECM
nd the cells resident at this site, including reticular cells and the
CAM-1+/ICAM-1+ stromal cells [54], marginal zone B cells
MZ B cells), and the ERTR-9+ [55] and MOMA-1+/SER-4+
56,57] macrophages. The ECM may either provide an adhe-
ive niche for one or more of these cell populations, or it may
ndirectly influence these cell populations by trapping specific
hemokines or cytokines at this site.
It is known that resident stromal cells in the marginal zone
onstitutively express the cell adhesion molecules, ICAM-1
nd VCAM-1. Interactions with these adhesion molecules and
41 and LFA-1 expressed on MZ and follicular B lympho-
ytes play important roles in the long-term retention of MZ B
ells at this site [54], and for B- and T-lymphocyte migration
nto the white pulp [50]. In addition to these adhesive events, a
alance between sphingosine-1-phosphate (S1P) and CXCL13
s required for maintaining MZ B cells in the marginal zone.
ormally, S1P interactions with S1P-1 receptor are associated
ith egression of lymphocytes from lymph nodes. However,
n the case of MZ B cells, which have high levels of S1P-1
eceptor, engagement of the receptor is required for their reten-
ion in the marginal zone [58]. This effect is partially due to
ailure to respond to the chemoattractant, CXCL13, produced
n the lymphoid follicle, and upregulation of ICAM-1/VCAM-
-mediated adhesion. However, molecules other than S1P are
nvolved in retention of MZ B cells in the marginal zone, since
n the absence of S1P and CXCR5 (the receptor for CXCL13)
Z B cells are still maintained at this site [58]. Whether the spe-
ialised ECM of the marginal zone contributes either directly or
ndirectly to any of the events described above remains to be
nvestigated.
. Potential function of ECM in the spleenThe close correlation between immune cell localisation and
tructurally and biochemically distinct ECM compartments in
he spleen leads to the question whether the reticular fibre net-
c
a
o
bmunology 20 (2008) 4–13
orks of the spleen have an impact on immune cell reactions. A
ajor direct effect on the trafficking of the highly dynamic recir-
ulating lymphocytes is unlikely, as most of the reticular fibres
re covered by the cellular processes of reticular fibroblasts
nd/or endothelial cells [18,45,59–61]. However, the few sites
here the ECM is exposed [26] it may provide anchorage for
essile leukocyte populations such as MZ B cells, macrophages
n marginal zone and red pulp, or resident dendritic cells in
he marginal zone and white pulp. In addition, it is likely that
he ECM exerts indirect effects on immune cells of the spleen
y 1) storage or presentation of cytokines, growth factors or
hemokines (as discussed above), and/or 2) as a major element
or survival, proliferation and differentiation of mesenchymal
nd endothelial stromal cells which have been shown to influence
rafficking [62–64], differentiation [65,66] and commitment [67]
f immune cells in the spleen.
.1. Cellular sources of ECM in the spleen
There is growing evidence for the heterogenity of splenic
tromal cells with the identification of new markers (reviewed
n Allen and Cyster, this volume; [34,35]) Fibroblastic reticu-
ar cell populations can be distinguished by antibodies against
p38 (white pulp PALS), smooth muscle actin (white pulp),
esmin (white pulp and red pulp) (see Fig. 2), BP-1 (white
ulp follicle), ICAM-1 (marginal zone and white pulp), VCAM-
(marginal zone and red pulp) and antibodies IBL-10 (white
ulp) and IBL-11 (white pulp PALS) against unknown epi-
opes [36]. In the B cell follicle, follicular dendritic cells (FDC)
epresent another mesenchymal FRC which is not tightly asso-
iated with the ECM [68,69]. Also endothelial cells show
eterogenity: Apart from the ubiquitous endothelial expression
f MECA-32Ag, Endomucin and PECAM-1 (not sinus-lining
ndothelium) (unpublished observations), antibodies have been
enerated that define distinct endothelial cell compartments in
he spleen [70,71]. Investigation of correlations between stromal
ell and ECM markers will contribute to the understanding of
hich cells produce the matrix of the reticular fibres in the red
ulp, marginal zone and white pulp.
In vitro data from fibroblastic reticular cell lines derived from
ymph nodes has shown that these cells are capable of syn-
hesising ERTR-7 antigen, laminins and fibronectin, and that
heir extracellular deposition is strongly promoted by either
ontact with lymphocytes or exogenously added TNF/LT
63], indicating an interplay between immune cells and stro-
al cells. Macrophages are an additional immune cell located
ithin the stroma that have been postulated to secrete ECM
olecules and are certainly sources of ECM modifying pro-
eases and cytokines that can alter ECM secretion by other cells
72,73].
Whether additional stromal cells exist in either the white
ulp or red pulp of the spleen which may contribute to ECM
tructures is not clear. Indeed, studies identifying the precise
ells responsible for synthesis of individual matrix components
nd regulating the ECM deposition and remodelling during sec-
ndary lymphoid organ development and homeostasis remain to
e performed.
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.2. Animal models for splenic ECM investigation
As discussed above, spleen compartments can now be char-
cterised not only by their immune cell composition, but also by
heir ECM structure and molecular composition. However, the
elationship between ECM and immune cell function remains
ntirely open to investigation. Due to the complexity of differ-
nt ECM types and the difficulty in reconstituting extracellular
atrices in vitro that faithfully reflect the in vivo situation,
uch analyses will require the use of transgenic mice defi-
ient in defined ECM molecules, but also investigation of ECM
olecules in mice known to lack specific splenic immune cell
r stromal cell populations. Not only will structural analyses be
mportant in these mice, but also studies of chemokine and/or
ytokine localisation.
Several transgenic mouse strains exist, which lack ECM
olecules normally expressed in different splenic compartments
hat are viable but have not been examined from point of view
f spleen structure or function. These include mice lacking the
icrofibrillar molecules collagen type VI and fibrillin 1, the
mall leucine-rich proteoglycans, fibromodulin, biglycan and
ecorin, expressed in the collagen core of reticular fibres [20],
r specific isoforms of basement membrane components such
s nidogens 1 and 2, and laminin 2 which occurs exclusively
n the reticular fibre network of the B cell area of the white
ulp (as described above) (ECM mouse mutants are reviewed
n Refs. [74,75]. Although complete elimination of the major
asement membrane or interstitial matrix components, such as
he laminins, collagen type IV, perlecan and fibronectin (see
efs. [74,75]) results in mouse embryoes that do not survive
ufficiently long for investigation of the spleen, several tissue-
pecific knockout mice are currently being generated that will
ot only provide models for investigation of the significance of
plenic ECM but also identification of their cellular source.
Non-ECM transgenic mice which will be particularly impor-
ant to investigate with respect to ECM expression include mice
eficient in the TNF superfamily members, which show anatom-
cal abnormalities in the formation of distinct B and T cell areas
s well as the marginal zone [76]. In particular, mice lacking lym-
hotoxin (LT)  in which T and B cells have no separate areas
nd are completely intermingled, and LT deficient mice which
how B cells localized in a ring around a central T cell area [76]
re likely to provide information on whether ECM is directly or
ndirectly involved in immune cell compartmentalisation.
. Conclusion
The spleen is traditionally characterised by its complex
mmune cell compartmentalisation, but can also be characterised
y its unique ECM. Substantial differences have been identi-
ed in ECM structure and molecular composition in the red
ulp, white pulp and the marginal zone. Most significant are
he variations in molecular composition of the reticular fibre
etworks in red pulp versus white pulp compartments, and the
nique expression of laminin 521 isoform and the heparan sul-
ate proteoglycan, agrin, characteristic of the marginal zone.
ifferences in localisation of the various ECM molecules in
[munology 20 (2008) 4–13 11
he spleen suggests that the ECM plays a role in the compart-
entalisation of the immune cells to their respective niches, an
rea which remains to be investigated. It is clear that future anal-
ses of ECM animal models require consideration of possible
mmunology defects, an aspect rarely considered to date, while
hemokine/immunological mouse models cannot overlook the
eed for analysis of stromal cells and the ECM.
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The microanatomy of T-cell
responses
Summary: The priming of a T cell results from its physical interaction
with a dendritic cell (DC) that presents the cognate antigenic peptide. The
success rate of such interactions is extremely low, because the precursor
frequency of a naive T cell recognizing a specific antigen is in the range of
1:105–106. To make this principle practicable, encounter frequencies
between DCs and T cells are maximized within lymph nodes (LNs) that
are compact immunological projections of the peripheral tissue they drain.
But LNs are more than passive meeting places for DCs that immigrated
from the tissue and lymphocytes that recirculated via the blood. The
microanatomy of the LN stroma actively organizes the cellular encounters
by providing preformed migration tracks that create dynamic but highly
ordered movement patterns. LN architecture further acts as a sophisticated
filtration system that sieves the incoming interstitial fluid at different levels
and guarantees that immunologically relevant antigens are loaded on DCs
or B cells while inert substances are channeled back into the blood
circulation. This review focuses on the non-hematopoietic infrastructure
of the lymph node. We describe the association between fibroblastic
reticular cell, conduit, DC, and T cell as the essential functional unit of the
T-cell cortex.
Keywords: lymph node, anatomy, conduit, stroma
Adaptive immunity depends on secondary
lymphatic tissues
Innate immune cells are constantly patrolling the body. Within
minutes of local infection, they are recruited to the site of
damage where they exert their defense function. The speed of
such responses is possible because the innate immune cells are
always available: some are resident within the tissue and some
are quickly recruited from the bloodstream, where they are
either freely circulating or patrolling along the endothelial
lumen (1–4). As there are only few types of specialized innate
immune cells, the copy number of each type is high, and
supply is always guarantied. Adaptive immune responses are
fundamentally different, because the number of specialized cell
types is in the range of many millions, as lymphocytes of
different specificity are randomly generated during somatic
development. Naturally, the copy numbers of each specific cell
type are extremely low. It was recently demonstrated that for an
average antigen, the number of specific T cells is in the range of
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a few hundreds (5, 6). Hence, the few specialized cells that
recognize an antigen have to be expanded before they can
effectively invade any tissue. The principle of lymphocyte
activation/expansion is based on stochastic encounters be-
tween the antigen-presenting cells of the innate immune
system, the dendritic cells (DCs), and T cells. Once the T cell
physically contacts the DC presenting its cognate antigen, it is
activated and expanded to a population size that is now
sufficient to effectively invade the infected sites.
Secondary lymphatic organs are the solutions to solve the
‘needle in the haystack’ problem of identifying and expanding
rare T cells within reasonable time frames. The prototypic
example of a secondary lymphatic organ is the lymph node
(LN), which we discuss in this review. LNs are compact
immunological projections of the patch of peripheral tissue
that they drain. DCs that collected information and antigens in
the periphery migrate via the afferent lymphatic vessels into the
draining LN. Once in the T-cell area, the immigrated DCs
display, based on the information they received in the
periphery, the antigen in a context that instructs the T cell to
differentiate into the adequate effecter type (7). T cells
recirculate through the LNs with the bloodstream that
they leave via high endothelial venules (8). Within the
T zone, the necessary high encounter rates between DCs and T
cells are maintained by rapid cell locomotion that is effectively
organized by chemokines (9). The big advantage of this
system is that instead of scanning the whole periphery,
naive T cells just visit the LN and receive all the instructions
they need. Indeed, the adaptive immune system is so
highly dependent on its organization centers that in the
absence of secondary lymphatic organs, adaptive immunity is
abolished (10).
Upon closer inspection, the schematic concept of
immigrating DCs being the representation of the periphery is
too simplified, and the reality is more complex. LNs are not
only receiving DCs with the afferent lymph but also the whole
stream of interstitial fluid with all its contents: soluble antigens,
intact microbes, microbial particles, and locally produced
extracellular signaling molecules like cytokines and
chemokines. LNs are fluid filters that are providing the
infrastructure to collect, select, and load soluble antigens on
DCs that are permanently residing in the T zone. The filter
function also physically prevents that replicable pathogens
spread systemically via the blood circulation. LNs are also
‘information hubs’ that are quickly relaying soluble signals
from the periphery toward the T cells in the blood circulation.
Finally, it seems likely that LNs are critical regulators of the
fluid balance between interstitium and blood.
The anatomy of LNs is complex, extremely dynamic, and
until 2001, it was largely ignored by immunologists. Only the
rise of intravital imaging technologies within the last years
brought structural aspects of the lymphatic system back into
the mind of the immunologist. Numerous excellent reviews
are available that summarize the emerging knowledge of
leukocyte motility patterns within LNs (11–13). However, the
focus was largely on the hematopoietic fraction of the LN that
is relatively easy to visualize. The mesenchymal infrastructure
of the LN that supports and directs the blood cells is still poorly
appreciated. Closely connected to the mesenchymal anatomy is
the question of fluid dynamics within the lymphatic system.
Although a detailed physiological knowledge of particle and
solute transport will be necessary to understand the kinetics of
infections at the organismic level, many aspects of these
processes are not investigated.
In this review, we describe the non-hematopoietic
infrastructure of the lymphatic system in the functional
context of cell migration and fluid drainage. Our focus is the
T-cell response, as the B-cell compartment has been reviewed
recently (14), but we mention the B cells when necessary for
comparative purposes. We use the skin and the draining LN as
an example. For two reasons we also include an overview over
the dermal microenvironment. First, almost every immune
response is initiated in the periphery, and the dermal fluid and
cell drainage system is critically involved in the initiation of
adaptive immunity. Second, molecular composition and
physiological characteristics of the dermal interstitium are
well investigated and serve as a model to further discuss
LN physiology that follows the same principles but is still an
open field.
Circulation patterns of fluids
While cells and some microbes have the possibility to move
autonomously, extracellular substances within vertebrates are
either immobilized to cells or molecular components of the
extracellular matrix (ECM) or they move with the bulk flow of
fluid by convective forces, meaning that they are flushed (15).
The interstitial fluid of vertebrates appears in several different
forms while it is recirculating through the body. The plasma
fraction of the blood is the most accessible variant. In the
capillary bed, plasma is filtrated from the vasculature and
becomes interstitial fluid, which is slowly percolating through
the interstitium into the afferent lymphatic vessels (16). From
there on it is termed afferent lymph. The afferent lymph is
filtered through the draining LN, and once it has exited the LN
is termed efferent lymph. In larger vertebrates and humans
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(but not in mice), the efferent lymph is filtered through a
hierarchy of second- and third-order LNs before it enters the
cisterna chyli and is further actively transported via the thoracic
duct back into the venous blood circulation (17, 18). All
particles will passively follow the convective drag of the
interstitial fluid if they are not immobilized or taken up by
cells, trapped by binding to ECM, or filtered at a barrier due to
size reasons. As a consequence of the different filtration steps,
plasma, interstitial fluid, afferent lymph, and efferent lymph
have quantitatively different molecular compositions, although
they are in continuous exchange (19) (Fig. 1).
The peripheral tissues: dermis
After breaking the barrier of the epidermis, extracellular
pathogens either spread laterally, grow into deeper areas, or
distribute systemically by accessing the blood vasculature. The
molecular architecture and the hydrostatic conditions within
the dermis dictate that the fluid and particle stream is strictly
directed from the blood vessel into the lymph vessel (16, 19).
This convective stream counteracts entry into the blood circu-
lation by flushing particles away from blood vessels. Further-
more, the small pore size of the interstitium acts as a sterical
barrier for active spreading. We start by describing general
features of the dermal compartment, with focus on the
questions of how molecular anatomy determines the transport
of solutes, particles, and immune cells. The dermal stroma
consists of two components: the stroma cell (typically a
fibroblast) and the ECM that the stroma cell produces. The
dermis is characterized by a wide extracellular space that is
scaffolded by dense arrays of biopolymers. The fibroblasts are
scattered within the tissue without forming cell–cell contacts.
They are rather embedded as single cells into the surrounding
ECM. Owing to the spacing, fibroblasts themselves do not form
any significant barrier for solutes, cells, or particles (20). The
ECM can be functionally divided into two categories: the
fibrillar fraction that consists of arrays of fibrillar collagen
bundles, elastic fibers, and microfibrils, and the non-fibrillar
fraction that consists mainly of long-chained aminosugars
(glycosaminoglycans) and proteoglycans. The fibrillar fraction
is mechanically stable and counteracts the tension produced by
the fibroblasts that contract the extracellular fibers via acto-
myosin forces (21). The interplay between fibroblasts and
fibers determines the mechanical characteristics of the skin.
The non-fibrillar fraction fills the volume between the fibers.
Unlike the fibrillar proteins, these extremely large sugars
(chains of hyaluronic acid can reach a length up to 5 mm and a
molecular weight of several million Daltons) are not tightly
interconnected, and biophysically they rather behave like a very
viscous fluid (22). Glycosaminoglycans are highly negatively
charged and therefore bind ions and, as a consequence, attract
and immobilize water. By sucking water, they act as ‘expansion
elements’ that counteract the tensile force of the fibrillar ECM
fraction (16).
Solute transport within the dermis
What are the driving forces of interstitial flow? The flow is a
function of Starling’s forces that set the capillary filtration rate:
the local hydraulic pressure difference (blood pressure–inter-
stitial pressure) across the blood vessel wall minus the colloid
osmotic pressure difference between blood and interstitium
(23). The hydraulic pressure of the dermal interstitium is
actively kept low by the suction force of the lymphatic vessels
that pump fluid away from the tissue and into the draining LN.
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Fig. 1. Circulation patterns of fluids. Small particles (small dots)
become filtrated from the blood stream (red) in the periphery, enter the
afferent lymphatic vessel (yellow), and are transported into the draining
LN. Here, they are directly reabsorbed into the bloodstream. Large
particles (large, open dots) also enter the afferent lymphatic vessel but
percolate through the sinus system of the LN and eventually (if they are
not trapped in the sinus) are channeled via the efferent lymphatic vessel
and the thoracic duct back into the blood circulation.
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Under normal conditions the interstitial flow is slow, because
the hydraulic conductivity of the interstitium is low. Conduc-
tivity is set by the pore size (the hydraulic radius) of the
interstitium that is determined by the surface area of glycosa-
minoglycans and fibrillar ECM that is filling the interstitium. In
the dermis, this radius is in the range of 100 nm, so that the
interstitium is a sterical barrier for bigger particles like viruses
or bacteria (24). The low mobility of interstitial water that is
caused by the charged glycosaminoglycans prevents quick
shifts of interstitial fluid upon pressure changes and restricts
the diffusive or convective distribution of soluble molecules,
even under mechanical stress. Only in the situation of periph-
eral lymphedema is the glycosaminoglycan fraction saturated
with water. This dilution leads to the effect that the excess
water moves freely (16, 25, 26). Therefore, edematous tissue
can be easily ‘squeezed out,’ which is used as a simple clinical
test: pushing into edematous skin but not into healthy skin
leaves a pit. To our knowledge, the consequences of edema for
particle transport have not been investigated systematically, but
it is a clinical fact that peripheral edema predisposes for local
infection (27) (Fig. 2).
There are two important implications for particle and solute
transport within the dermis. (i) In principle, solutes and small
molecules can freely diffuse, but their transport is dominated
by the convection caused by the bulk fluid movement that is
directed from the capillaries into the lymphatic vessels. The
dermis is in a state of constant fluid secretion, and although this
is frequently stated, re-absorption of fluid and solutes in the
efferent capillary bed or across venules does not occur
normally. (ii) For larger particles, the pore size of the
interstitium is a sterical barrier. They ‘become filtered,’ and
the only way to spread is by autonomous movement, digestion
of the ECM, and subsequent increase of the pore size, or by
‘hitchhiking’ with cells.
Cell migration within the dermis
A soluble molecule or a particle can reach the draining LN via
two principal routes: passively with the interstitial flow or
carried by cells. The usual cell type that carries antigens into the
LN is the DC. In the steady state, DCs are forming an area-wide
network that constantly samples the tissue for internal (da-
mage) or external (microbes) danger signals (7). Within the
skin, there are two populations of resident DCs: the Langerhans
cells of the epidermis that reside between the keratinocytes
above the epidermal basement membrane (28, 29) and the
dermal DCs that are scattered within the interstitium (30).
Upon danger sensing, DCs undergo so-called maturation. DCs
transiently become phagocytotic and subsequently acquire
a state of high motility (7, 31). This metamorphosis from
a rather static cell that adheres to the ECM via integrins to a very
motile cell is associated with the upregulation of the chemo-
kine receptor 7 (CCR7) that guides the cells toward the afferent
lymphatics that are expressing the CCR7 ligand CCL21 (31).
How do DCs migrate through the interstitial microenviron-
ment? Considering the textbook paradigm that cell migration
in metazoans relies on integrin-mediated coupling of cytoske-
letal force to the ECM (32), it seems rather paradoxical
that we and others found that upon maturation, DCs function-
ally inactivate their integrins (28, 29). However, we recently
learned that DC migration in the interstitium is completely
integrin independent. We rather found that DCs move through
the fibrillar scaffold of the interstitium by a protrusive flowing
of the actin cytoskeleton and by occasional contractions of the
trailing edge that facilitates squeezing of the non-elastic
nucleus through narrow areas (T. La¨mmermann et al., unpub-
lished observations). Proteolytic digestion of fibrillar matrices
is not required for this very quick mode of movement, and
the spacing of the fibers is obviously large enough for the
cells to squeeze through (33). Hence, leukocyte migration
through the interstitium happens without causing permanent
damage by remodeling or rearrangement of ECM; the cells
move along the path of least resistance (34). It is currently
Basement membrane
Interstitial matrix
Fibroblast
Fig. 2. Interstitial flux within the dermis. Plasma becomes filtrated
from the blood vessel (red). The endothelium and the endothelial
basement membrane (brown) form a semi-permeable membrane. The
interstitial flux (arrow) is strictly directed from the blood vessel toward
the lymphatic vessel (yellow) that has no continuous basement mem-
brane but flap valves opening toward the lumen. The interstitial matrix
(blue) consists of collagen fibers (thick lines), microfibrils (thin lines),
and glycosaminoglycans (brush like structures). Fibroblasts (green)
associate with the interstitial matrix.
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unclear how cells handle the tight network of glycosaminogly-
cans that fills the space between the fibers. It is likely that these
polymers are just pushed away. This is possible because the
glycosaminoglycan network is not tightly crosslinked and is
rather fluid.
The basement membrane as a specialized ECM
Although the interstitial matrix is not allowing unrestricted
movement of particles, there is a variant of the ECM of much
lower permeability: the basement membrane. Basement mem-
branes underlie epithelia and endothelia and surround axons,
fat, and muscle cells. Rather than a loose scaffold like the inter-
stitial matrix, basement membranes are dense sheets of tightly
interconnected glycoproteins of the laminin and the non-
fibrillar collagen IV families that are coupled together by bridg-
ing molecules like nidogens (35). Basement membranes do
not only serve mechanical functions but also act as molecular
sieves, anchoring structures and polarity signals for polarized
cells, pathways or barriers for migrating cells, and, importantly,
they harbor heparan sulfate proteoglycans like perlecan and
agrin. These sulfated proteoglycans are again serving as mole-
cular sinks, storage sites, or presentation platforms for the
many heparan sulfate-binding growth factors and chemokines
(36). Basement membranes strongly vary in their molecular
composition, depending on the cell type they are produced by
and associated with. Sixteen different laminin isoforms with
distinct tissue-specific and developmental expression patterns
and distinct cell-binding and biophysical characteristics are
only one example of the highly specialized and not well-
explored specializations of basement membranes (37).
Role of basement membranes for solute transport
The role of basement membranes in fluid filtration is not well
investigated, except in the kidney where the primary urine is
filtered through the basement membrane associated with the
podocyte endfeet. Here, a dual role as a sterical and a charge
filter for molecules above the size of albumin has been
proposed (38). Three basement membranes transect the skin
in a way that they might be relevant for fluid filtration: the
basement membrane of the epidermal–dermal junction, of the
blood vessel endothelium, and of the lymphatic endothelium.
Although no functional studies are available, it appears likely
that the endothelial basement membrane contributes to the
semi-permeability of the blood vessel (39). The same is
possible for the epidermal basement membrane, while the
basement membrane of the lymphatic endothelium appears to
be functionally different. It has long been doubted that lymph
vessels have at all an underlying basement membrane and
lymphatic endothelial cells can be differentiated from blood
endothelial cells by very low expression levels of collagen IV
and laminins (40–42). Only recently it became clear that the
basement membrane of lymph vessels exists but that it is very
fragile and also fragmented (43, 44). This structural config-
uration makes it unlikely that the lymphatic basement mem-
brane is a significant barrier to fluid movement.
The role of basement membranes for cell migration
Basement membranes are structurally dense and as such
require specialized mechanisms if they should be transmi-
grated (45). Leukocytes can circumvent most dermal basement
membranes, and the only sites where transmigration is neces-
sary are the endothelial basement membrane of venules and the
epidermal basement membrane. Cells have to penetrate these
barriers to leave the bloodstream and the epidermis, respec-
tively. Passing the epidermal basement membrane clearly
requires proteolytic degradation and likely also integrin-
mediated adhesion, as demonstrated for epidermal Langerhans
cells and autoreactive T cells (45–48). For extravasating
leukocytes that have traversed the endothelial monolayer and
face the underlying basement membrane, this is less clear.
Recently, it has been suggested that preformed openings (also
called low expression sites as they show low levels of laminins
and collagen IV) allow neutrophils to squeeze through the
membrane without creating defects (49). Passing the rudimen-
tary basement membrane of the lymphatics does not require
active proteolytic mechanisms, and DCs likely enter via pre-
formed openings (our unpublished data).
The lymphatic vessels
Entry of fluid into the lymphatic vessels
The lymphatic vessels actively pump interstitial fluid out of the
tissue and thereby keep the interstitial pressure low and
guarantee that flow is unidirectional away from the capillary
bed. In most tissues, the lymphatic vessels are the only route of
fluid absorption, and efferent capillaries and venules are not
pathways of significant absorption (LNs and the gut are
exceptions as we discuss below) (19). Unlike blood vessels,
lymph vessels openly communicate with the interstitium. No
tight endothelial barrier or continuous basement membrane
restricts the movement of solutes. The suction force of the
lymph vessel is generated by the interplay of four functional
units: (i) the smooth muscle layer around the lymphatic
collector vessels (the proximal part of the lymphatics) periodi-
cally contracts and thereby pushes fluid toward the draining
LN, (ii) backflush of fluid into the periphery during contractile
phases is prevented by the semilunar valves between segments
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of collector vessels, (iii) the lymphatic endothelial cells of the
blind ending initial (distal) part of the lymphatics are arranged
in an overlapping pattern that forms flap valves that allow entry
but prevent exit of fluid, and (iv) the abluminal side of the
lymph vessels are anchored to the interstitial fibrillar matrix via
elastic filaments. Using the tensile force of the interstitial ECM,
these filaments pull the lumen of the lymphatics open, even
when interstitial pressure rises during edema. Edema rather
enforces the opening of the lumen as it raises the tension
within the interstitial matrix (50).
Cellular entry into the lymphatic vessels
How cells enter lymphatic vessels has not been thoroughly
investigated in vivo. Several adhesion molecules have been
implicated in this process based on in vitro assays or pharmaco-
logical inhibition. These molecules include the cell surface
receptor clever 1 (51) and the interaction between leukocyte
function-associated antigen-1 (LFA1) and very late antigen 4
(VLA4) on the DC and its counter ligands vascular cell adhesion
molecule-1 (VCAM-1) and intracellular adhesion molecule-1
(ICAM-1) on the abluminal side of the lymphatic vessels (52).
However, a recent report (and our own data) suggests that like
for fluid transport, for cellular trafficking, the lymphatic vessels
might not be a considerable barrier. The cell–cell contacts
between the lymphatic endothelial cells at the level of initial
lymph vessels are discontinuous. Instead of the continuous
adherens junctions that are found between blood endothelial
cells, the junctions between lymphatic endothelial cells are
organized as ‘buttons’. Within the buttons, the same molecular
connectors, platelet-endothelial cell adhesion molecule-1
(PECAM-1) and VE Cadherin, are found as in the blood vessels.
The spacing between the buttons is in the range of 3 mm (53).
Although not formally demonstrated, the resulting gaps would
be sufficient for DCs and lymphocytes to squeeze through
without using specialized mechanisms of intravasation. Such a
passive model would imply that lymphatic entry is only
determined by the chemokine cue that guides the cells into
the vessel. Lymphatic vessels express high levels of CCL21 (54),
which could result in a diffusive gradient that attracts the
leukocytes into the vessel. However, the mechanism of this
process is far from clear, as the continuous interstitial flux
would counteract a diffusive distribution of chemokine away
from the lymphatic vessel and would instead suck CCL21 into
the vessel. Recently, Swartz and colleagues (55, 56) suggested
an alternative model for chemotactic migration within the
dermis that was termed ‘autologous chemotaxis.’ Many cells
expressing CCR7 also express the ligand CCL19, which seems
paradox at first sight. However, within the interstitium, con-
vection will drag the secreted chemokine toward the lymph
vessel and thereby create a gradient that can then be followed
by the same cell. Autologous chemotaxis was demonstrated for
metastatic tumor cells moving into lymph vessels and also was
suggested as a driving force for DC migration into the
lymphatics (55, 56). Although this concept appears appealing,
it remains to be challenged in vivo by either testing if CCL19-
deficient DCs migrate less or, more importantly, showing that
even in the absence of CCL21 on lymphatic vessels DCs can
move directionally into the lymph vessels.
Transport within the lymphatic vessels
It is beyond doubt that transport within the lymphatic vessels is
the same for solutes and cells. It is a passive flowing with the
stream of interstitial fluid that is powered by the periodic
contractions of the lymphatic vessels. Cells and fluid are
pumped directly into the subcapsular sinus of the node (50).
Within the sinus, the sieving function of the LN starts. In the
following we describe anatomy and physiology of the LN, and
as in the previous section, we separately discuss the implica-
tions for the transport of solutes and the migration of cells.
The LN sinuses
Two anatomically distinct compartments of the LN are distin-
guished: the sinus and the cortex. Both consist of a stromal and
a hematopoietic component. The most simplified view of a LN
is that of an organ bathing within the lumen of a dilated
lymphatic vessel. The sinuses represent the remaining lumen of
the vessel, and the cortex represents the actual organ. Usually
LNs mark sites where lymph vessels coming from different
drainage areas meet, and therefore every LN has several afferent
but most times only one efferent lymph vessel. The entry side
of the LN that is close to the afferent vessels is called
subcapsular sinus, and the one close to the efferent vessel is
called the medullary sinus (57). As the sinus system surrounds
the whole LN, the subcapsular and medullary sinuses are
directly interconnected, and there is an open communication
between them. Hence, cells, fluid, and soluble molecules can
pass through the LN without contacting the cells of the cortex
(58). In larger LNs, there are also intermediate sinuses that
penetrate the parenchyma and constitute a direct route be-
tween afferent and efferent lymph (57, 59, 60). It has further
been described that the deep cortex harbors a lymphatic
labyrinth that is connected to the medullary sinus. These are
blind ending sinuses that likely collect emigrating lymphocytes
and lead them into the medulla (59, 60).
The subcapsular sinus is populated by different resident cell
types. The stromal cell of the sinus is the sinus reticular cell or
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retothelial cell (61–64). This cell type has morphological
similarities with the fibroblastic reticular cell (FRC) of the
T-cell area but is also carrying some typical surface markers of
the lymphatic endothelial cell lineage (65). The retothelial cells
constitute a three dimensional meshwork that is the backbone
of the sinus and bridges the LN capsule with the LN cortex (60,
66). The retothelial cells are assembled around an ECM scaffold
that appears different from the stroma of the periphery and
already shows features of the conduit structures of the T-cell
area. Bundles of fibrillar collagens transect the sinus and
connect the fibrous capsule of the LN with the ECM of the
conduits in the T-cell area (67). These collagen bundles are
partially surrounded by a basement membrane and are
completely enwrapped with stroma cells (59, 68–70). They
form a structure that resembles the conduit of the T-cell stroma.
Unlike in conduits, in the sinus the basement membrane is
discontinuous and rather resembles rings or spirals. At some
places where the basement membrane is more patchy, it takes
the configuration of buttons that are connecting the cells with
the interstitial matrix of the fibers (71). The functional
significance of this ECM assembly has not been investigated. It
appears likely that such a structure facilitates fluid drainage and
at the same time gives structural support. The discontinuous
nature of the basement membrane is also reminiscent of the
button-like cell–cell adhesions of the initial lymphatics, with
the exception that the retothelial cells build a three dimensional
sponge-like structure instead of the two-dimensional sieve
structure of the lymphatics. The interstitial matrix of the sinus is
not qualitatively different from the interstitium of the dermis – it
is just assembled in a more organized and condensed manner.
The same is the case for the retothelial cells that appear like a
condensed form of the dermal mesenchyme. While the dermal
fibroblasts are scattered within the interstitium as single cells, the
retothelial cells assemble a unique and complex type of cell–cell
junctions that have been termed puncta adherentia (62).
The connective tissue of the sinus is not only populated by
stroma cells, passaging lymphocytes, and DCs that wander
through the sinus in search of danger; there is also a resident
population of rather immobile subcapsular macrophages that
settle between the retothelial cells. They constitute a big part of
the cell mass of the sinus. It is unknown if subcapsular
macrophages couple to the retothelial cells, if they bind to the
ECM within the sinus, and if there are specific signals that
localize these cells to the sinus. Interestingly, the subcapsular
macrophages are not 100% restricted to the sinus but also leak
into the first 10–30 mm of the cortex, which might support
their function as antigen relays (72). The morphological details
of the intermediate and medullary sinuses and the lymphatic
labyrinth are poorly described. As there is a continuum
between the subcapsular and the medullary sinus, the stroma
of both areas has strong similarities. Additionally, the
medullary sinus harbors antibody-secreting plasma cells.
The configuration of the sinuses is extremely flexible in
inflammatory situations. It has been shown that during the
course of a local LN activation by peripheral inflammation, the
sinuses enlarge within hours and become more extended and
also ‘infiltrate the cortex.’ This expansion has been interpreted
as a consequence of proliferating lymphatic endothelial cells
that invade the cortex and possibly make influx from the
periphery more effective (73). However, how closely the
retothelial cells indeed are related to the lymphatic lineage and
if they respond to the same growth factors as lymphatic
endothelia deserves further investigation. It is also possible
that the stroma cell population within the sinus is not
homogenous and that a population of lymphatic endothelial
cells exists in parallel to the retothelial cells (Fig. 3).
A remarkable but rarely mentioned characteristic of the sinus
is that it lacks blood vessels, and oxygenation has to be
provided by the underlying cortex (60). Teleologically, a lack
of blood vessels makes sense when viewing the sinus as the first
level of particle filtration with large pore sizes. A direct
connection to the blood circulation would bring along a high
risk of hematogenic distribution of infectious particles.
Consequently, all blood vessels in the LN are shielded from the
permeable sinus and are embedded into the filtrating conduit
system of the FRC network.
Solute transport within the sinus
Soluble molecules, particles, and cells periodically arrive with
the pumping contractions of the lymphatic vessels. At pressure
peaks, lymphatic fluid is actively pushed into the subcapsular
sinus. Although direct measurements are lacking, intravital
microscopy data suggest that fluid transport within the sinus
is rather unrestricted (2). The hydraulic radius of the sinus is
likely very large and allows not only soluble molecules but also
particles and cells to float through the meshwork of resident
cells. The solute distribution within the sinus can therefore be
described as percolation: the resident cells are bathed within
the unrestricted stream of afferent lymph. As the sinus system
allows open communication between subcapsular and medul-
lary areas, solutes can take a shortcut from afferent to efferent
lymph. This route is preferentially taken by immunologically
inert particles and larger molecules that are excluded from the
cortex, as they do not have access to the conduit system of the
T-cell cortex and further to the blood circulation.
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The requirement for such a ‘bypass route’ becomes especially
evident in the intestine, where the lymph does not only play a
role in fluid drainage and immune surveillance but also
transports the absorbed nutrients. Chylomicrons are collected in
the initial lymphatic vessel of the villus (the lacteal), are
channeled through the mesenteric nodes, and are transported
via the thoracic duct into the blood circulation. Immunologically,
all particles that pass through the sinus are irrelevant; they are not
visible for DCs, T, or B cells if they are not trapped in the sinus.
Selective trapping of solutes contained within the percolating
lymph is achieved by the resident cells of the sinus. Both
retothelial cells and macrophages catch soluble antigens and
efficiently endocytose particles and microbes (29, 74).
Accordingly, macrophages but also retothelial cells carry a rich
surface repertoire of scavenger receptors (C-type lectins and
many others) (65, 75) that unspecifically immobilize various
microbial antigens. How the retothelial cells contribute to
immune responses after antigen trapping is unclear, while it has
been recently shown that subcapsular macrophages can ‘hand
over’ antigen and even whole virus particles to B cells through the
floor of the subcapsular sinus (76–78). Junt et al. (77)
demonstrated the important concept that the filtering capacity of
subcapsular macrophages serves both innate and adaptive
immune functions. First, it is essential to mount effective B-cell
responses to viruses that arrive with the interstitial fluid. Second,
it prevents the hematogenic spreading of the virus itself. When
subcapsular macrophages were depleted from the sinus, virus
passed the LNwithout accessing the parenchyma and recirculated
via the efferent lymph and the thoracic duct into the blood
circulation (77).
It is a widely ignored fact that an access route for small
molecules into the sinus exists that is independent of afferent
lymphatics. The interstitium of the sinus is directly connected
to the ECM that constitutes the fibrous capsule of the node. The
capsule consists of fibroblasts, their fibrillar collagen matrix,
and likely many other components of a normal interstitium.
Although the capsule encases and mechanically protects the LN,
it does not shield it from interstitial fluids that surround the
node. It was shown that tracers injected close to the node
distribute along the capsular ECM and directly drain into the
sinus and most likely also further into the conduit system of the
T-cell cortex. This means that the ECM of the capsule forms a
fluid exchange continuum with the ECM of the sinus and the
parenchyma (79).
Cell movement within the sinus
Although histologically most areas of the sinus appear rather
densely packed with cells, intravital microscopy studies showed
that spacing of cells and interstitium is (at least in some areas of
the sinus) obviously loose enough to allow free floating of single
cells (2). Especially during pressure peaks caused by the peristal-
tic compressions of the afferent lymphatic pump, round cells are
flushed through the sinus. However, other intravital microscopic
studies also showed active amoeboidmigration of DCs and T cells
within the sinus (80, 81). Hence, both active migration and
passive flowing occur in the sinus. Exit from the sinus has not
been studied intensively. One intravital microscopy study sug-
gested that the medullary sinus has preformed openings that
allow active exit from the medullary sinus into the efferent
lymphatics (82). Scanning electron microscopic studies favored
the lymphatic labyrinth that continuously connects to the
medullary sinus as the site of massive lymphocyte exit (59, 60).
It was shown by intravital microscopy that the sinus contains
a population of motile DCs that wander between the static
Subcapsular macrophage
Rethotelial cell
Microbial antigen
Inert particle (large)
Inert particle (small)
Fig. 3. Particle movement within the sinus. The LN capsule consists of
interstitial matrix (blue) that is continued within the sinus. Here, the
matrix is surrounded by retothelial cells (green). Subcapsular macro-
phages (orange) are associated with the retothelial cells. Large particles
percolate through the sinus and become trapped on macrophages and
retothelial cells if they are immunologically relevant (triangles) and pass
into the efferent lymph if they are inert (round dots). Small molecules can
enter from the capsule and the sinus into the conduits of the T-cell cortex
from where they access the blood.
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retothelial cells and macrophages (80). It has not been addressed
if these DCs are representing a specialized subset or if they are
dermal DCs and Langerhans cells in steady state transit from the
periphery toward the T-cell cortex. Independent of their origin,
it is likely that these DCs are foraging for antigen and danger
signals that are immobilized on the retothelial cells or
macrophages. Once they detect a target, they likely go through
their usual program: they transiently arrest and phagocytose,
subsequently become motile, and actively enter the T-cell cortex
to present the antigen.
The sinus–cortex interface
The floor of the sinus is demarcated by a basement membrane
that has direct connections with the conduit system of the
cortex. However, this basement membrane is not continuous
and gaps allow cellular traffic without the need for proteolytic
degradation. The stroma cell that is directly covering the floor
of the sinus has been termed, describing its position, the sinus-
lining cell. It has not been addressed if this cell is a morpho-
logical variant of the retothelial cell, a form of lymphatic
endothelial cell, or a separate specialized cell lineage.
Penetration of fluid and small molecules into
the parenchyma
Almost 50 years ago, tracer experiments demonstrated that
there is no free exchange of small molecules between the sinus
and the T-cell parenchyma (70). Although not widely acknowl-
edged in textbooks, these findings clearly argued against free
percolation being the principle of interstitial flux in the T-cell
area. In their seminal tracer studies, the laboratories of
Anderson and Shaw (58, 83) showed that rather than percolat-
ing through the parenchyma, small molecules are channeled
through the conduit system of the T-cell area. Interestingly,
molecules with a molecular weight above the size of albumin
(70 kDa) were excluded from the parenchyma and were
exclusively detectable within the sinus (58). Most large mole-
cules and particles eventually exit the node via the efferent
lymphatic vessel, without ever becoming immunologically
visible. The fraction of large molecules that is not bypassing
the T zone is trapped by retothelial cells or sinus macrophages
and further processed.
The communication between the sinuses and the T-cell
cortex is restricted for large soluble molecules and bigger
particles. Small molecules can enter the cortex but remain
confined to the conduit system instead of percolating between
the T cells. The morphological correlate of the size-selective
sinus-cortex barrier is not known. Below we put forward the
idea that a physical barrier is not required to explain the
exclusion of soluble molecules from the T-cell parenchyma
but that this is just a consequence of a lacking interstitium
between T cells.
Passage of cells through the sinus floor
Restricted movement of soluble molecules suggests that also
cellular trafficking between sinus and cortex is restricted.
However, this does not seem to be the case. It has been shown
by intravital microscopy that T cells can effortlessly glide into
the subcapsular sinus when exposed to artificial gradients of
chemokine (81). Observations of DCs penetrating the subcap-
sular sinus suggested the same: locomotion kinetics of cells at
the sinus cortex interface did not indicate that a barrier has to
be traversed (84). If the sinus lining cells are discontinuous, if
they ‘open the gate’ on demand, or if they are traversed
transcellularly is unknown. Taken together, active cellular
movement between sinus and cortex is possible while the
passive movement of solutes and particles is restricted. Mole-
cules, be it foreign antigens or endogenous factors dissolved
in the interstitial fluid, with a size below 70 kDa can enter the
T-cell cortex via the conduit. Larger molecules are excluded and
have to enter as cellular cargo on the surface or inside incoming
DCs or are relayed into the B-cell follicle by macrophages.
The T-cell cortex
The stromal backbone
The anatomy of the T-cell cortex is dominated by the densely
packed T cells that constitute more than 95% of the cellular
mass. The remaining space is occupied by resident DCs and the
T-cell stroma cells. The stroma is the infrastructure that dictates
shape and organization of the T zone. It is the only stable
component while T cells are in continuous motion to maintain
the high contact frequencies with DCs. The T-cell stroma is
condensed to a minimal volume and has an extremely unusual
appearance. It forms a filigrane three-dimensional network that
is highly interconnected via cell–cell contacts and structurally
resembles the skeleton of a sponge (67). The cells forming this
network are called FRCs, and the ECM they assemble has been
termed conduit, after its function to channel small molecules
through the cortex. The stromal endoskeleton of the LN is
therefore not only a structural backbone but also a complex
system of tubes that forms one continuously interconnected
fluid exchange system with physical connections to all sinuses
and all blood vessels.
The conduit
The conduit, varying in diameter from 200 nm to 3 mm,
contains all known types of ECM molecules from peripheral
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tissues, with the decisive distinction that they are assembled in
a highly ordered manner. The center of the conduit is formed
by parallel bundles of fibrillar collagens (I, III). Associated with
these bundles, depending on the size of the conduit, are the
typical collagen-associated stabilizing and crosslinking molecules
like fibromodulin, decorin, and lumican (our unpublished data).
The collagen fibers vary in number from 20 to 200 per cross-
section, and the individual thickness varies around 50nm (57,
85). They are not tightly packed. Transmission electron micro-
scopy studies demonstrated that an unordered meshwork of
5–10 nm fibrils, morphologically resembling microfibrils, fills
the space between the collagen fibers (86). The whole array of
collagen bundles is embedded in a coat of microfibrils. Accord-
ingly fibrillins, the molecular constituents of microfibrils have
been detected between and especially around the collagen fibers
(29). Although not been thoroughly investigated, it is most
likely that, as in the interstitium of the periphery, glycosamino-
glycans are filling the gaps between fibers and fibrils. In human
LNs, dermatan sulfate was detected in association with the
conduit ECM, but studies of other sugars are missing (87). The
fibrillar core is a cell-free compartment that is tightly enclosed by
a basement membrane that forms a cylindrical cover, giving the
conduit the ultrastructural appearance of a tube. The cell that
produces and settles on the basement membrane is the FRC. It
forms a cellular sleeve around the conduit by anchoring to the
basement membrane. The FRC continuously enwraps the con-
duit, and by forming intracellular cell–cell contacts, they seal the
conduit against the T-cell-containing parenchyma. Along the
longitudinal axis, the individual FRCs connect with intercellular
junctions (57). The exact nature of the cell–cell junctions
between the FRCs remains to be determined. Although more
than 95% of the conduit is covered with FRCs, gaps remain that
are covered by hematopoietic cells (29, 88, 89). These cells are
mainly resident DCs that are embedded in the FRC layer and
extend processes into the lumen of the conduit.
The conduit as a compacted interstitium
The conduit structure by itself appears rather unusual, as
basement membranes normally form two-dimensional sheets
that separate mesenchymal from epithelial compartments.
However, when envisaging the conduit core as a very con-
densed form of a conventional interstitium, the whole arrange-
ment appears more familiar and could be viewed as a
compacted and tiny version of the peripheral interstitium that
we described for the dermis. It is compacted to an extent that it
appears as a system of microchannels that are bordered by a
basement membrane. To appreciate the similarity between
peripheral interstitium, we suggest the following thought
experiment: imagine a vascularized mesenchymal tissue and
extend the luminal surface of the endothelium until the
interstitium almost disappears. The curvature of the endothelial
lumen eventually bends backwards, and the interendothelial
junctions reconnect without changing endothelial polarity. The
endothelial cells would now ‘internalize’ their own intersti-
tium, and by wrapping around the ECM, they will seal it against
the ‘luminal’ surface that is in contact with the hematopoietic
cells. Such a tissue would now resemble the T-cell cortex,
where the blood cells occupy the labyrinthine ‘lumen’ formed
by the FRCs, and the extravasacular space would be too tiny to
contain any cells. In such a view, the T-cell cortex would rather
be a specialized intravascular compartment than an extravascu-
lar space. In the T-cell cortex, FRCs take the function of both
interstitial fibroblasts and endothelial (or epithelial) cells. FRCs
clearly display features of epithelial and endothelial cells (apical
basal polarity, cell–cell junctions, an underlying basement
membrane, expression of cytokeratins) but also have character-
istics of a fibroblast with myofibroblastic features (production
of interstitial matrix, smooth muscle actin, expression of
desmin and vimentin) (57, 90, 91).
LN anatomy during development and inflammation
The FRC network is an extreme variant of stromal differentia-
tion that is already emerging in the sinus where a certain but
not as extensive condensation of stroma and ECM occurs. This
morphological continuity becomes obvious when looking at
large collagen bundles that branch off the fibrous capsule, cross
the subcapsular sinus (here they are loosely decorated with
basement membrane patches and covered with retothelial
cells), and enter the T-cell parenchyma, where they become
incorporated into the conduit network. The view of a con-
densed interstitium is also consistent with the ontogeny of the
FRC. During developmental and inflammatory lymphorgano-
genesis, FRCs are described as ‘organizer cells’ that are differ-
entiating in a mutual crosstalk with hematopoietic ‘inducer
cells’ that provide lymphotoxin signals. These lymphotoxin
signals drive the transformation process of undifferentiated
scattered mesenchymal cells into the FRC lineage (92, 93). The
origin of undifferentiated mesenchyme in adult tissues is
unclear, but the pericyte pool might be an interesting source.
The FRC differentiation, which goes along with the formation
of cell–cell junctions and polarization, resembles mesenchymal
condensations or mesenchymal epithelial transitions that are
well described in many other organogenetic processes like
bone formation or kidney development (94).
In terms of anatomical features, the T-cell area is rather
homogenous and does not show qualitatively distinct regions.
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A quantitatively distinguishable area has been termed ‘cortical
ridge.’ This is the T-cell area in close vicinity to the B-cell
follicles. The cortical ridge shows a high density of high
endothelial venules, and also the spacing of the reticular fibers
was described as more densely packed (95).
The T-cell area shows enormous plasticity. During acute
inflammation, LNs massively expand within hours, and the
number of lymphocytes in the node multiplies. Theoretically,
the sponge-like architecture of the T-zone stromawould allow for
a certain swelling without increasing the surface area of the FRC
network that could at the same time maintain structural integrity.
However, mechanical expansion does not seem to be the critical
factor, as it has been shown that during LN swelling the FRC
surface expands. Although quantitative data on FRC spacing
during LN expansion are lacking, qualitative data indicate that
the FRC network grows with the increasing number of
lymphocytes (96). It will be interesting to find out which
factors keep the FRC to T-cell ratio constant. One possibility is
that such a homeostatic balance might be regulated by factors that
also regulate organogenesis like lymphotoxins.
Solute transport within the T-cell zone: entry into
the conduit system
While in the periphery and in the sinus interstitial fluid and
particles percolate around the cells through the interstitial
space, the situation is radically different within the T zone.
Large molecules are completely excluded from the parenchy-
ma; they remain restricted to the sinus. Small molecules cannot
be detected between the T cells either, but they have access to
the conduit core. After subcutaneous injection, small molecular
weight tracer molecules exclusively locate within the conduits,
where they are sheltered from the T cells by the conduit
basement membrane and the FRC layer around it (29, 57,
87). The conduit system is not a blind ending network but is
highly connected with the capillaries and venules of the cortex
(67). The conduits drain their fluid into the bloodstream:
subcutaneously injected small molecules appear within the
lumen of the high endothelial venules within minutes, demon-
strating a shortcut between lymphatic fluid and blood at the
level of the first draining LN (58, 83).
What is the physiological mechanism behind this size
selective and directed transport? It has been proposed that
flow within the conduit is active, meaning that sinus-lining
cells at the sinus cortex interface (where the conduits start)
pump the interstitial fluid into the conduits in a size-selective
manner. Gretz et al. (57) suggested that a high transcytotic
activity of the sinus-lining cells might support this function.
However, it is entirely unclear how the conduit system could
actively maintain pressure gradients that promote directed
movement of fluid through such a complex and highly
interconnected meshwork. A theory of active transport would
also require an active exclusion mechanism that prevents entry
of solutes into the T zone and a resulting percolation between
the T cells. A recently published study showed that a small
molecular tracer quickly distributed from the subcapsular sinus
into the B-cell follicles, where it located diffusely between the
lymphocytes. Interestingly, within the T zone the tracer
distribution was restricted to the conduits (97). As there is
clearly no anatomical barrier between T and B zone, such
observations are difficult to include in a theory of active fluid
transport through the conduits.
We propose that solute distribution within the T zone is
a simple consequence of the biophysical characteristics of the
T-zone interstitium. Instead of postulating that solutes are
actively pushed into and confined within the conduit
compartment, we propose that the conduit is the only space
where interstitial fluid can distribute for reasons of hydraulic
conductivity. As mentioned above, the FRCs are highly
polarized, and on their apical side, they do not display or bind
any ECMmolecules (29). As T cells or DCs do not produce their
own ECM, the T-cell compartment does not contain any
interstitium that fills the intercellular space. This is a highly
unusual situation and means that T cells are shielded from any
ECM environment. Even the ‘fluid phase ECM’ of the blood, the
serum proteins, are absent as the interstitial fluid is exclusively
channeled through the conduit. This is indicated by tracer
experiments where soluble molecules below 10 kDa were not
visible between the T cells but restricted to the conduit (58).
Hence, T cells move within a ‘vacuum’ and are packed at
maximal density (98). As such, the T-cell compartment
resembles a cell pellet after centrifugation. It is likely that the
hematopoietic cells in the T zone are so tightly packed that they
almost slide along each other in a membrane to membrane
fashion, just separated by a layer of transmembrane proteins
and cell surface glycosaminoglycans (that remain to be
characterized in detail).
Although direct measurements of the hydraulic conductivity
within the T-cell area are missing, it is likely that both diffusion
and convection are extremely low between the T cells and that
all significant fluid movements happen in the porous
environment of the conduit core. Such a ‘passive’ view of the
conduit system also explains that tracers continuously disperse
from the LN capsule through the sinus into the conduit system.
The continuity of the interstitial matrix allows for a free
distribution within the interstitium, driven by Starling’s forces
that define the direction of flow.
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The simple model of the conduit as a compact version of the
dermal interstitium that is following the same physiological
rules also implies that the B-cell area is behaving fundamentally
differently, as it allows the free distribution of small soluble
molecules. In this context, it is interesting that B-cell follicles
show a diffuse staining for hyaluronic acid (our unpublished
data) and are positive for the ECM molecule vitronectin (99).
These findings open the possibility that B cells are surrounded
by an interstitium with larger hydraulic conductivity than the
T cells.
The driving force of solute distribution in the
conduit system
In most peripheral tissues, the capillary system is in a state of
continuous filtration, while the lymphatics absorb the filtered
fluid volume. The situation changes in tissues where fluid
enters via a separate route and creates a fluid excess. This is the
case for submucosal tissues, where fluid enters across the gut
epithelium, and for LNs, where interstitial fluid enters via the
sinus (19). In gut and LN, Starling’s forces result in an
interstitial flux toward efferent capillaries and venules and
cause a flow of fluid and small molecules into the blood
system. Hence, LNs are in a continuous state of fluid absorp-
tion, which is reflected by measurements that show that the
protein content of the afferent lymph is far below that of the
efferent lymph (100–104). It is likely that absorption in the LN
is as important for maintaining peripheral fluid homeostasis as
the recirculation of interstitial fluid via the thoracic duct.
Unfortunately, comparative measurements of the molecular
weight distribution of proteins within afferent and efferent
lymph are lacking. Such data would allow to quantitatively test
the 70 kDa size exclusion volume of the conduit. They might
be further of pharmacological importance, as the lymph-blood
shortcut at the level of the draining LN might be an important
route for how subcutaneously applied substances enter the
blood circulation. To understand the interstitial flow within the
conduit, we further require a more detailed view of its
molecular composition and biophysical properties. The extent
to which sugars carrying fixed charges are embedded within
the core region and the basement membrane will be required
to estimate its swelling force and the hydraulic conductivity.
It will be interesting also to test the conduit function during
altered physiological states like in the absence of afferent lymph
drainage and elevated venous pressure. Under homeostatic
conditions, the conduit system does not fill via the blood
system, but this might change upon alterations of hydrostatic
conditions. It has been shown that artificially increasing the
venous pressure not only leads to a higher peripheral filtration
rate of plasma but also causes dilution of the efferent lymph.
This steeper decrease in protein content of the afferent versus
the efferent lymph was due to decreased fluid absorption in the
draining LN (100). High venous pressures might even lead to
retrograde filling of the conduits via the blood. Studying the
fluid balance of LNs in detail would tell us if the conduit system
does indeed follow the rules of Starling or if active transport
mechanisms, like water transport via aquaporin channels that
are expressed in sinus-lining cells and LN endothelium (60),
play a role.
When reflecting the physiology of fluid transport in LNs, it
is interesting that the conduits of the spleen (105) and the
thymic medulla (our unpublished data) fill via the blood
system. In both cases, the conduits are solely connected to the
blood vessels and the organs have no additional supply via
lymphatics. Hence, these tissues should be in a state of
continuous apillary filtration which matches the direction of
interstitial flux within their conduits.
Small molecules and fluid are channeled through the conduit
system of the T-cell cortex and drain into the vasculature. If
access into the T-cell area is completely restricted and no solutes
leak into the parenchyma, then where does the filtration take
place and which sense does it make to channel all liquid
through the T-cell cortex? It was demonstrated that the cell
type that has best access to the content of the conduit is the
resident DC that extends processes through the FRC layer into
the lumen of the conduit (29, 30, 88, 106). Via this route, DCs
can sample the content of the interstitial fluid like any other DC
in the periphery can. Soluble antigens can be acquired and
presented but also extracellular signaling molecules produced
in the periphery can potentially be sensed. Via the conduit, the
resident DCs of the LNs are rapidly informed about the state of
the periphery. In other words, the soluble periphery is
continuously projected into the conduits, and resident DCs
can read out its condition. Immunologically, this principle is
most effective, as the only cell that has to collect environmental
information is the DC. T cells are not involved in ‘decision
making’; they just receive instructions from the DC (7). The
anatomy of the T zone guaranties that they are not exposed to
information they never need.
Functional implications of the conduit system
Even more enigmatic than these proximate aspects of conduit
mechanisms is the ultimate question concerning the adaptive
value of excluding large molecules from the conduit. We
propose that size exclusion is a universal and efficient way to
prevent that the lymph–blood shunt within the draining node
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is exploited by infectious agents. By depleting subcapsular
macrophages, Junt et al. (77) demonstrated that the filtering
function of the sinus is essential for preventing the spread of
virus particles via the blood circulation. In the absence of the
scavenger function of the macrophages, virus arriving with the
interstitial fluid quickly distributed via the thoracic duct into
the blood and became systemic (77). Especially in bigger
animals (and humans), many LNs are connected ‘in row’
(17), and it is likely that if virus is not cleared in the first node
it becomes trapped in one of the following. If the conduits
would not filter out large particles that have the potential to
replicate, the lymph–blood shortcut would support hemato-
genic distribution and therefore would be a fatal distribution
system for pathogens. In other words: as the LN blood vessels
absorb fluid, a LN interstitium without a size exclusion volume
would compromise the entire filtering concept of the LN.
We think that a larger exclusion size of the conduit would be
dangerous for the organism. But what would be the
consequence if the FRC network were to lack an interstitium,
if the conduits would not exist? Why are they useful? The
experiment to genetically eliminate the FRC interstitium has
not been done, so we have to rely on indirect evidence.
Immunologically, there seem to be two main functions of
conduits: distribution of soluble antigens and endogenous
signaling molecules toward resident DCs and information
relay from the periphery into the lumen of high endothelial
venules. In the absence of conduits, resident DCs would most
likely have no access to soluble antigens or cytokines produced
in the periphery – all the information would need to be
(slowly) carried in by infiltrating DCs. Although this sounds
like a dramatic change, it is far from clear what role soluble
molecules have for the course of T-cell immune responses.
Itano et al. (106) showed that soluble antigen presented on
resident DCs can elicit T-cell responses. However, these
responses were not sustained, and it is possible that they
rather act as initiators that have to be consolidated by later
incoming DCs. The only infectious model where immunity has
been shown to be mainly triggered by soluble antigen is
leishmaniasis (107). It remains to be shown how general such
processes are and if soluble antigens are as important for the
triggering of T-cell responses as they are for humoral
immunity. Current data suggested that for tolerance induction,
soluble antigens are not decisive, as maintaining tolerance is
completely dependent on CCR7-mediated steady state
migration of DCs (108). Much work has to be done on the
role of soluble antigen.
The conduits as an information distribution system for
resident DCs have not been addressed directly, and it would be
interesting to see how resident DCs react to soluble cytokines
or chemokines that arrive with the afferent lymph. Conduits as
information superhighways have been studied in another
context. It was demonstrated that chemokines produced in the
periphery are rapidly (within seconds) channeled with the
interstitial flux via the conduits into the lumen of high
endothelial venules (109, 110). Here, they became
immobilized to the luminal side of the endothelium, were
sensed by circulating lymphocytes, and modulated their entry
into the parenchyma. This system was interpreted as a remote
control of the LN by the peripheral tissue and completes the
picture of the LN as an immunological projection of the
periphery that can rapidly adapt to peripheral threats (110).
A completely neglected context in which conduits might
play a decisive role is fluid homeostasis. The fact that high
amounts of fluids are resorbed into the blood circulation
within the draining LN suggests that in the absence of
conduits, interstitial fluid would either recirculate entirely via
the efferent lymph and the thoracic duct or peripheral edema
would develop. Unfortunately, data on the thoracic duct
transport volume and the hydration state of peripheral tissues
in mice lacking LNs for genetic reasons are not available.
Cell migration within the T-cell cortex
The functions of the FRC network are not entirely connected
with the formation of conduits. As the only non-hematopoietic
cells of the T-cell cortex, the FRCs are also organizing the
migratory patterns of the blood cells. Cell migration patterns
within the T-cell cortex were subjects of intense investigation
during the last years, and many excellent reviews on this topic
are available (9, 11–13). Here, we focus on the direct role of
the stromal network for T-cell and DC migration. Although
Gretz et al. (57) predicted that the FRC network plays a decisive
role in guiding T cells through the LN, the reticular network
was long ignored by intravital microscopists studying the
swarming of T cells. The pathway taken by T cells was
described as a random walk, and the encounters with DCs were
regarded as random collisions (11, 57, 111). Bajenoff et al.
(112) demonstrated that the opposite is the case: they showed
that the routes of T-cell migration are not at all random but
rather deterministic, as they lead preferentially along the FRC
network. A theoretical model that tried to match experimental
data on T-cell movement came to the same conclusion (113).
By simultaneously visualizing T cells and FRCs in vivo, Bajenoff
et al. (112) showed that the migration tracks of most T cells
were aligned with the FRC scaffold. The migration direction of
the T cells on the tracks was random. Hence, the FRCs appear to
be an adhesive and chemokinetic surface that lack intrinsic
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directional information (112, 114). FRCs are the producers of
the homeostatic chemokines CCL19 and CCL21 that bind to the
chemokine receptor CCR7 that is expressed on naive T cells
(54, 115, 116). Both chemokines trigger and maintain the
motile state of T cells and are essential for their swarming
behavior. As CCL21 immobilizes to the FRC network, it is
possible that the FRC network forms a chemokinetic surface
that keeps the T cells dynamic and at the same time restricts
their migration to the T-cell area. Such a system of chemoki-
netic surfaces has the attractive potential to generate high
migration dynamics within sharp boundaries. In an indepen-
dent study, the Germain laboratory (117) proved another
important principle: cytotoxic T cells are able to respond
quickly and flexibly to chemokines that are locally released by
a successfully interacting pair of DC and helper T cell. Single
cell tracking in vivo revealed that cytotoxic T cells actively
chemotax toward the signal source (117). This finding means
that the chemokinetic principle of swarming can be locally
overcome by gradients that steer cells in a certain direction. If
this directional migration is still guided along the FRC network
or if T cells become autonomous from the chemokinetic
scaffold once they follow soluble gradients is unknown. Many
issues have to be resolved until a cell biological model of
migration within the cortex will be available. Determining the
role of soluble versus immobilized chemokines is one, while
the question how T cells adhere to the FRC surface is another. It
is also unclear how FRCs exactly handle the chemokines they
produce. Interestingly, most of the CCL21 in the LN associates
with the basement membrane of the conduit, where it likely
immobilizes to the heparan sulfate residues (our unpublished
data). Can the FRCs actively shuttle chemokine onto their apical
surface where the T cells can sense it, and could such a step be
flexibly regulated?
It is likely that DC migration within the cortex follows in
principle similar rules: the population of resident DCs is
partially embedded into the FRC layer, and it was shown also
that antigen-carrying DCs immigrating from the periphery
become incorporated into these networks (80). Like naive
T cells, immigrating DCs respond primarily to CCR7 ligands
(31). How the resident DCs couple to the FRC network is
unknown, but it is most likely that they use cell surface
receptors to interact with conduit and FRCs. One study
showed that the DC population most tightly associated with
conduits expresses high levels of a collagen-binding integrin
(118). Importantly, migration along the FRC tracks leads the
T cells directly into the DC networks and is therefore an ideal
strategy to maximize encounters. However, testing the importance
of these optimization strategies will require immunological
methods that challenge the detection limit of the adaptive
immune system. Most of the common manipulations work with
high doses of antigen and high frequencies of (transgenic) T cells
that easily find each other, even in the absence of sophisticated
guidance systems.
The functional unit of the T zone
We reviewed the anatomical and physiological features of a LN
that define its function as a filter for soluble molecules and as an
organizer of cellular encounters. We described in detail how
the conduit, its FRC sleeve, the DCs embedded between the
FRCs and the T cells gliding along the FRC surface form the
functional unit of the T-cell zone. This functional unit is the
Dendritic cell
Fibroblastic reticular cell
T cell
Basement membrane
Interstitial matrix CONDUIT
Fig. 4. Functional unit of the T-cell cortex. Upper schematic: the T-cell
cortex is packed with T cells (gray) and dendritic cells (orange) and is
interspersed with FRCs (green) that contain interstitial matrix in their
lumen and connect with the blood vessels (red). Lower schematic: FRCs
enwrap the conduit that consists of interstitial matrix and a surrounding
basement membrane (brown). DCs associate with the FRCs and extend
processes into the conduit lumen that can take up small molecules that are
flushed through the conduit toward the blood vessels. T cells move on the
surface of the FRCs and collide with the DCs.
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essential environment that supports the principle of the
adaptive immune system, where rare cell–cell encounters have
to be selected. Accordingly, the functional unit characterizes
not only all secondary lymphatic organs but it forms almost
everywhere in the sustained presence of lymphocytes. Likely
driven by cell surface lymphotoxin, the mesenchymal conden-
sation is triggered that ultimately leads to the assembly of
conduits, FRC networks, embedded DCs, and swarming T cells
that are searching their cognate antigen. Accordingly, conduit-
like structures are not only found in secondary but also in
tertiary lymphatic organs and even in chronically inflamed
areas like the perivascular space and the parenchyma of brains
of multiple sclerosis patients (119, 120) (Fig. 4).
Conclusion
Although LNs gained much attention during the last years of
intense dynamic imaging, they are still frequently viewed as
simple containers for swarming and interacting blood cells.
However, they are much more, and it is beyond doubt that the
LN’s complex stromal infrastructure is absolutely essential for
organizing the dynamic state of order required for the high
encounter rates between innate and adaptive immune cells. We
are still far away from an integrated physiological concept of
lymph nodes as the filter stations of the interstitium. It will be
necessary to collect basic physiological data on LN fluid home-
ostasis under normal and inflammatory conditions and inte-
grate them into the concept of adaptive immune priming.
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ARTICLES
Rapid leukocyte migration by integrin-
independent flowing and squeezing
Tim La¨mmermann1, Bernhard L. Bader3, Susan J. Monkley4, TimWorbs5, Roland Wedlich-So¨ldner2, Karin Hirsch1,
Markus Keller3, Reinhold Fo¨rster5, David R. Critchley4, Reinhard Fa¨ssler1 & Michael Sixt1
All metazoan cells carry transmembrane receptors of the integrin family, which couple the contractile force of the
actomyosin cytoskeleton to the extracellular environment. In agreement with this principle, rapidlymigrating leukocytes use
integrin-mediated adhesion when moving over two-dimensional surfaces. As migration on two-dimensional substrates
naturally overemphasizes the role of adhesion, the contribution of integrins during three-dimensional movement of
leukocytes within tissues has remained controversial.We studied the interplay between adhesive, contractile and protrusive
forces during interstitial leukocyte chemotaxis in vivo and in vitro. We ablated all integrin heterodimers from murine
leukocytes, and show here that functional integrins do not contribute to migration in three-dimensional environments.
Instead, these cells migrate by the sole force of actin-network expansion, which promotes protrusive flowing of the leading
edge. Myosin II-dependent contraction is only required on passage through narrow gaps, where a squeezing contraction of
the trailing edge propels the rigid nucleus.
The current model ofmetazoan cell migration is frequently described
as a multistep cycle: F-actin polymerization at the cell front pushes
out a membrane protrusion that subsequently becomes anchored to
an extracellular substrate by transmembrane receptors of the integrin
family. Integrins are dynamically coupled to the cytoskeleton and
transduce the internal force that is generated when myosin II con-
tracts the actin network. Contraction imposes retrograde pulling
forces on the integrins, which in turn facilitates forward locomotion
of the cell body1–3. The mammalian integrin family consists of 24
different functional heterodimers with individual binding specifici-
ties for cellular and extracellular ligands4. The integrin repertoire of
each cell type defines which substrate it can use for this ‘haptokinetic’
(adhesion driven)mode ofmigration. Such intimate linkage between
substrate-specific adhesion and migration restricts the migrating
cells to preformed pathways, and thereby creates the determinism
that is essential formany of the precise cell trafficking and positioning
processes underlying compartmentalization and patterning during
development and regeneration. As all mammalian cells with the
exception of erythrocytes carry integrins on their surface, it is rea-
sonable to assume that haptokinesis is a universal phenomenon4,5.
Leukocytes are outstanding cells, as they are scattered throughout
the body and have the potential to infiltrate any type of tissue. Rather
than following exact routes and being restricted to specific compart-
ments, leukocytes frequently undergo stochastic swarming with single
cell migration velocities that are up to 100 times faster than mesench-
ymal and epithelial cell types6,7. What makes leukocytes so quick and
flexible? In contrast to slow cells, migrating leukocytes undergo fre-
quent shape changes and were therefore morphologically described as
‘‘amoeboid’’8. How these shape changes relate to actual locomotion is
poorly investigated, and it is currently unknown if amoeboid migra-
tion represents a specialized strategy or just an accelerated variant of
the above introduced migration paradigm that is only well established
for slow cells. We therefore studied the inter-dependency of adhesion,
protrusion and contraction in inflammatory cells. We demonstrate
that integrin-mediated adhesion is only necessary to overcome tissue
barriers like the endothelial layer, while interstitial migration is auto-
nomous from the molecular composition of the extracellular environ-
ment. Such adhesion-independent migration is driven by protrusive
flowing of the anterior actin network of the cell and supported by
squeezing actomyosin contractions of the trailing edge to propel the
rigid nucleus through narrow spaces.
Dendritic cells migrate without integrins
As a model system to study interstitial leukocyte migration in vivo, we
focused on dendritic cells (DCs), phagocytes that reside within peri-
pheral tissues such as skin. They become activated upon wounding or
infection, sample antigens and quickly migrate via the afferent lymph-
atic vessels into the draining lymph node where they act as antigen
presenting cells9. DCmigration is primarily guided by the two chemo-
kines CCL19 and CCL21; these are expressed in lymphatic endothe-
lium and the lymph nodes’ T-cell area, and bind the CC-chemokine
receptor 7 (CCR7), which is upregulated on DCs upon activation10.
Flow cytometric analysis of DCs generated from mouse bone-
marrow-derived stem cells revealed expression of the b1, b2, b7 and
av integrin families (Fig. 1a). To investigate the role integrins play in
DC migration in vivo, we used a combinatorial mouse genetics
approach to delete all integrin heterodimers from the surface of
DCs, thereby generating phenotypically normal pan-integrin-
deficient (integrin2/2) DCs (Fig. 1a, see Supplementary Material,
Methods, and Supplementary Figs 1, 2, 4c). We co-injected 1:1 mix-
tures of differentially labelled integrin2/2 and wild-type DCs into the
dermis of mouse footpads and quantified their arrival in T-cell areas
of the draining lymph nodes. Surprisingly, wild-type and integrin2/2
DCs arrived and localized in the T-cell area in an indistinguishable
manner (Fig. 1b, c, Supplementary Fig. 3), whereas CCR72/2 DCs,
which cannot interpret the directional information, failed to enter
the lymph node (Fig. 1c) as previously described10. We next targeted
integrin functionality indirectly by deleting the talin1 gene in DCs
1Department ofMolecularMedicine, 2Junior Research Group Cellular Dynamics and Cell Patterning, Max Planck Institute of Biochemistry, 82152Martinsried, Germany. 3Department
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(Supplementary Fig. 4a). The interaction of talin1 with integrin
cytoplasmic domains is required for integrin activation, ligand bind-
ing and coupling of F-actin to adhesion sites11. Accordingly, talin1
gene ablation in DCs did not affect the levels of integrin expression,
but completely abolished their ability to bind ligands (Supple-
mentary Fig. 4b–d). Again, arrival of talin12/2 DCs in lymph nodes
did not significantly differ from wild-type DCs (Fig. 1c).
To allow for a detailed comparison of the cellular dynamics of
wild-type and integrin2/2 DCs within the different physiological
environments of their migration route, we employed two in situ
imaging approaches (Fig. 2). Representing the starting point of DC
migration, the interstitial space of the dermis is dominated by fibrillar
arrays of collagen bundles12. Using a newly developed set-up of ex vivo
live cell imaging within explanted ear dermis, we could directly visu-
alize DCsmoving towards and entering the afferent lymphatic vessels
by wide-field microscopy (Fig. 2b, c, Supplementary Fig. 5). Single
cell tracking revealed no difference in the migratory behaviour of
wild-type, integrin2/2 and talin12/2 DCs (Fig. 2c, d).
The lymphnode constitutes a fundamentally different environment
for cellular migration, as it contains almost no freely accessible extra-
cellular matrixmolecules but is densely packed with lymphocytes and
stroma cells13,14. To analyse the dynamics of intranodal DCmigration
from the subcapsular sinus towards the T-cell area, we employed a
set-up of intravital two-photon microscopy of the popliteal lymph
nodes15. Evaluating a range of motility parameters, including cell
velocity, directional persistence, mean square displacement, motility
coefficients andmorphology, we found that themovement behaviour
of wild-type and integrin2/2 DCs was indistinguishable (Fig. 2e, f,
Supplementary Videos 1–3, data not shown).
2D but not 3D migration is integrin-dependent
On their way into the lymph node, DCs do not cross significant tissue
barriers, such as continuous endothelial or epithelial linings12. As
these processes have been shown to be integrin-dependent16, we also
tested for extravasation of integrin2/2 leukocytes from the blood
stream into the inflamed dermis, and found that it was indeed abo-
lished (Fig. 2g, Supplementary Fig. 6). This finding corroborates the
extravasation model in which integrin-mediated tight immobiliza-
tion of leukocytes to the luminal endothelial surface is necessary to
counteract the shear forces imposed by the blood flow16. In line with
this in vivo finding, we found that integrin2/2 DCs were entirely
unable to adhere to andmigrate on two-dimensional (2D) substrates.
Gravity was obviously not sufficient to confine the non-adherent cells
to planar surfaces and allow the transduction of traction forces
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a, Flow cytometric analysis of integrin subunits of wild-type (WT) and
integrin-deficient (Itg2/2) dendritic cells (DCs) (integrin, unshaded; isotype
control, grey-shaded). b, c, In vivo migration of DCs after subcutaneous
injection into hind footpads of WT mice. At the time points indicated,
arrival of differentially labelled DCs in the lymph node was analysed.
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c, Quantitative histology. Dotted line at 0.5, 50% of DCs that migrated into
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(Fig. 3a, b, Supplementary Fig. 4d, Supplementary Video 4). We
conclude that extravasation requires integrin-mediated adhesion.
To better mimic the interstitial microenvironment, we established
chemotaxis assays within artificial three-dimensional (3D) matrices
of fibrin (a ligand for b2 and b3 integrins) and collagen I (a ligand for
several members of the b1 integrin subfamily). In this system, DCs
persistently migrated along soluble gradients of CCL19 and showed
amoeboid morphology and velocities that were comparable to our
(and previously published17) in vivo observations. In agreement with
our in vivo data and in contrast to 2D migration, integrin2/2 and
talin12/2 DCs migrated with speed and directional persistence that
were indistinguishable from wild-type cells (Fig. 3c, Supplementary
Fig. 7a, Supplementary Video 5). We also observed integrin-
independent migration for chemotaxing B cells and granulocytes,
suggesting a broader prevalence of this functional principle (Fig. 3d,
Supplementary Fig. 7b).
Functional dissociation of front and back
To mechanistically understand how cells can move in the absence of
integrin-mediated traction forces, we compared the integrin-
dependent movement pattern of fibroblasts with that of leukocytes
and found a striking difference. Leading edge protrusions of
fibroblasts translocated collagen fibres towards the cell body, indi-
cating the presence of rearward pulling forces and demonstrating
that protrusion, adhesion and contraction are tightly coupled in this
cell type (Supplementary Video 6)18,19. In contrast, chemotaxing DCs
protruded without signs of anterior pulling forces while the trailing
edge displayed an irregularly alternating contractile pattern. Con-
traction was characterized by shrinkage of the cell rear with con-
comitant forward-streaming of cytoplasmic matter (Supplementary
Video 7). When we dynamically visualized activated myosin II, the
motor system mediating contraction1,2,20, by time-lapse imaging of
DCs expressing a myosin light chain–GFP fusion protein, we found
accumulation at the cell rear during contractile phases (Fig. 4a,
Supplementary Fig. 8a, Supplementary Video 8). During non-
contractile phases, the trailing edge remained motionless and
appeared to be passively dragged by the protruding cell front
(Supplementary Video 7). These observations suggest that in
contrast to slow moving cells, protrusion and contraction are
spatio-temporally dissociated in leukocytes.
Receptor-mediated force transduction can only support forward
movement if retrograde (contractile) but not anterograde (protrus-
ive) forces are coupled to the environment2,3. To address how
actomyosin contraction functionally contributes to leukocyte loco-
motion, we pharmacologically inhibited myosin II or its upstream-
activator, Rho kinase. Irrespective of the presence of integrin
function, either treatment severely reduced migration speeds of
DCs, granulocytes and B cells (Fig. 4b, Supplementary Fig. 8e, data
not shown). Nevertheless, the chemotactic gradient was still able to
polarize the cell population. The leading edges of cells remained
dynamic and protruded with normal speed towards the chemokine
source. However, the cells were unable to move their trailing edges
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(Fig. 4b–e, Supplementary Fig. 8b–d, Supplementary Video 9). This
functional dissociation between front and back caused up to 30-fold
cell elongation, and demonstrates that the leading edge migrates
autonomously and without a need for receptor-mediated coupling
of contractile forces to the extracellular matrix.
Trailing edge contraction propels the nucleus
How does trailing edge contraction contribute to cell body loco-
motion? In fibroblasts and leukocytes moving on 2D substrates,
actomyosin contraction at the back is required to disassemble recep-
tor binding-sites and subsequently retract the membrane2,21,22.
Hence, blocking contraction causes membrane tethers at the trailing
edge. Consistent with an adhesion-independent migration mode, we
could not observe membrane tethers in myosin II-inhibited leuko-
cytes migrating in 3D gels. We considered that the elongated pheno-
type with its rounded back was caused by the inability to move an
internal resistance through narrow gaps within the gel. As the nucleus
is the least elastic cellular compartment23, we visualized DNA within
chemotaxing DCs and granulocytes. In untreated cells, we observed
continuous shape changes of nuclei, indicating deformation forces,
while upon myosin II inhibition, spherical nuclei were immobilized
at the rear ends of the cells (Figs 4d, e, Supplementary Fig. 8b–d,
Supplementary Videos 10, 11).
Protrusion drives basal locomotion
Although ‘locked’ nuclei caused migration arrest in most cells, a few
still showed locomotion. This residual migration was often charac-
terized by cell body elongation and dragging of the nucleus (Fig. 5a,
Supplementary Video 12). Such non-contractile movement was in
line with our previous observations showing motile phases in the
absence of trailing edge contractions. We hypothesized that such
myosin II-independent migration might occur in areas of the col-
lagen gel where external resistance was low due to increased spacing
of the collagen fibres. To establish the relationship between internal
contractile force and external resistance, we analysed DC chemotaxis
in collagen gels of varying fibre spacing (Fig. 5b). In all collagen
densities, myosin II-inhibited DCs were slower than untreated cells
but importantly, they ‘caught up’ at lowest gel densities (Fig. 5b,
Supplementary Video 13). A comparison of instantaneous velocities
further showed that myosin II inhibition did not prevent DCs from
reaching the same peak values as untreated cells (Supplementary
Fig. 9a–c).
We conclude that, in contrast to the ‘blebbing’ model of amoeboid
cell migration24, cortical actin network contraction does not mediate
locomotion itself but rather facilitates a protrusive mode of migra-
tion in confined environments where protrusion alone is unable to
act against counter-forces. So in constricted areas, the cell overcomes
internal and external resistance (rigidity of the nucleus and fibre
density) by contraction (myosin II). Contractile force deforms the
resistance and facilitates a purely protrusive mode of migration.
To challenge the concept of protrusive movement, we treated che-
motaxing DCs with latrunculin B, which interferes with actin poly-
merization by depleting the pool of available functional G-actin
monomers25. We found that this treatment reduced cell migration
velocity in a dose-dependent manner (Fig. 5c). At intermediate con-
centrations, the trailing edge remained contractile and the nucleus
was ‘pushed’ to the cell front (Fig. 5d, Supplementary Video 14).
Consistent with a model where protrusion determines the speed of
cell migration while contraction is only activated to overcome
external resistances, the speed reduction of latrunculin B-treated cells
was independent of gel density (Fig. 5b, c).
Discussion
We show that leukocytes migrate in the absence of specific adhesive
interactions with the extracellular environment. This subversion of
the metazoan principle makes them autonomous from the tissue
context, and allows them to quickly and flexibly navigate through
any organ without adaptations to alternating extracellular ligands.
This strategy is in stark contrast to the haptokinetic migration prin-
ciple that leads along preformed pathways and therefore promotes
deterministic positioning. Adhesion independency better suits stoch-
astic movement or chemotaxis where cells randomly migrate or fol-
low soluble cues. Astonishingly, the protrusive flow of F-actin
appears sufficient to drive rapid leukocyte locomotion in environ-
ments with large pore-size. This resembles the locomotion principle
of nematode sperm cells that is entirely driven by treadmilling poly-
mers of major sperm protein26. Only in narrow areas do leukocytes
activate the contractile module to squeeze and propel the internal
resistance of the nucleus in a manner resembling neuronal
nucleokinesis27. This ‘flowing and squeezing’ migration model
fulfils a central requirement for immune cell movement: the pericel-
lular environment is transiently deformed but never digested28 or
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otherwise permanently remodelled which avoids ‘collateral damage’,
caused by infiltrating cells.
The fact that leukocytes are able to move autonomously generates
a new level of regulatory possibilities. Because surface bound chemo-
kines and other immobilized extracellular signals do trigger integrin
affinity16 (unlike soluble chemokines), leukocyte integrins should no
longer be viewed as force transducers during locomotion but as
switchable immobilizing anchors that stop, slow down or confine
high intrinsic motility to specifically assigned surfaces29,30. The role
of integrins is therefore mostly to mediate retention, invasion, cell–
cell communication and cell–cell adhesion31.
METHODS SUMMARY
Generation of integrin-deficient leukocytes. Integrins and talin1 were targeted
by generatingmice with the genotype av
flox/flox (Supplementary Fig. 1), b1
flox/flox
(ref. 32), b2
2/2 (ref. 33), b7
2/2 (ref. 34), Mx1Cre1/2 (ref. 35) and talin1flox/flox
(ref. 36), Mx1Cre1/2, respectively. Cre expression in the haematopoietic system
was induced by intraperitoneal injection of 250mg Poly (I)?Poly (C) (Amersham
Biosciences). 10–14 d after knockout induction DCs were generated from bone
marrow suspension andmaturedwith lipopolysaccharide (LPS). TheDC culture
was depleted for granulocytes and remaining integrin-positive contaminants by
magnetic sorting (Miltenyi Biotech). DCs used for migration assays were.99%
enriched for b1 and av integrin knockout cells.
In situ live cell imaging. For dermal ex vivo microscopy, mouse ears were
mechanically separated in dorsal and ventral halves, fluorescently stained with
LYVE-1 antibody and immobilized with the epidermal side down. The dermis
was overlaid with fluorescently labelled DCs and time lapse movies were
recorded with an automated Leica MZ 16 FA stereomicroscope (Visitron
Systems).
In vitro 3D chemotaxis assays.Cells were suspended in PureCol (INAMED) and
cast in custom built migration chambers (standard collagen concentration:
1.6mgml21). After polymerization, gels were overlaid with culture medium
containing the chemoattractant (CCL19, C5a and CXCL13 for DCs, granulo-
cytes and B cells, respectively) and subsequently imaged using wide-field fluor-
escence video microscopes with differential interference contrast (Zeiss). For
nucleus visualization, SYTO-dyes (Invitrogen) were used. For visualization of
myosin light chain, DCs were nucleofected using Amaxa technology. Inhibitors
were titrated and used 50mm blebbistatin (Sigma) and 30 mm Y27632
(Calbiochem).
Statistical analysis. t-tests and analysis of variance (ANOVA) were performed
after data were confirmed to fulfil the criteria of normal distribution and equal
variance, otherwise Kruskal–Wallis tests or Mann–Whitney U-tests were
applied. If overall ANOVA or Kruskal–Wallis tests were significant, we per-
formed a post hoc test. Analyses were performed with Sigma Stat 2.03. For
further statistical details, see Supplementary Table.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Generation of integrinav
1/floxmice.To generate a conditional floxedav allele, a
targeting vector spanning 8.2 kb of the murine av integrin locus
37 was con-
structed. First, the 2.2 kb genomic subclone pXB2.2 encoding the 59 upstream
region, exon 1 and part of the intron 1 of the av gene was used to introduce two
loxP-sites. The 59-loxP1-site including an EcoRI-restriction site to facilitate
the identification of the targeted locus was cloned into the HindIII-site in the
59-upstream region (nucleotide position, nt-pos., –310) of the av gene. The
39-loxP2-site was introduced into the BamHI-site in intron 1 (nt-pos. 1528).
The genomic subclone pBS6 harbouring this BamHI-site at its 59-end and
,6 kb 39-downstream intron 1 sequences was used to clone a pgk-neo;pgk-tk-
tandem gene selection-cassette (neoTK) flanked by two frt-sites (provided by
G. R. Martin) into the BamHI-site. These two modified genomic regions of the
av gene were then fused at the corresponding BamHI-site to obtain the av gene
targeting vector. ES cell transfection, selection and screening was carried out as
described37 except that R1 ES cells38 were used. Homologously targeted clones
were identified by Southern blotting of EcoRI- or BamHI-digestedDNAwith 59-
or 39-external probes A or B, respectively. To excise the neoTK selection cassette,
targeted ES cells (flneoTK) were transiently transfected with the CAGGS-FLPe-
expression construct39 (provided by A. F. Stewart) and counterselected with
ganciclovir. Loss of the selection cassette in the av floxed allele was then con-
firmed by Southern blotting. ES cell clones were injected into blastocysts of
C57Bl/6 mice, and resulting germline transmitting male chimaeras were mated
to C57Bl/6 females to generate heterozygous floxed av mice and wild-type F1
mice following protocols as described37. Two independent lines carrying the
av
1/flox allele were established and initially maintained on a 129SV/C57BL/6
mixed background. av
1/flox and av
flox/flox mice show no obvious phenotype.
Southern blot and PCR analyses: wild-type and mutant av alleles were assessed
by Southern blot hybridization and/or PCR from DNA isolated from ES cells,
mouse tail biopsies or from yolk sacs of embryos as described37. In brief, 10 mg of
genomic DNA was digested with EcoRI or BamHI and analysed using radio-
labelled 59-external probe A (419 bp-EcoRI/XbaI DNA-fragment) or a 39-
external probe B (690 bp-SphI/EcoRI DNA-fragment), respectively (see
Supplementary Fig. 1). Genomic DNA digested with EcoRI was used to confirm
the presence or absence of the selection cassette with probe C encoding a 800 bp-
PstI fragment of the neomycin-resistance gene. For genotyping wild-type (WT,
1) and floxed av allele (flox) as well as the cre-mediated knockout allele (av
Dex1),
PCR amplifications with genomic DNA and the specific primer set (see below)
were performed. The positions of the primers are located in close vicinity to the
loxP-sites. PCR amplifications using Taq-polymerase and standard reaction
buffer adjusted to a final concentration of 1mM MgCl2 were carried out as
follows. PCR samples were initially denatured at 94 uC for 3min, followed by
35 cycles of amplification (94 uC for 1min, 60 uC for 2min, 72 uC for 3min), and
a final 10min extension at 72 uC followed. PCR amplification products were
separated through agarose gel electrophoresis. The allele-specific primer
sequences, pairs and orientation (forward, Fw; reverse, Rev), the primer pairs
and their corresponding PCR-product sizes are as follows: Primer-set (F30: 59-
AGGATGGAAGGGGAGGGAAATG-39 (Fw; WT), F20: 59-CTTGACCGCAA-
GCGCACAGCACAG-39 (Fw; WT), I2: 59-CTGGATGCTGAGTGTCAGGT-39
(Rev; WT)), PCR products (F20/I2: 499 bp (wild-type av allele, WT); F20/I2:
614 bp (floxed av allele, av
flox); F30/I2: 339 bp (cre-mediated av knockout allele,
av
Dex1)).
Mouse strains.Micewith constitutive deletions of integrinb7, integrinb2, CCR7
and conditional b1
flox/flox mice were described10,32–34. All mice were kept on a
mixed 129SV/C57BL/6 genetic background. The integrin targeted strains were
inter-crossed with Mx1Cre transgenic mice to generate av
flox/flox, b1
flox/flox,
b2
2/2, b7
2/2, Mx1Cre1/2 animals. Talin1flox/flox mice36 were crossed with
Mx1Cre transgenic mice to obtain talin1flox/flox, Mx1Cre1/2 mice. All control
animals were on a mixed 129SV/C57BL/6 genetic background. The mice were
bred in a conventional animal facility at the Max Planck Institute of
Biochemistry, and according to the local regulations.
Induction of the haematopoietic knockout. At an age between 8 and 12weeks,
mice of the desired genotype received a single intraperitoneal injection of 250mg
Poly (I)?Poly (C) (AmershamBiosciences), diluted in 0.5ml phosphate buffered
saline (PBS). Mice were killed 10–14 d after injection and knockout efficiency of
haematopoietic precursors was estimated by flow cytometric analysis of
peripheral blood platelets40. Bone marrow (BM) of mice with .85% integrin
b1-negative platelets was processed for dendritic cell (DC) culture or cell isola-
tion. Platelet knockout efficiencies usually correspondedwith knockout efficien-
cies of DCs and granulocytes, whereas peripheral B cells frequently showed lower
efficiency.
Cell generation, separation and purification.DCs were generated from flushed
BM suspension as described previously41. At day 8–10 of culture, 200 ngml21
LPS (Sigma-Aldrich; E. coli 0127:B8) was added overnight and the pan-integrin-
deleted DCs were subsequently depleted of remaining Gr-11 and integrin b1
1
contaminants. For depletion, cells were incubated with biotinylated antibodies
against Gr-1 (RB6-8C5) and integrin b1 (Ha2/5) (both BD Pharmingen), fol-
lowed by streptavidin-microbead separation according to the manufacturers
protocol (Miltenyi Biotech). The negatively selected DCs used for migration
assays were.99% enriched for b1 integrin knockout cells and b1-deficient cells
were always 100% deleted for integrin av. After enrichment the cells are referred
to as integrin2/2DCs. Talin12/2DCswere generated identically and depleted of
Gr-11 contaminants. To determine knockout efficiencies, DC lysates were
loaded on 12–15% gradient gels for electrophoresis under reduced conditions
and western blotting. Talin was detected with mouse anti-pan-talin antibody
(T3287, Sigma), and the loading control was performed with rabbit anti-mouse
actin antibody (A2066, Sigma). Integrin b1 was detected with the rabbit poly-
clonal anti-integrin b1 antibody 1244
42. Integrin av was detected with a rabbit
polyclonal anti-integrin av antibody (Chemicon). Bound primary antibodies
were detected with anti-mouse or anti-rabbit horse radish peroxidase (HRP)
or anti-rabbit HRP (both Bio-Rad) as secondary antibodies, respectively. DCs
with no detectable talin stain were chosen for experiments, guaranteeing that the
cells were deleted for talin1 and that talin2was neither expressed nor induced as a
compensation mechanism in DCs. Granulocytes were isolated by staining whole
bone marrow suspension with anti-Gr-1 PE or anti-Gr-1 PE/anti-b1 FITC and
subsequent fluorescent activated cell sorting using a FACSAria (BDBiosciences),
revealing .96% purity. Before incorporation into the gels, granulocytes were
treated for 30minwith 20 ngml21 TNF-a (Roche) at 37 uC. B lymphoblasts were
generated by mincing spleens through a 70 mm nylon cell strainer (BD
Pharmingen), lysing erythrocytes with ACK lysis buffer (0.15M NH4Cl, 1mM
KHCO3, and 0.1mM EDTA), and subsequent magnetic cell sorting (MACS)
with mouse CD43MicroBeads on LS columns (Miltenyi). The negatively sorted
B cells were stimulated with 10 mgml21 LPS (Sigma) for 72 h at 37 uC, 5% CO2.
Streptavidin-microbead separation of integrin b1
1 cells (see DCs) revealed
.98% pan-integrin-deficient B lymphoblasts that we refer to as integrin2/2 B
lymphoblasts.
Flow cytometry. Mature DCs were identified as CD11c1, MHCIIhigh cells for
wild-type and talin1-deficient cells. For integrin2/2 cells, MHCIIhigh cells cor-
responded tomature DCs as they carried enhanced levels of maturationmarkers
CD86 and CD40. B lymphoblasts were identified as B2201 cells, granulocytes as
Gr-11 cells. Employed antibodies were against the mouse antigens: Gr-1 biotin
and PE (RB6-8C5), B220 FITC (RA3-6B2), CD11c FITC and biotin (HL3), I-A/
I-E biotin (2G9) and I-A/I-E PE (M5/114.15.2) (all from BD Pharmingen). For
integrin expression profiles, the above cell markers were combined with anti-
bodies raised against the mouse integrin chains: a2 FITC (Ha 1/29), aIIB FITC
(MWReg30), aMPE (M1/70), a4 PE (9C10), a5 PE (5H10-27), a6 PE (GoH3), aE
PE (M290), av (RMV-7), b1 biotin (Ha2/5), b2 biotin (C71/16), b3 biotin
(2C9.G2), b7 biotin (2C3.G2) (all from Pharmingen), a1 FITC (HMalpha1),
b4 PE (346-11A) (both from Serotec), aL biotin (M17/4) (eBiosciences) and
b1 PE (HMbeta1-1) (BioLegend). The following isotype-matched antibody con-
trols were employed: rat IgG2a PE (B39-4, R35-95), rat IgG1 PE (R3-34), ham-
ster IgG2 FITC (Ha4/8), hamster IgM FITC (G235-1) (all Pharmingen), rat
IgG2a biotin, rat IgG2b FITC (eB149/10H5), rat IgG1 FITC (all eBiosciences),
hamster IgG PE (HTK888), hamster IgM biotin (HTK204) (both BioLegend)
and rat IgG2a PE (YTH71.3) (Serotec). Biotinylated antibodies were detected
with secondary streptavidin-Cy5 (Jackson). Flow cytometric analysis was per-
formed with a FACScalibur and CellQuest Pro Software (BD Biosciences).
Quantitative RT–PCR.RNAwas isolated from sortedDCs (see above) using the
Absolutely RNAMicroprep Kit (Stratagene) and the RNeasy Mini Kit (Qiagen).
One microlitre cDNA, generated from 15 ng RNA using the iScript cDNA
Synthesis Kit (Bio-Rad), was subjected to real-time PCR with the iQ SYBR
Green Supermix (Bio-Rad) on the iCycler (Bio-Rad). Primers for integrin b1
59-AGACTTCCGCATTGGCTTTG-39 and 59-GCTGGTGCAGTTTTGTTCAC-
39, and integrin av 59-CAAGCTCACTCCCATCAC-39 and 59-GGGTGTCTT-
GATTCTCAAAGGG-39 were used. Integrin gene expression in wild-type and
integrin2/2 DCs was quantified with the Gene Expression Analysis Program for
the iCycler iQ Real-Time PCRDetection System (Bio-Rad). GAPDHwas used to
normalize gene expression, and integrin expression levels in wild-type DCs were
set to 1.
In vivo migration assay. Gr-1-depleted wild-type and integrin2/2 DCs were
labelled with 3.5mM cell-permeable 5-(and-6)-carboxyfluorescein succinimidyl
ester (CFSE) or 1mM tetramethylrhodamine (TAMRA) (both Invitrogen),
respectively, and vice versa (the fluorescent labels did not influence DC migra-
tion (not shown)). 13 106 DCs at a 1:1 ratio were suspended in 20 ml PBS and
injected subcutaneously into the hind footpads of C57BL/6 mice. 32 and 48 h
after injection, mice were killed by CO2 suffocation, popliteal lymph nodes
frozen in cryomatrix (Thermo) and sectioned in 12 mm slices. To visualize the
doi:10.1038/nature06887
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lymph node compartments, methanol-fixed cryosections were stained after
blocking with 1% BSA in PBS with pan-laminin antibody (L9393, Sigma) and
secondary anti-rabbit Cy5 (Jackson). Three different layers of the T cell cortex of
each lymph node were documented using an Axio Imager upright microscope
(Zeiss). Quantification of DCs within the T cell cortex was performed with
MetaMorph (Molecular Devices). Using inverse thresholding, the greyscale
images of both fluorescence channels were separately binarized. DCs appeared
as dots that were quantified using the morphometric analysis tool. The ratio of
migrated knockout DCs was calculated as the number of knockout cells divided
by the total number ofDCs in the T cell cortex, with 0.5 as the value where 50%of
knockout cells and 50% wild-type cells located in the centre of the lymph node.
To confirm that fluorescent cells in the lymph node represent DCs that migrated
from the injection site (Supplementary Fig. 3), DCs were labelled with 3 mMCell
Trace Oregon Green 488 (Invitrogen). 13 106 DCs of either wild-type or integ-
rin2/2DCswere injected as described above and 48 h laterDCswere identified as
green cells expressing CD86 by flow cytometric analysis.
Ex vivo wide-field microscopy in ear dermis. Ears of killed C57BL/6 mice were
removed and mechanically split into dorsal and ventral halves. During separa-
tion the dermis detached from the cartilage layer that remained on one of the
halves. The cartilage free half was left unfixed and incubated with a rabbit poly-
clonal anti-LYVE-1 antibody (R&D Systems), washed with PBS and stained with
a A488 conjugated anti-rabbit secondary antibody (Molecular Probes). The
stained ears were mounted on custom-made migration chambers with the
dermal surface exposed. LPS-matured BM-derived, MACS-purified, TAMRA-
labelled DCs (see above) were re-suspended in culture medium, added on top of
the dermis and incubated for 30min at 37 uC, 5% CO2. After gently washing
away non-infiltrated DCs, the ear sheets were imaged in a custom-built climate
chamber using a fully motorized upright Leica MZ 16 FA stereomicroscope
equipped with a Spot camera and operated via MetaMorph software (system
implemented by Visitron Systems). For multiple immunofluorescence stainings
(Supplementary Fig. 5), ear sheets were fixed with 1% PFA after 120min immig-
ration of DCs and stained as described in the extravasation section. Cells were
manually tracked using ImageJ as described below.
Two-photon intravital microscopy in lymph nodes. Intravital microscopy was
performed as described previously43. Briefly, BM-derived DCs were matured
overnight with LPS, purified and selected by MACS for the desired integrin
deficiency (see above), differentially labelled with TAMRA and CFSE and sub-
cutaneously injected into footpads of C57BL/6 mice. After 32 h popliteal lymph
nodes were surgically exposed and imaged using an upright Leica DM LFSA
microscope equipped with a 320 0.95 NA water immersion objective
(Olympus) and a MaiTai Ti:sapphire-pulsed laser (Spectra-Physics). 3D cell
tracking was performed using Imaris software (Bitplane) as described.
In vivo ear irritation in bone marrow chimaeric mice. BM chimaera of
talin1flox/flox, Mx1Cre1/2 and av
flox/flox, b1
flox/flox, b2
2/2, b7
2/2, Mx1Cre1/2 ani-
mals were generated by sublethal irradiation of wild-type mice and immediate
reconstitution with 13 106 suspended BM cells of the indicated genotype. Six
weeks after irradiation Poly (I)?Poly (C) was injected and 10 d later 20ml of 1%
croton oil (Sigma) in acetone44 was applied on mouse ears. Mice were killed 12 h
after applicationof crotonoil. For histological analysis dorsal and ventral halves of
earswere subjected towholemount immunostaining.After fixationwith 1%PFA,
ear halves were blocked with 1%BSA (PAA) in PBS for 1 h at RT (while shaking),
stained with anti-Gr-1 (RB6-8C5, Pharmingen) and anti-pan-laminin antibody
(L9393, Sigma) in 1% BSA in PBS overnight at 4 uC (while shaking) and washed
with 1% BSA in PBS. Primary antibodies were detected with a repeated cycle of
staining with anti-rabbit A488 (Molecular Probes) and anti-rat Cy3 (Dianova)
antibodies before tissuewas embedded in elvanol and representative images taken
with an Axio Imager (Zeiss) equipped with the Apotome. Concentration of gran-
ulocytes in blood was measured by staining peripheral blood with Gr-1 PE (BD
Pharmingen) and counting all granulocytes per blood sample by flow cytometry
using a FACSCalibur (BD Pharmingen). The numbers of granulocytes that extra-
vasated into ear dermis were quantified by morphometric analysis employing
MetaMorph imaging software (Molecular Devices).
3D collagen gel chemotaxis assay. For standard assays, PureCol (INAMED) in
13 minimum essential medium eagle (MEM, Sigma) and 0.4% sodium bicar-
bonate (Sigma) was mixed with cells in RPMI (Invitrogen), 10% fetal calf serum
(FCS, Invitrogen) at a 2:1 ratio, resulting in gels with a collagen concentration of
1.6mgml21. Final cell concentrations in the assay were 13 106 cells per ml gel
for DCs and 1.63 106 cells per ml gel for granulocytes and B lymphoblasts. For
collagen titration experiments, above ratios were adapted. For gels with
3–5mgml21 collagen concentration, Nutragen (INAMED) was employed.
Collagen-cell mixtures were cast in custom-made migration chambers with a
thickness of 0.5–1mm. After 30min assembly of the collagen fibres at 37 uC, the
gels were overlaid with 50 ml of the following recombinant chemokines (all R&D
Systems) diluted in RPMI, 10% FCS: CCL19 (0.6mgml21, DCs), C5a
(0.1mgml21, granulocytes) and CXCL13 (2.5mgml21, B cells). For inhibition
studies, leukocytes were pre-incubated for 30min with 50mM blebbistatin
(Sigma), 30 mM Y27632, 100 nM or 500 nM latrunculin B (both Calbiochem)
before casting the gels. Inhibitors were also present in the same end-
concentrations in the gel.
3D fibrin gel chemotaxis assay. Cells were taken up in 0.2% (w/v) human
fibrinogen (IMCO) in RPMI, 10% FCS to a final concentration of 13 106 cells
per ml gel. Before casting the gels in custom-made migration chambers,
0.125Uml21 thrombin (Calbiochem) was added. After 30min polymerization
of the fibrin gels at 37 uC, the gels were overlaid with 50 ml of 0.6mgml21 CCL19
(R&D Systems) in RPMI, 10% FCS.
Analysis of chemotaxis assays. For comparison of DC velocities in collagen and
fibrin gel assays in the absence of inhibitors (Fig. 3b and Supplementary Fig. 7a),
movies were converted to kymographs using MetaMorph imaging software.
Straight lines in the kymographs represent migrating cells and lead angles were
measured to calculate single cell velocities.Manual single cell tracking of random
samples employing ImageJ and the Manual Tracking Plugin revealed the same
results.Manual tracking was applied to all other 3D chemotaxis assays. Here cells
were tracked over 4 h (forDCs, 2min per frame) or 15min (for granulocytes, 15 s
per frame). Speed and directionality parameters were calculated and visualized as
plots and movies by analysing the acquired data with the Chemotaxis and
Migration Tool Plugin (http://www.ibidi.de/applications/ap_chemo.html).
For quantification of ‘‘resting’’ and ‘‘moving’’ phases in 0.75mgml21 collagen
gels (Supplementary Fig. 9) instantaneous velocities (distance per 2min) were
categorized as ‘‘resting’’ if velocity ,1mm per 2min and ‘‘moving’’ if velocity
$1mm per 2min. Average velocities during mobile phases were calculated by
excluding the resting fraction. The percentage of resting phases was calculated as
resting time / (resting time 1 moving time).
Time-lapse videomicroscopy. Lowmagnification bright-fieldmovies of DCs in
gels were recorded in indicated time intervals using inverted Axiovert 40 (Zeiss)
cell culture microscopes, equipped with custom-built climate chambers (5%
CO2, 37 uC, humidified) and PAL cameras (Prosilica) triggered by custom-made
software (SVS Vistek). High magnification DIC and fluorescence movies were
recorded using a fully automated Axiovert 200M inverted fluorescence micro-
scope with a 403 objective (Zeiss) and a CoolSNAP HQ CCD camera. The
microscopic set-up (Visitron Systems) was controlled by MetaMorph software.
Transfection and labelling of cells.DCswere transfectedwithMLC-GFP (gift of
M. Olson45) between days 8–10 of culture using the primarymouse T cell kit and
the Amaxa nucleoporator (Amaxa). Cells were transfected according to the
manufacturer’s recommendations and immediately after transfection LPS was
added for overnight maturation. For nucleus visualization of DCs and granulo-
cytes nucleic acid dyes SYTO11 and SYTO13 (Invitrogen) were used, respect-
ively, according to the manufacturers recommendations.
2D adhesion assays. Adhesion assays were performed in 24-well plates coated
with 10mgml21 fibronectin (Calbiochem) or 10mgml21 recombinant mouse
ICAM-1 (R&D). 33 105 DCs per well were seeded in RPMI medium containing
10%FCS in the presence of 200ngml21 LPS and incubated for 30min at 5%CO2,
37 uC. Same cell numbers of LPS-maturated DCs were seeded in the presence of
200ngml21 phorbol 12-myristate 13-acetate (Calbiochem) for 30min. Cellswere
washed manually 3 times with PBS, 1% BSA and subsequently photo-documen-
ted and counted manually. Time-lapse video microscopy of chemokine-induced
spreading of LPS-matured DCs (see Supplementary Video 4) was performed on
10mgml21 mouse CCL21 (R&D)-coated plastic of cell culture dishes.
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Neutrophil	granulocytes	form	the	body’s	first	line	of	antibacterial	defense,	but	they	also	contribute	to	tis-
sue	injury	and	noninfectious,	chronic	inflammation.	Proteinase	3	(PR3)	and	neutrophil	elastase	(NE)	are	2	
abundant	neutrophil	serine	proteases	implicated	in	antimicrobial	defense	with	overlapping	and	potentially	
redundant	substrate	specificity.	Here,	we	unraveled	a	cooperative	role	for	PR3	and	NE	in	neutrophil	activa-
tion	and	noninfectious	inflammation	in	vivo,	which	we	believe	to	be	novel.	Mice	lacking	both	PR3	and	NE	
demonstrated	strongly	diminished	immune	complex–mediated	(IC-mediated)	neutrophil	infiltration	in	vivo	
as	well	as	reduced	activation	of	isolated	neutrophils	by	ICs	in	vitro.	In	contrast,	in	mice	lacking	just	NE,	neu-
trophil	recruitment	to	ICs	was	only	marginally	impaired.	The	defects	in	mice	lacking	both	PR3	and	NE	were	
directly	linked	to	the	accumulation	of	antiinflammatory	progranulin	(PGRN).	Both	PR3	and	NE	cleaved	
PGRN	in	vitro	and	during	neutrophil	activation	and	inflammation	in	vivo.	Local	administration	of	recom-
binant	PGRN	potently	inhibited	neutrophilic	inflammation	in	vivo,	demonstrating	that	PGRN	represents	a	
crucial	inflammation-suppressing	mediator.	We	conclude	that	PR3	and	NE	enhance	neutrophil-dependent	
inflammation	by	eliminating	the	local	antiinflammatory	activity	of	PGRN.	Our	results	support	the	use	of	
serine	protease	inhibitors	as	antiinflammatory	agents.
Introduction
Neutrophils belong to the body’s first line of cellular defense and 
respond quickly to tissue injury and invading microorganisms (1). 
In a variety of human diseases, like autoimmune disorders, infec-
tions, or hypersensitivity reactions, the underlying pathogenic 
mechanism is the formation of antigen-antibody complexes, so-
called immune complexes (ICs), which trigger an inflammatory 
response by inducing the infiltration of neutrophils (2). The sub-
sequent stimulation of neutrophils by C3b-opsonized ICs results 
in the generation of ROS and the release of intracellularly stored 
proteases leading to tissue damage and inflammation (3). It is 
therefore important to identify the mechanisms that control the 
activation of infiltrating neutrophils.
Neutrophils abundantly express a unique set of neutrophil 
serine proteases (NSPs), namely cathepsin G (CG), proteinase 3 
(PR3; encoded by Prtn3), and neutrophil elastase (NE; encoded 
by Ela2), which are stored in the cytoplasmic, azurophilic gran-
ules. PR3 and NE are closely related enzymes, with overlapping 
and potentially redundant substrate specificities different from 
those of CG. All 3 NSPs are implicated in antimicrobial defense by 
degrading engulfed microorganisms inside the phagolysosomes of 
neutrophils (4–8). Among many other functions ascribed to these 
enzymes, PR3 and NE were also suggested to play a fundamental 
role in granulocyte development in the bone marrow (9–11).
While the vast majority of the enzymes is stored intracellular-
ly, minor quantities of PR3 and NE are externalized early dur-
ing neutrophil activation and remain bound to the cell surface, 
where they are protected against protease inhibitors (12, 13). 
These membrane presented proteases were suggested to act as 
path clearers for neutrophil migration by degrading components 
of the extracellular matrix (14). This notion has been addressed 
in a number of studies, which yielded conflicting results (15–17). 
Thus, the role of PR3 and NE in leukocyte extravasation and 
interstitial migration still remains controversial.
Emerging data suggest that externalized NSPs can contribute 
to inflammatory processes in a more complex way than by simple 
proteolytic tissue degradation (18). For instance, recent observa-
tions using mice double-deficient for CG and NE indicate that 
pericellular CG enhances IC-mediated neutrophil activation and 
inflammation by modulating integrin clustering on the neu-
trophil cell surface (19, 20). Because to our knowledge no Prtn3–/– 
mice have previously been generated, the role of this NSP in 
inflammatory processes has not been deciphered. Moreover, NE-
dependent functions that can be compensated by PR3 in Ela2–/– 
animals are still elusive.
Nonstandard	abbreviations	used: CG, cathepsin G; EBM, extravascular basement 
membrane; GRN, granulin; HPF, high-power field; IC, immune complex; MPO, 
myeloperoxidase; NE, neutrophil elastase; NSP, neutrophil serine protease; PGRN, 
progranulin; phox, phagocyte oxidase; PR3, proteinase 3; RPA, reverse passive Arthus 
reaction.
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One mechanism by which NSPs could upregulate the inflam-
matory response has recently been proposed. The ubiquitously 
expressed progranulin (PGRN) is a growth factor implicated in 
tissue regeneration, tumorigenesis, and inflammation (21–23). 
PGRN was previously shown to directly inhibit adhesion-depen-
dent neutrophil activation by suppressing the production of ROS 
and the release of neutrophil proteases in vitro (23). This antiin-
flammatory activity was degraded by NE-mediated proteolysis of 
PGRN to granulin (GRN) peptides (23). In contrast, GRN peptides 
may enhance inflammation (23) and have been detected in neu-
trophil-rich peritoneal exudates (24). In short, recent studies pro-
posed PGRN as a regulator of the innate immune response, but 
the factors that control PGRN function are still poorly defined 
and its relevance to inflammation needs to be elucidated in vivo.
In the present study, we generated double-deficient Prtn3–/–
Ela2–/– mice to investigate the role of these highly similar serine 
proteases in noninfectious neutrophilic inflammation. We estab-
lished that PR3 and NE are required for acute inflammation in 
response to subcutaneous IC formation. The proteases were found 
to be directly involved in early neutrophil activation events, because 
isolated Prtn3–/–Ela2–/– neutrophils were poorly activated by ICs in 
vitro. These defects in Prtn3–/–Ela2–/– mice were accompanied by 
accumulation of PGRN. We demonstrated that PGRN represents 
a potent inflammation-suppressing factor that is cleaved by both 
PR3 and NE. Our data delineate what we believe to be a previously 
unknown proinflammatory role for PR3 and NE, which is accom-
plished via the local inactivation of antiinflammatory PGRN.
Results
Generation of Prtn3–/–Ela2–/– mice. To analyze the role of PR3 and NE 
in neutrophilic inflammation, we generated a Prtn3–/–Ela2–/– mouse 
line by targeted gene disruption in embryonic stem cells (see Sup-
plemental Figure 1; supplemental material available online with 
this article; doi:10.1172/JCI34694DS1). Positive recombination of 
the Prtn3/Ela2 locus was proven by Southern blotting of embry-
onic stem cell clones (Figure 1A). Prtn3–/–Ela2–/– mice showed no 
expression of mRNA for PR3 and NE in bone marrow cells, as 
assessed by RT-PCR (Figure 1B). The successful elimination of 
PR3 and NE was confirmed at the level of proteolytic activity in 
neutrophil lysates using a PR3/NE-specific chromogenic substrate 
(Supplemental Figure 3) as well as by casein zymography (Figure 
1C). The substantially reduced casein degradation by heterozygous 
neutrophils indicates gene-dosage dependence of PR3/NE activi-
ties. Furthermore, PR3 and NE deficiency was proven by Western 
blotting using cell lysates from bone marrow–derived neutrophils, 
while other enzymes stored in azurophilic granula, such as CG 
and myeloperoxidase (MPO), were normally detected (Figure 1D). 
Crossing of heterozygous Prtn3+/–Ela2+/– mice resulted in regular 
offspring of WT, heterozygous, and homozygous genotype accord-
ing to the Mendelian ratio. Despite the absence of 2 abundant ser-
ine proteases, and in contrast to expectations based on previous 
reports (9–11), we found unchanged neutrophil morphology (Fig-
ure 1E) and regular neutrophil populations in the peripheral blood 
of the mutant mice, the latter as assessed via flow cytometry to 
determine the differentiation markers CD11b and Gr-1 (Figure 1F) 
Figure 1
Generation and characterization of Prtn3–/–Ela2–/– mice. (A) Southern blot showing the WT (+/+) 11.5-kb band of the nontargeted allele and the 
presence of an additional 7.5-kb band in a heterozygous (+/–) PR3/NE-targeted embryonic stem cell clone. (B) RT-PCR revealed the complete 
lack of mouse PR3 (mPR3; 437 bp) and mouse NE (743 bp) transcripts in bone marrow cells from Prtn3–/–Ela2–/– mice (–/–), while expression of 
β-actin (699 bp) was normal. (C) Casein zymography showed prominent casein degradative activity at 27 kDa in WT neutrophil lysates, while 
intermediate degradation by heterozygous lines and no degradation by Prtn3–/–Ela2–/– lines was found at this size. M, marker. (D) Western blot 
analysis of granule enzyme expression in bone marrow–derived neutrophils. In Prtn3–/–Ela2–/– neutrophils, no signals for PR3 and NE were 
detected, while CG (~26 kDa), MPO (~59 kDa), and a smaller degradation product of MPO were detected at the same levels as in WT neutro-
phils. (E) Microscopic analysis of H&E-stained blood smears revealed normal granulocyte morphology in Prtn3–/–Ela2–/– mice, with a polymor-
phic nucleus (dark blue) identical to that of WT neutrophils. Original magnification, ×20. (F) Flow cytometry of peripheral blood with gating on 
Gr-1hiCD11b+ showed regular neutrophil populations (boxed regions) in Prtn3–/–Ela2–/– mice. Plots are representative of data obtained from 3 
mice per group. Percentages denote percent cells in the boxed regions.
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(25, 26). Moreover, Prtn3–/–Ela2–/– mice demonstrated normal per-
centages of the leukocyte subpopulations in the peripheral blood, 
as determined by the Diff-Quick staining protocol and by hemo-
cytometric counting (Supplemental Figure 2, A and B). Hence, the 
proteases are not crucially involved in granulopoiesis, and ablating 
PR3 and NE in the germ line represents a valid approach to assess 
their biological significance in vivo.
PR3 and NE are dispensable for neutrophil extravasation and inter-
stitial migration. To examine neutrophil infiltration into the 
perivascular tissue, we applied phorbol esters (croton oil) to the 
mouse ears. At 4 h after stimulation, we assessed the neutrophil 
distribution in relation to the extravascular basement membrane 
(EBM) by immunofluorescence microscopy of fixed whole-mount 
specimens (Figure 2A). We found that Prtn3–/–Ela2–/– neutrophils 
transmigrated into the interstitium without retention at the EBM 
(Figure 2B), resulting in quantitatively normal and widespread 
neutrophil influx compared with WT mice (Figure 2C). More-
over, we analyzed chemotactic migration of isolated neutrophils 
through a 3-dimensional collagen meshwork in vitro (Supple-
mental Video 1) and found unhampered chemotaxis toward a 
C5a gradient, based on the directionality (Figure 2D) and velocity 
(Figure 2E) of Prtn3–/–Ela2–/– neutrophils. These findings led us to 
conclude that PR3 and NE are not principally required for neutro-
phil extravasation or interstitial migration.
Reduced inflammatory response to ICs in Prtn3–/–Ela2–/– mice. The 
formation of ICs represents an important trigger of neutrophil-
dependent inflammation in many human diseases (2). To deter-
mine the role of PR3 and NE in this context, we induced a classic 
model of subcutaneous IC-mediated inflammation, namely the 
reverse passive Arthus reaction (RPA) (27). At 4 h after RPA induc-
tion, we assessed the cellular inflammatory infiltrates by histology 
using H&E-stained skin sections (Figure 3A). Neutrophils, which 
were additionally identified by Gr-1 immunohistochemistry, 
made up the vast majority of all cellular infiltrates (Figure 3A). 
We found that neutrophil infiltration to the sites of IC formation 
was severely diminished in Prtn3–/–Ela2–/– mice. Indeed, histologi-
cal quantification revealed significantly reduced neutrophil influx 
in Prtn3–/–Ela2–/– mice compared with WT mice, while Ela2–/– mice 
Figure 2
PR3 and NE are not principally required for neutrophil extravasation and interstitial migration. (A and B) Phorbol ester–treated ear tissues of 
WT and Prtn3–/–Ela2–/– mice were immunostained for laminin (LN; green) to visualize EBM and Gr-1 (red) to identify neutrophils. Lesions were 
examined 4 h after stimulus application by fluorescence microscopy as described in Methods. (A) Representative images of tissue from WT and 
Prtn3–/–Ela2–/– mice. Both genotypes developed strong and widespread neutrophil infiltrations. (B) Higher-magnification images of boxed regions 
in A. Prtn3–/–Ela2–/– neutrophils showed no retention at the EBM. Scale bars: 200 μm (A); 25 μm (B). (C) Overall neutrophil infiltrates were quanti-
fied as the percentage of Gr-1–positive cells per microscopic field. Data are mean ± SEM. Intravascular cells were excluded. No significant differ-
ence between WT and Prtn3–/–Ela2–/– mice was found (P = 0.63). In vitro migration of WT and Prtn3–/–Ela2–/– neutrophils directed by C5a through 
3-dimensional collagen matrices was analyzed by time-lapse video microscopy (see Supplemental Video 1). (D) The tracks of WT (n = 41) 
and Prtn3–/–Ela2–/– (n = 42) neutrophils are shown, and the factor for directionality ± SEM is indicated. No impairment was observed regarding 
chemotactic directionality of Prtn3–/–Ela2–/– versus WT neutrophils (P = 0.19). (E) Velocities of single cells (individual points) were calculated and 
averaged (red bar). Prtn3–/–Ela2–/– neutrophils showed no significant difference versus WT cells (P = 0.30).
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showed marginally reduced neutrophil counts (Figure 3B). These 
results indicate that PR3 and NE fulfill an important proinflam-
matory function during IC-mediated inflammation.
PR3 and NE enhance neutrophil activation by ICs in vitro. Because PR3 
and NE were required for the inflammatory response to IC (Figure 
3), but not to phorbol esters (Figure 2), we considered the enzymes 
as enhancers of the neutrophil response to IC. We therefore assessed 
the oxidative burst using dihydrorhodamine as a readout for cellular 
activation of isolated, TNF-α–primed neutrophils in the presence of 
ICs in vitro. While both WT and Prtn3–/–Ela2–/– neutrophils showed 
a similar, approximately 20-min lag phase before the oxidative burst 
commenced, the ROS production over time was markedly reduced, 
by 30%–40%, in the absence of PR3 and NE (Figure 4A). In contrast, 
oxidative burst triggered by 25 nM PMA was not hindered in Prtn3–/–
Ela2–/– neutrophils (Figure 4B), which indicated no general defect in 
producing ROS. We also performed a titration series ranging from 
0.1 to 50 nM PMA and found no reduction in oxidative burst activ-
ity in Prtn3–/–Ela2–/– neutrophils at any PMA concentration used 
(Supplemental Figure 4). These data are consistent with our in vivo 
experiments showing that neutrophil influx to ICs was impaired 
(Figure 3), whereas the inflammatory response to phorbol esters was 
normal (Figure 2, A–C), in Prtn3–/–Ela2–/– mice. To compare neutro-
phil priming in WT and Prtn3–/–Ela2–/– neutrophils, we analyzed cell 
surface expression of CD11b after 30 min of incubation at various 
concentrations of TNF-α and found no difference (Supplemental 
Figure 5). Moreover, we observed normal neutrophil adhesion to IC-
coated surfaces (Supplemental Figure 6A) and unaltered phagocyto-
sis of opsonized, fluorescently labeled E. coli bacteria (Supplemental 
Figure 6, B and C) in the absence of both proteases. We therefore 
hypothesized that PR3 and NE enhance early events of adhesion-
dependent neutrophil activation after TNF-α priming and binding 
of ICs. It is important to note that Ela2–/– neutrophils were previ-
ously shown to react normally in the same setup (20). Regarding the 
highly similar cleavage specificities of both proteases, we suggested 
that PR3 and NE complemented each other during the process of 
neutrophil activation and inflammation.
Antiinflammatory PGRN is degraded by PR3 and NE during IC-medi-
ated neutrophil activation. This reasoning prompted us to search for 
substrates that are processed by both PR3 and NE and are thereby 
able to enhance neutrophilic activation. In a previous study, PGRN 
was described as a potent inhibitor of the adhesion-dependent oxi-
dative burst of human TNF-α–primed neutrophils in vitro, which 
can be inactivated by NE (23). Because we observed a substantial 
reduction in ROS production in Prtn3–/–Ela2–/– neutrophils com-
pared with WT cells (Figure 4A), we evaluated a potential link 
between PGRN cleavage and oxidative burst of neutrophils activat-
ed by ICs. We analyzed the culture supernatant as well as the cel-
lular pellet of IC-activated neutrophils for the presence of PGRN 
by IB (Figure 4C). Indeed, the inhibitory, intact form of PGRN was 
detected in the supernatant of Prtn3–/–Ela2–/– neutrophils only. We 
also found a cellular pool of PGRN in all genotypes that was more 
abundant in Prtn3–/–Ela2–/– cells than in WT or Ela2–/– neutrophils. 
This led us to conclude that PGRN was released and degraded by 
PR3 and NE during neutrophil activation.
PGRN inhibits neutrophil activation by ICs in vitro. To show that the 
reduced oxidative burst of Prtn3–/–Ela2–/– neutrophils can be caused 
by defective PGRN degradation, we evaluated the amount of cell-
associated and secreted PGRN detected by IB (Figure 4C). We tested 
whether these concentrations inhibited the IC-mediated oxidative 
burst of WT neutrophils when added to the cells in vitro. Indeed, 
when 100 nM PGRN was applied to WT granulocytes activated by 
ICs, the ROS response markedly decreased (Figure 4D). In positive 
control experiments, activation of neutrophils was unaffected by 
PGRN application when they were stimulated with PMA (Figure 
4E). These data endorse the inhibitory effect of intact PGRN on 
innate immune cell activation and prove that defective PGRN deg-
radation may cause the reduced activation and oxidative burst of 
Prtn3–/–Ela2–/– neutrophils triggered by ICs.
Both PR3 and NE process PGRN in vitro. In previous studies, NE 
was proposed as the principal PGRN-converting protease (23). 
Our experiments revealed an equally important role of PR3 in 
this pathway, because Ela2–/– neutrophils were not impaired in 
Figure 3
Impaired inflammatory response to locally formed ICs in Prtn3–/–Ela2–/– mice. (A) Representative photomicrographs of inflamed skin sections 4 h 
after IC formation. Neutrophils were identified morphologically (polymorphic nucleus) in H&E stainings and by Gr-1 staining (red). The cellular 
infiltrates were located to the adipose tissue next to the panniculus carnosus muscle (asterisks) and were primarily composed of neutrophil 
granulocytes. Scale bars: 200 μm. (B) Neutrophil infiltrates in lesions from Prtn3–/–Ela2–/– mice were significantly diminished compared with 
Ela2–/– mice and WT mice. Neutrophil influx in Ela2–/– mice was slightly, but not significantly, diminished compared with WT mice. Results are 
mean ± SEM infiltrated neutrophils per HPF. *P < 0.05.
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their degradation of PGRN (Figure 4C). We further substantiated 
this concept by incubating recombinant PGRN with the purified 
proteases in vitro. Both enzymes completely degraded PGRN as 
early as 5 min after incubation, although the pattern of lower–
molecular weight cleavage products analyzed by silver-stained 
SDS-PAGE was not identical for both proteases (Figure 5, A and 
B). Hence, both PR3 and NE are potent converters of PGRN, indi-
cating biological redundancy of the proteases in this process.
PR3 and NE are major PGRN-degrading enzymes of neutrophils. To eval-
uate the significance of PR3 and NE as PGRN-degrading enzymes, 
we next incubated recombinant mouse PGRN with neutrophil 
lysates from WT and protease-deficient mice. Anti-PGRN Western 
blot revealed that PGRN degradation was minimally reduced in the 
absence of NE, but strongly impaired when both PR3 and NE were 
lacking (Figure 5C). This observation demonstrates that PR3 and 
NE are major PGRN-converting enzymes of neutrophils, a finding 
supported by previous experiments showing that CG, the third 
NSP of primary granules, does not cleave PGRN (23).
PGRN inhibits IC-mediated inflammation in vivo. To provide in vivo evi-
dence for the relevance of PGRN as an antiinflammatory mediator, 
we administered 2 μg recombinant PGRN to IC-mediated inflam-
mation in mice. PGRN-treated lesions were directly compared with 
untreated lesions in the same mouse (Figure 6A). In both WT and 
Prtn3–/–Ela2–/– mice, neutrophil accumulation was diminished at the 
PGRN-treated sites of IC-mediated inflammation, demonstrating 
that PGRN is a crucial inhibitory factor for neutrophilic inflam-
mation. Neutrophil infiltration was reduced to a greater extent 
in Prtn3–/–Ela2–/– (40% reduction, P < 0.01; Figure 6C) than in WT 
mice (25% reduction, P < 0.05; Figure 6B), which likely reflected the 
impact of the PGRN-degrading proteases in this pathway.
PR3 and NE cleave PGRN during inflammation in vivo. Finally, we 
aimed to demonstrate defective PGRN degradation in Prtn3–/–Ela2–/– 
mice during neutrophilic inflammation in vivo. For practical 
reasons, we harvested infiltrated neutrophils from the inflamed 
peritoneum 4 h after casein injection and subjected the lysates of 
these cells to anti-PGRN Western blot. Intact, inhibitory PGRN 
was detected in Prtn3–/–Ela2–/– neutrophils, but not in WT cells 
(Figure 6D). These data prove that neutrophilic inflammation is 
accompanied by proteolytic removal of antiinflammatory PGRN 
and that the process of PGRN degradation is essentially impaired 
in vivo in the absence of PR3 and NE.
Discussion
Chronic inflammatory and autoimmune diseases are often per-
petuated by continuous neutrophil infiltration and activation. 
According to the current view, the role of NSPs in these diseases is 
mainly associated with proteolytic tissue degradation after their 
release from activated or dying neutrophils. However, recent obser-
Figure 4
Impaired oxidative burst and PGRN degradation by IC-activated Prtn3–/–Ela2–/– neutrophils. Oxidative burst as the readout for neutrophil activa-
tion by ICs was measured over time. (A) While no difference was observed during the initial 20-min lag phase of the oxidative burst, Prtn3–/–
Ela2–/– neutrophils exhibited diminished ROS production over time compared with WT neutrophils. (B) Bypassing receptor-mediated activation 
using 25 nM PMA restored the diminished oxidative burst of Prtn3–/–Ela2–/– neutrophils. Results are presented as normalized fluorescence in AU 
(relative to maximum fluorescence produced by WT cells). Data (mean ± SD) are representative of 3 independent experiments each conducted 
in triplicate. (C) Isolated mouse neutrophils were activated by ICs in vitro and tested for PGRN degradation by IB. In the cellular fraction, the 
PGRN (~80 kDa) signal was markedly increased in Prtn3–/–Ela2–/– cells compared with WT and Ela2–/– neutrophils. Intact PGRN was present in 
the supernatant (SN) of IC-activated Prtn3–/–Ela2–/– neutrophils only, not of WT or Ela2–/– cells. (D and E) Exogenous administration of 100 nM 
PGRN significantly reduced ROS production of neutrophils activated by ICs (D), but not when activated by PMA (E). Data (mean ± SD) are 
representative of 3 independent experiments each conducted in triplicate.
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vations suggest that NSPs such as CG may contribute to nonin-
fectious diseases in a more complex manner, namely as specific 
regulators of inflammation (18). Here, we demonstrate that PR3 
and NE cooperatively fulfilled an important proinflammatory role 
during neutrophilic inflammation. PR3 and NE directly enhanced 
neutrophil activation by degrading oxidative burst–suppressing 
PGRN. These findings support the use of specific serine protease 
inhibitors as antiinflammatory agents.
Much attention has been paid to the degradation of extracellular 
matrix components by NSPs. We therefore expected that ablation 
of both PR3 and NE would cause impaired neutrophil extrava-
sation and interstitial migration. Surprisingly, we found that 
the proteases were principally dispensable for these processes: 
Prtn3–/–Ela2–/– neutrophils migrated normally through a dense, 
3-dimensional collagen matrix in vitro and demonstrated regular 
extravasation in vivo when phorbol esters were applied (Figure 2). 
This finding is in agreement with recent reports that neutrophils 
preferentially and readily cross the EBM through regions of low 
matrix density in the absence of NE (28).
Conversely, we observed that PR3 and NE were required for the 
inflammatory response to locally formed ICs (Figure 3). Even iso-
lated Prtn3–/–Ela2–/– neutrophils were challenged in performing 
oxidative burst after IC stimulation in vitro (Figure 4A), showing 
that the proteases directly enhanced the activation of neutrophils 
also in the absence of extracellular matrix. However, when recep-
tor-mediated signal transduction was bypassed by means of PMA, 
neutrophils from Prtn3–/–Ela2–/– mice performed normal oxidative 
burst (Figure 4B), indicating that the function of the phagocyte 
oxidase (phox) complex was not altered in the absence of PR3 and 
NE. These findings substantiate what we believe to be a novel para-
digm: that all 3 serine proteases of azurophilic granules (CG, PR3, 
and NE), after their release in response to IC encounter, potentiate 
a positive autocrine feedback on neutrophil activation.
In contrast to CG, the highly related proteases PR3 and NE coop-
erate in the effacement of antiinflammatory PGRN, leading to 
enhanced neutrophil activation. Previous studies already demon-
strated that PGRN is a potent inhibitor of the adhesion-dependent 
oxidative burst of neutrophils in vitro, which can be degraded by NE 
(23). Here, we showed that PR3 and NE play an equally important role 
in the regulation of PGRN function. 
Ela2–/– neutrophils were sufficiently 
able to degrade PGRN. Only in the 
absence of both PR3 and NE was 
PGRN degradation substantially 
impaired, resulting in the accumu-
lation of antiinflammatory PGRN 
during neutrophil activation in 
vitro (Figure 4C) and neutrophilic 
inflammation in vivo (Figure 6D). 
Moreover, we provided in vivo evi-
dence for the crucial role of PGRN 
as an inflammation-suppressing 
mediator, because administration 
of recombinant PGRN potently 
inhibited the neutrophil influx 
to sites of IC formation (Figure 6, 
A–C). Hence, the cooperative degra-
dation of PGRN by PR3 and NE is a 
decisive step for the establishment 
of neutrophilic inflammation.
The molecular mechanism of PGRN function is not yet completely 
understood, but it seems to interfere with integrin (CD11b/CD18) 
outside-in signaling by blocking the function of pyk2 and thus 
dampens adhesion-related oxidative burst even when added after 
the initial lag phase of oxidase activation (23). PGRN is produced by 
neutrophils and stored in highly mobile secretory granules (29). It 
was recently shown that PGRN can bind to heparan-sulfated proteo-
glycans (30), which are abundant components of the EBM and vari-
ous cell surfaces, including those of neutrophils. Also, PR3 and NE 
are known to interact with heparan sulfates on the outer membrane 
of neutrophils, where the enzymes appear to be protected against 
protease inhibitors (12, 13, 31). These circumstantial observations 
support the notion that PGRN cleavage by PR3 and NE takes place at 
the pericellular microenvironment of the neutrophil cell surface.
Impaired outside-in signaling most likely reduced the oxidative 
burst in Prtn3–/–Ela2–/– neutrophils adhering to ICs. In support of 
this hypothesis, we excluded an altered response to TNF-α prim-
ing (Supplemental Figure 5) as well as reduced adhesion to immo-
bilized ICs and defective endocytosis of serum-opsonized E. coli in 
Prtn3–/–Ela2–/– neutrophils (Supplemental Figure 6). MPO content 
and processing was also unchanged in Prtn3–/–Ela2–/– neutrophils 
(Figure 1D); hence, the previously discussed inhibitory effect of 
MPO on phox activity (32, 33) does not appear to be stronger in 
neutrophils lacking PR3 and NE. Because there was no difference 
in the lag phase of the oxidative burst, initial IC-triggered receptor 
activation was probably not affected by either PRGN or PR3/NE. 
Our concept is consistent with all these observations and takes 
into account that PGRN unfolds its suppressing effects in the 
second phase, when additional membrane receptors, endogenous 
PGRN, and some PR3/NE from highly mobile intracellular pools 
are translocated to the cell surface. The decline and cessation of 
ROS production suggested to us that outside-in signaling was 
not sustained and that active oxidase complexes were no longer 
replenished in the absence of PR3 and NE. Our present findings, 
however, do not allow us to exclude other potential mechanisms, 
such as accelerated disassembly of the active oxidase complex.
During cutaneous inflammation, PGRN is provided by multiple 
sources, including skin cells and neutrophils themselves, which 
produce and release PGRN as they infiltrate the tissue (21, 29). 
Figure 5
PR3 and NE are major PGRN processing enzymes of neutrophils. (A and B) Silver-stained SDS-PAGE 
analysis of recombinant human PGRN incubated at a 1:10 enzyme/substrate ratio with purified human 
NE (A) and recombinant mouse PR3 (B). Both NE and PR3 completely cleaved ~80-kDa PGRN to small-
er molecular fragments within 5 min of incubation. (C) Recombinant mouse PGRN was incubated with 
neutrophil lysates from WT, Ela2–/–, and Prtn3–/–Ela2–/– mice for 1 h at 37°C and analyzed by anti-mouse 
PGRN Western blot. Compared with untreated PGRN (control), WT neutrophils completely degraded 
PGRN. In Ela2–/– neutrophils, a faint band of intact PGRN was detected, while in Prtn3–/–Ela2–/– neutro-
phils, a distinct PGRN band remained, comparable to control.
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Thus, PGRN represents a prominent factor to control extravascu-
lar neutrophil function during skin inflammation. Proteolytic pro-
cessing of PGRN was previously shown to generate GRN peptides 
that accumulate in inflammatory exudates, such as during casein-
induced peritonitis (34). In contrast to the precursor PGRN, these 
GRN peptides might be proinflammatory and induce the release of 
neutrophil-attracting IL-8 from epithelial cells (23). In the absence 
of PR3 and NE, neutrophils are no longer able to provide the switch 
from inflammation-suppressing PGRN to proinflammatory GRN 
peptides. The activation of neutrophils by ICs is a decisive event in 
the cascade of reactions during the RPA. IC-activated neutrophils 
are known to release cytokines and chemokines and thus establish 
an inflammatory milieu. We hypothesize that the local persistence 
of PGRN dampens neutrophil activation and release of ROS as well 
as other inflammatory mediators in response to ICs, which results 
in diminished recruitment of further neutrophils in Prtn3–/–Ela2–/– 
mice. Hence, defective PGRN degradation can account for the 
impaired inflammation in the absence of PR3 and NE (Figure 7).
NSPs are strongly implicated as effector molecules in a large 
number of destructive diseases, such as emphysema or the autoim-
mune blistering skin disease bullous pemphigoid (14, 35–37). Nor-
mally, PR3/NE activity is tightly controlled by high plasma levels of 
α1-antitrypsin. This balance between proteases and protease inhibi-
tors is disrupted in patients with genetic α1-antitrypsin deficiency, 
which represents a high risk factor for the development of emphyse-
ma and certain autoimmune disorders (38). The pathogenic effects 
of NSPs in these diseases have so far been associated with tissue 
destruction by the proteases after their release from dying neutro-
phils. Our findings showed that PR3 and NE were already involved 
in much earlier events of the inflammatory process, because the 
enzymes directly regulated cellular activation of infiltrating neutro-
phils by degrading inflammation-suppressing PGRN. This concept 
is further supported by previous studies showing increased inflam-
mation in mice lacking serine protease inhibitors such as SERPINB1 
or SLPI (39, 40). Blocking PR3/NE activity using specific inhibitors 
therefore represents a promising therapeutic strategy to treat chron-
ic, noninfectious inflammation. Serine protease inhibitors as anti-
inflammatory agents can interfere with the disease process at 2 dif-
ferent stages, because they attenuate both early events of neutrophil 
activation and proteolytic tissue injury caused by released NSPs.
Methods
Mice. Simultaneous deficiency of the Prtn3 and Ela2 gene cluster in 
129S6/SvEv mice was generated by homologous recombination in embry-
onic stem cells as detailed in Supplemental Methods. Ela2–/– mice on the 
129S6/SvEv genetic background were previously generated (41) and were 
obtained as frozen embryos from the Medical Research Council Harwell 
(Oxford, United Kingdom). These and WT control mice were kept under 
pathogen-free conditions at the GSF Neuherberg (Munich, Germany). For 
most experiments, mice at 5–8 weeks of age were used. All animal experi-
ments were performed with approval by the District Government of Upper 
Bavaria (Munich, Germany).
Characterization of Prtn3–/–Ela2–/– mice. We analyzed the caseinolytic activity of 
neutrophil lysates from WT Prtn3+/+Ela2+/+ mice, heterozygous Prtn3+/–Ela2+/– 
mice, and homozygous Prtn3–/–Ela2–/– mice by casein zymography. In short, 
1.5 mg/ml casein (Sigma-Aldrich) was added to SDS polyacrylamide gels, and 
the lysate of 2.5 × 105 cells per well was separated under nonreducing condi-
tions at 4°C. Gels were then washed in PBS with 2.5% Triton X-100 followed 
by incubation overnight in Tris/HCl (pH 7.4), 10 mM CaCl2, and 0.02% Brij 35. 
Gels were washed, stained with Coomassie blue, and destained in acetic acid.
Figure 6
PGRN is a potent inhibitor of IC-stimulated inflammation in vivo. Recombinant mouse PGRN (2 μg) was intradermally applied with anti-OVA 
IgG, and the RPA was started in WT and Prtn3–/–Ela2–/– mice (n = 5 per group). (A) After 4 h, the effect of PGRN application was evaluated by 
histological analyses. Representative images show neutrophil infiltrates at the panniculus carnosus muscle (asterisks). Scale bars: 200 μm. (B 
and C) Effect of PGRN administration on neutrophil influx. In both WT (B) and Prtn3–/–Ela2–/– (C) mice, neutrophil infiltration was significantly 
diminished at PGRN-treated sites compared with untreated sites. This effect appeared to be more pronounced in the protease-deficient mice. 
Data are mean ± SEM infiltrated neutrophils per HPF. *P < 0.05; **P < 0.01. (D) Neutrophils isolated ex vivo from inflamed peritoneum of WT and 
Prtn3–/–Ela2–/– mice were analyzed by anti-mouse PGRN Western blot of concentrated neutrophil lysates. Intact PGRN was found abundantly in 
Prtn3–/–Ela2–/– but not WT neutrophils. Loading was controlled using anti-actin Western blot.
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To confirm the successful and specific knockout of PR3 and NE, we per-
formed Western blot analyses of bone marrow–derived neutrophils. After 
reducing SDS-PAGE of neutrophil lysates and electrotransfer onto nitrocel-
lulose, we probed the membranes with polyclonal rabbit sera specific for the 
granule serine enzymes PR3, NE, CG, and MPO as previously described (42).
To control normal neutrophil differentiation in Prtn3–/–Ela2–/– mice, 
peripheral blood neutrophils were characterized by flow cytometry using 
fluorescently labeled Gr-1– and CD11b-specific antibodies (BD Biosci-
ences — Pharmingen) as previously described (25, 26). Blood smears were 
prepared and stained on glass slides according to the Diff-Quick proto-
col (Dade-Behring), and neutrophil morphology was analyzed by light 
microscopy. Differential blood leukocytes were identified by morphology 
and counted under the microscope to determine the percentage of each 
population. Moreover, the cell count per milliliter blood of each leukocyte 
population was determined using a hemocytometer (improved Neubauer 
chamber). For detailed descriptions of genetic characterization of Prtn3–/–
Ela2–/– mice, see Supplemental Methods.
Recombinant and purified proteins. Recombinant mouse PR3 was produced 
and purified as previously described (43). Human NE was purchased from 
Elastin Products. Recombinant human PGRN was prepared as previously 
described (21). Recombinant mouse PGRN (aa 18–589) was produced with 
an N-terminal S-tag by transient expression into the supernatant of H5 
insect cells using a modified pIEx-5 vector (Novagen; Merck) and the secre-
tion signal of the adipokinetic hormone. Transfection of H5 insect cells cul-
tured in TC-100 medium (Gibco; Invitrogen) was done using the Fugene HD 
transfection reagent (Roche) according to the manufacturer’s instructions. 
At 6 days after transfection, the supernatant was harvested, and recombinant 
mouse PGRN was purified using an S-protein agarose column (Novagen; 
Merck). Following extensive washing of the column with PBS, the bound 
protein was eluted by 3 M magnesium chloride. Immediately thereafter, frac-
tions were dialyzed against PBS and analyzed by silver-stained SDS-PAGE. 
Pure fractions were pooled and dialyzed against 20 mM ammonium bicar-
bonate, lyophilized, and stored at –80°C until use. For experiments, lyophi-
lized protein was reconstituted in sterile PBS (Gibco; Invitrogen).
Skin inflammation models. Croton oil (Sigma-Aldrich) was diluted to 1% in 
acetone, and this dilution was topically applied to the ventral and the dor-
sal sides (20 μl each) of the ears of WT and Prtn3–/–Ela2–/– mice (n = 4 per 
group). After 4 h, mice were sacrificed by CO2 inhalation. The earflap was 
split into 2 halves by carefully separating the dorsal and ventral skin. For his-
tological analysis, dorsal and ventral halves of ears were subjected to whole-
mount immunostaining. After fixation in paraformaldehyde, ear halves 
were blocked with 1% BSA (PAA Laboratories) in PBS for 1 h at room tem-
perature, probed with biotin-labeled anti–Gr-1 (RB6-8C5; BD Biosciences — 
Pharmingen) to identify neutrophil granulocytes and anti–pan-laminin 
(L9393; Sigma-Aldrich) to visualize the EBM, diluted in 1% BSA in PBS over-
night at 4°C (while shaking), and washed with 1% BSA in PBS. Antibodies 
were detected with a repeated cycle of staining with anti-rabbit Alexa Fluor 
488 (Invitrogen) and anti-rat Cy3 (Dianova) before tissue was embedded in 
elvanol and representative images taken with a Zeiss Axio Imager equipped 
with an ApoTome (Zeiss). Location of neutrophils was analyzed in detail for 
potential accumulation at the basement membrane. For quantification of 
neutrophil influx, at least 3 images of the inflamed skin were taken using 
a ×10 objective to quantify total neutrophil infiltrates (calculated as the 
percentage of Gr-1 signal per microscopic field) using Metamorph software 
(Molecular Devices), while intravascular signal was excluded.
The RPA, a widely used model of IC-mediated inflammation, was induced 
in the skin of mice using OVA (grade V; Sigma-Aldrich) as the antigen and 
purified rabbit anti-OVA antibodies of the IgG class (Rockland Immuno-
chemicals Inc.). Initially, the hair was removed from the ventral skin, and 
the area was cleaned with 70% alcohol. Anti-OVA IgG (2 μg/μl) was depos-
ited intradermally in a volume of 30 μl using a 27-gauge needle. Intradermal 
injection of 30 μl unspecific polyclonal rabbit IgG (2 μg/μl; Sigma-Aldrich) 
served as a negative control in the same animal. Without delay, the anti-
gen solution (OVA; 20 mg/kg body weight) was injected i.v. After 4 h, mice 
were sacrificed by CO2 asphyxiation, and the inflammatory response was 
assessed by histology. Paraffin-embedded sections of the specimens were 
processed for H&E staining and analyzed by light microscopy for inflamma-
tory cellular infiltrates. Neutrophils were additionally identified using Gr-1 
immunohistochemistry. Briefly, deparaffinized tissue sections were incu-
Figure 7
Proposed function of PR3 and NE in IC-mediated inflammation. TNF-α– 
primed neutrophils extravasate from blood vessels, translocate PR3/NE 
to the cellular surface, and discharge PGRN to the pericellular envi-
ronment (i). During transmigration of interstitial tissues (ii), neutrophil 
activation is initially suppressed by relatively high pericellular levels of 
antiinflammatory PGRN (green shading), which is also produced local-
ly by keratinocytes and epithelial cells of the skin. Until IC depots are 
reached, neutrophil activation is inhibited by PGRN. Surface receptors 
(e.g., Mac-1) recognize ICs, which results in signal transduction (black 
dotted arrow) and activation of the phox. The molecular pathway of 
PGRN-mediated inhibition is not completely understood, but it may 
interfere with integrin signaling after IC encounter (green dotted line 
inside the cell). Adherence of neutrophils to ICs (iii) further increases 
pericellular PR3 and NE activity. PR3 and NE cooperatively degrade 
PGRN in the early stage of neutrophilic activation to facilitate optimal 
neutrophil activation (red shading), resulting in sustained integrin sig-
naling (red arrow) and robust production of ROS by the phox system. 
Subsequently, neutrophils release ROS together with other proinflam-
matory mediators and chemotactic agents, thereby enhancing the 
recruitment of further neutrophils and establishing inflammation (iv). 
In the absence of PR3/NE, the switch from inflammation-suppressing 
(ii) to inflammation-enhancing (iii) conditions is substantially delayed, 
resulting in diminished inflammation in response to ICs (iv).
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bated with a rat anti–Ly-6G antibody (BD Biosciences — Pharmingen) fol-
lowed by a biotinylated goat anti-rat antibody (BioGenex). Bound antibod-
ies were labeled with streptavidin–alkaline phosphatase and visualized with 
fast red (BioGenex). Sections were counterstained with Mayer hematoxylin 
solution (Merck Eurolab). Random high-power fields (HPFs) of the lesions 
were photographed using a Leica DFC320 CCD camera (Leica) attached to 
a Zeiss Axioplan 2 microscope (Zeiss) with a ×10 objective. Digitized images 
were used to enumerate neutrophils as mean number per HPF in lesions 
from WT (n = 12), Ela2–/– (n = 13), and Prtn3–/–Ela2–/– mice (n = 12).
To study the inhibitory capacity of PGRN on IC-stimulated inflamma-
tion, we deposited 2 μg recombinant mouse PGRN by intradermal injec-
tion together with 30 μl anti-OVA solution as described above. In the same 
mouse at different sites of the ventral skin, we intradermally applied anti-
OVA alone and control IgG as positive and negative controls, respectively. 
The RPA was started by i.v. administration of OVA. Mice were sacrificed 4 h 
after initiation, and biopsies were taken to histologically quantify neutro-
phil infiltrates per HPF in PGRN-treated and untreated lesions from WT 
and Prtn3–/–Ela2–/– mice (n = 5 per group).
Collagen gel chemotaxis assay. For migration assays, PureCol (INAMED) in 
1× MEM (Sigma-Aldrich) and 0.4% sodium bicarbonate (Sigma-Aldrich) 
was mixed with cells in RPMI (Invitrogen) with 10% FCS (Invitrogen) at a 
2:1 ratio, resulting in gels with a collagen concentration of 1.6 mg/ml. Neu-
trophils were primed by 10 ng/ml mouse TNF-α (Roche) for 15 min at 37°C. 
Final cell concentrations in the assay were 1.6 × 106 granulocytes per millili-
ter of gel. Collagen-cell mixtures were cast in custom-made migration cham-
bers with a thickness of 0.5–1.0 mm. At 30 min after the assembly of the col-
lagen fibers at 37°C, the gel surface was covered with 50 μl of 0.1 μg/ml C5a 
solution (R&D Systems). Pictures of migrating cells were taken every 20 s 
using a Zeiss Axioplan 2 light-field microscope (Zeiss), and stacks of images 
were used to generate time-lapse videos in .AVI format using Metamorph 
(Molecular Devices). Chemotactic parameters were calculated and visualized 
as plots by analyzing the acquired data with a Chemotaxis and Migration 
Tool plug-in (http://www.ibidi.de/applications/ap_chemo.html).
Isolation of mouse neutrophils. Mouse neutrophils were purified from the 
bone marrow using a discontinuous percoll gradient (Amersham Bioscience) 
as previously described (44). Neutrophil preparations were characterized by 
Gr-1 and CD11b (Mac-1) double immunostaining using flow cytometry and 
were found to be at least 80% pure. To isolate murine neutrophils ex vivo from 
an inflammatory environment, we injected 1 ml of a 9% sterile casein solution 
in PBS to induce peritonitis. At 4 h after injection, cells were harvested by 
peritoneal lavage using sterile PBS without Ca2+ or Mg2+ (Gibco; Invitrogen). 
Peritoneal cells were layered on a discontinuous histopaque 1119–1077 gradi-
ent (Sigma-Aldrich), and, after centrifugation for 30 min at 700 g, neutrophils 
were isolated from the 1.119–1.077 kg/l interphase. For anti-PGRN Western 
blots and PR3/NE activity assays, neutrophil lysates were prepared. In brief, 
neutrophils were lysed in 50 mM Tris/HCl (pH 7.4), 150 mM NaCl, 0.5 mM 
EDTA, and 0.5% nonidet by mechanical disruption using syringes with 
27-gauge needles. Cell debris was pelleted by centrifugation. All steps were 
carried out at 4°C, and supernatant was frozen until used.
Neutrophil oxidative burst in vitro. To test neutrophil activation by ICs in 
vitro, we prepared immobilized ICs using an OVA/anti-OVA system as 
described previously (20). Isolated neutrophils were resuspended at a den-
sity of 2 × 106 cells/ml in phenol red–free RPMI (Gibco; Invitrogen) con-
taining 10 ng/ml mouse TNF-α (Roche) and added to immobilized ICs. 
Activation by 25 nM PMA (Sigma-Aldrich) without TNF-α served as a 
positive control. We also determined the oxidative burst of neutrophils as a 
function of increasing PMA concentrations (0.1–50 nM) in order to define 
the concentrations that yield submaximal responses in mouse neutrophils. 
ROS production as the readout for neutrophil activation was detected 
using dihydrorhodamine 6G (catalog no. D633; Invitrogen) according to 
the manufacturer’s instructions, and the increase in fluorescence was mea-
sured over time with the fluorometer FLUOstar OPTIMA (BMG Labtech) 
at 37°C. For each time point, the IC-specific oxidative burst was determined 
by subtracting the mean fluorescence read on negative control coating from 
that on IC coating. To compare independent experiments, we normalized 
oxidative burst relative to maximum ROS production by WT neutrophils.
To examine the effect of PGRN on neutrophil activation in vitro, we first 
approximated the concentration of cell-associated and secreted PGRN in 
the absence of PR3/NE during IC-mediated neutrophil stimulation by 
comparison with the positive control band in anti-PGRN Western blot, 
estimated to be approximately 100 nM. We then added recombinant PGRN 
at a final concentration of 100 nM to isolated WT neutrophils stimulated 
by ICs or PMA. We compared the oxidative burst between PGRN-treated 
and untreated cells as described above.
Adhesion assay. Isolated neutrophils were labeled with Calcein AM 
(Invitrogen) and plated on ICs in the presence of 10 ng/ml TNF-α as previ-
ously described (20). In brief, wells were washed with PBS at the indicated 
time points, the number of adhering cells was determined using a fluores-
cence reader, and the percentage was calculated.
Phagocytosis assay. Neutrophil phagocytosis of opsonized, FITC-labeled 
E. coli was determined by flow cytometry using the Phagotest (Orpegen Phar-
ma) according to the manufacturer’s instructions, with some modifications. 
Briefly, 100 μl heparinized blood was incubated with 20 μl FITC-labeled E. coli 
suspension (109 bacteria/ml) and incubated for 30 min at 37°C. After wash-
ing and DNA staining (using DNA staining solution from the Phagotest kit), 
samples were analyzed by flow cytometry. Bacterial aggregates were excluded 
based on their lower DNA content, and neutrophil granulocytes were gated 
in the forward/side scatter analysis. Phagocytosis of FITC-labeled E. coli by 
neutrophil granulocytes was determined using the FL-1 channel regarding 
percentage as well as fluorescence intensity of phagocytosing cells.
Analysis of PGRN degradation. PGRN processing activity was tested with 
recombinant mouse PR3 and human NE each at a molar enzyme/substrate 
ratio of 1:10 according to the buffer conditions described by Zhu et al. (23). 
Recombinant human PGRN (2.5 μg) was added to enzymes and incubated at 
37°C. At the time points indicated in the figures, samples were placed on ice, 
and the pattern of cleavage products was analyzed by reducing SDS-PAGE 
and subsequent silver staining.
To determine whether PGRN-degrading enzymes other than PR3 and 
NE existed in neutrophils, we incubated recombinant mouse PGRN with 
lysates from 3 × 104 WT, Ela2–/–, and Prtn3–/–Ela2–/– neutrophils for 1 h at 
37°C. Samples were separated by SDS-PAGE and transferred onto nitrocel-
lulose membranes. After incubation for 2 h in blocking buffer (5% fat-free 
dry milk in PBS/0.2% Tween-20), mouse PGRN was detected by Western 
blotting with sheep anti-mouse PGRN antibody (R&D Systems) at a con-
centration of 0.4 μg/ml and unspecific sheep IgG as a negative control 
(1 μg/ml; catalog no. I5131; Sigma-Aldrich). Bound antibodies were visual-
ized using peroxidase-conjugated donkey anti-sheep Igs (1:10,000; Jackson 
ImmunoResearch Laboratories) and ECL reagents (Amersham Pharmacia). 
For actin detection, the membranes were incubated in a 1:5,000 dilution 
of anti-actin mouse monoclonal antibody (clone JLA-20; Calbiochem) fol-
lowed by peroxidase-conjugated goat anti-mouse IgG and IgM incubation 
(1:10,000; Pierce) and subsequent ECL detection.
For detection of PGRN from neutrophils activated by ICs in vitro, we 
harvested the supernatant as well as the cellular pellet of isolated TNF-α– 
primed neutrophils after 3 h of IC stimulation. The concentrated super-
natant as well as the cellular pellet of 2 × 105 IC-activated neutrophils was 
separated by reducing SDS-PAGE and subjected to anti-PGRN Western 
blotting as described above.
To analyze whether PGRN was cleaved by PR3/NE during inflammation 
in vivo, we harvested neutrophils from the inflamed peritoneum of WT 
research article
	 The	Journal	of	Clinical	Investigation   http://www.jci.org   Volume 118   Number 7   July 2008 2447
and Prtn3–/–Ela2–/– mice. Lysates were prepared from these cells as described 
above, but in the presence of 75 μg/ml PMSF and protease inhibitor cock-
tail (Calbiochem). Total lysates from 8 × 105 cells were subjected to anti-
PGRN Western blotting, which was carried out as described above.
Statistics. All results are given as mean and SEM for data derived from 
different in vivo experiments and as mean and SD for data resulting from 
triplicate in vitro assays using isolated cells or cell lysates. Normal distribu-
tion of data sets was determined by the Kolmogorov-Smirnov test before 
we applied an unpaired Student’s t test to compare 2 groups. Calculations 
were done using GraphPad Prism software. A P value less than 0.05 was 
considered statistically significant.
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Plenary paper
Cdc42-dependent leading edge coordination is essential for interstitial dendritic
cell migration
Tim La¨mmermann,1 Jo¨rg Renkawitz,1 Xunwei Wu,2 Karin Hirsch,1 Cord Brakebusch,2 and Michael Sixt1
1Hofschneider Group Leukocyte Migration, Department of Molecular Medicine, Max Planck Institute of Biochemistry, Martinsried, Germany; and 2Biotech
Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
Mature dendritic cells (DCs) moving from
the skin to the lymph node are a proto-
typic example of rapidly migrating amoe-
boid leukocytes. Interstitial DC migration
is directionally guided by chemokines,
but independent of specific adhesive in-
teractions with the tissue as well as peri-
cellular proteolysis. Instead, the protru-
sive flow of the actin cytoskeleton directly
drives a basal mode of locomotion that is
occasionally supported by actomyosin
contractions at the trailing edge to propel
the cell’s rigid nucleus. We here delete
the small GTPase Cdc42 in DCs and find
that actin flow and actomyosin contrac-
tion are still initiated in response to che-
motactic cues. Accordingly, the cells are
able to polarize and form protrusions.
However, in the absence of Cdc42 the
protrusions are temporally and spatially
dysregulated, which leads to impaired
leading edge coordination. Although this
defect still allows the cells to move on
2-dimensional surfaces, their in vivo mo-
tility is completely abrogated. We show
that this difference is entirely caused by
the geometric complexity of the environ-
ment, as multiple competing protrusions
lead to instantaneous entanglement within
3-dimensional extracellular matrix scaf-
folds. This demonstrates that the deci-
sive factor for migrating DCs is not spe-
cific interaction with the extracellular
environment, but adequate coordination
of cytoskeletal flow. (Blood. 2009;113:
5703-5710)
Introduction
Cells of the hematopoietic lineage are fundamentally different from
mesenchymal or epithelial cells. Many of them are not restricted to
a specific tissue compartment, but rather circulate through the
whole organism to perform surveillance or renewal functions. The
difference between resident and mobile cells is reflected by the fact
that mesenchymal and epithelial cells are constitutively adherent to
specific extracellular substrates, whereas hematopoietic cells can
flexibly accommodate their adhesive properties.1 Dendritic cells
(DCs) are excellent examples for both principles as their function
relies on the switch from the sessile to the motile state.2 The sessile
immature DC samples antigens in peripheral tissues. Endogenous
or exogenous danger signals trigger the differentiation into the
motile state and at the same time induce the expression of the
CC-chemokine receptor 7 (CCR7) that directionally guides the
cells through the interstitium of the dermis and via the lymphatic
vessels into the T-cell area of the lymph node.3,4 In the T-cell area,
DCs present the peripherally acquired antigens to naive T cells and
upon cognate interaction instruct T-cell differentiation and prolifera-
tion. Acquisition of the motile state in DCs is accompanied by a
functional deactivation of cell-cell adhesion and integrin receptors
that allows the cells to detach from their substrates and move freely
through the dermal interstitium.5-7 Nonadhesiveness endows the
cells with enormous flexibility as they become autonomous from
the molecular composition of their environment and can directly
follow soluble guidance cues like chemokines. We could recently
show that nonadhesive DC migration in 3-dimensional (3D)
environments can be driven solely by the protrusive flow of actin
polymerization at the cell front, whereas actomyosin contractions
of the trailing edge served to propel the nucleus through narrow
spaces.7 Theoretic modeling confirmed that within confined envi-
ronments actomyosin dynamics can directly drive cellular locomo-
tion without requiring transmembrane force coupling via adhesion
receptors.8 The fact that 2-dimensional (2D) surfaces, as often used
to study cell migration, cannot support such nonadhesive move-
ment explains that cell biology has largely neglected the underlying
mechanisms. The migration of leukocytes is likely to be more
simplistic than that of adherent cells, as in 3D environments the
sheer initiation and polarization of actin flow together with cortical
shape changes likely explain most of its aspects.
The universally expressed small GTPases Rac, RhoA, and
Cdc42 are commonly accepted to be the key switches determining
cell shape.9,10 One of their main functions is the coordination of the
actin cytoskeleton and closely interrelated phenomena such as
adhesion and microtubule dynamics. It is firmly established that the
Rac family members are essential for actin polymerization and
RhoA regulates actomyosin contractility.10 Both effects have been
demonstrated in DCs: Abolishing Rac activity in mature DCs by
genetically deleting the 2 expressed isoforms Rac1 and Rac2 leads
to rounding and concomitant immobility of the cells,11 which is in
line with completely abrogated actin polymerization dynamics.
Blockade of RhoA downstream effectors leaves actin protrusion at
the leading edge intact, but affects the trailing edge of mature DCs
and neutrophils. Here, actomyosin contraction is required to
perform squeezing contractions to propel the cell’s rigid nucleus
through small pores.7
The roles of Cdc42 are less clear cut and many functions such as
filopodia formation appear to be cell type–specific.12 The most
conserved function of Cdc42 is the coordination of the polarity
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module, and many cell types require Cdc42 to stabilize and
maintain spatial and temporal asymmetries.10,13 Morphologically,
asymmetries usually manifest through the actin cytoskeleton,
leading to diverse phenomena such as axon formation or apical
basal orientation of epithelia.14 In motile leukocytes, polarity
determines the direction of movement, and accordingly loss of
chemotactic path finding has been observed upon intervention with
Cdc42 in neutrophils,15,16 macrophages,17 hematopoietic stem
cells,18 and Drosophila melanogaster hemocytes.19
The signaling pathways involved in Cdc42-dependent leuko-
cyte polarization have been studied mainly in neutrophils. Here, a
positive feedback loop has been described whereupon G protein–
coupled receptor signaling the kinase PAK1 recruits the guanine
nucleotide exchange factor PIX, which activates Cdc42 that in
turn positively regulates PAK1 activity.20 In T cells, Cdc42 is
activated by Rap1 and induces the Par polarity complex consisting
of Par3, Par6, and PKC. This triggers Tiam1, which connects the
Par polarity complex to Rap1 at sites of polarity initiation.21
Although Cdc42 has not been deleted in DCs until now, studies
using dominant-negative versions of the molecule revealed defects
in the endocytotic pathway,22 antigen presentation,23 podosome
formation,24 and dendrite formation25 of immature DCs.
Using DCs deficient for Cdc42, we here address the question of
how coordination of actin flow influences migration. Whereas
chemotactic movement of Cdc42-deficient DCs is only moderately
impaired in 2D assays, it is completely abolished in the dermal
interstitium. We show that the severe phenotype results from a
defective coordination of multiple protrusions that leads to entangle-
ment in the 3D fibrillar network. These findings demonstrate that
the internal stabilization of polarity becomes increasingly impor-
tant when the cells have to navigate through geometrically complex
environments.
Methods
Animals
Conditional Cdc42flox/flox mice26 were intercrossed with Mx1Cre transgenic
mice27 to generate Cdc42flox/flox Mx1Cre/ animals and kept on a mixed
129SV/C57BL/6 genetic background. Control animals were littermates
(Cdc42flox/flox Mx1Cre/ or Cdc42flox/ Mx1Cre/). At an age between
6 and 10 weeks, mice received a single intraperitoneal injection of 250 g
Poly (I)Poly (C) (250 g; GE Healthcare, Little Chalfont, United King-
dom), diluted in 0.5 mL phosphate-buffered saline (PBS). Mice were killed
10 to 14 days after injection. The mice were bred in a conventional animal
facility at the Max Planck Institute of Biochemistry and according to the
local regulations. Mouse breeding and all experimental procedures were
approved by the Regierung von Oberbayern.
Dendritic cells
DCs were generated from flushed bone marrow (BM) suspension as
previously described in detail.7,28 At days 8 to 10 of culture, 200 ng/mL LPS
(Sigma-Aldrich, Munich, Germany; Escherichia coli 0127:B8) was added
for 24 hours, and subsequently the culture was depleted of remaining Gr-1
contaminant cells. For depletion, cells were incubated with biotinylated
antibodies against Gr-1 (RB6-8C5; BD Pharmingen, Heidelberg, Ger-
many), followed by anti–biotin-microbead separation according to the
manufacturer’s protocol (Miltenyi Biotec, Bergisch Gladbach, Germany).
The purified DCs were used for migration assays. To determine knockout
efficiencies, DC lysates were loaded on 12% polyacrylamide gels for
electrophoresis under reduced conditions and Western blotting. Cdc42 was
detected with mouse anti–mouse Cdc42 antibody (clone 44; BD Transduc-
tion Laboratories, Heidelberg, Germany), and the loading control was
performed with rabbit anti–mouse actin antibody (A2066; Sigma-Aldrich).
Bound primary antibodies were detected with anti–mouse or anti–rabbit
horseradish peroxidase (HRP; both Bio-Rad, Hercules, CA) as secondary
antibodies, followed by chemiluminescence with Western Lightning Re-
agent Plus (PerkinElmer, Boston, MA). Only DC batches without detect-
able Cdc42 signal were chosen for experiments. Maturation of DCs was
analyzed by flow cytometry using antibodies against the mouse antigens:
CD11c (HL3, FITC-conjugated), I-A/I-E (2G9), CD40 (3/23), CD86 (GL1;
all PE-conjugated; all from BD Pharmingen), and CCR7 (PE-conjugated;
eBiosciences, San Diego, CA) with the corresponding isotype controls.7
Flow cytometric analysis was performed with a FACSCalibur and CellQuest
Pro Software (BD Biosciences, San Diego, CA).
In vivo migration assay
Gr-1–depleted wild-type (WT) and Cdc42-deficient DCs were labeled with
3 M cell-permeable Cell Trace Oregon Green 488 or 1 M tetramethylrho-
damine (TAMRA; both from Invitrogen, Karlsruhe, Germany), respec-
tively, and vice versa. DCs (106) at a 1:1 ratio were suspended in 20 L PBS
and injected subcutaneously into the hind footpads of C57BL/6 mice.
Forty-eight hours after injection, mice were killed by CO2 suffocation, and
popliteal lymph nodes were frozen in cryomatrix (Thermo, Pittsburgh, PA)
and sectioned in 12-m slices. To visualize the lymph node compartments,
cryosections were methanol-fixed, blocked with 1% BSA in PBS, and
stained with pan-laminin antibody (L9393; Sigma-Aldrich) and secondary
antirabbit Cy5 (Dianova, Hamburg, Germany). Three different layers of the
T-cell cortex of each lymph node were documented using an Axio Imager
upright microscope (Zeiss, Jena, Germany). Quantification of DCs within
the T-cell cortex was performed with MetaMorph (Molecular Devices,
Ismaning, Germany). Using inverse thresholding, the greyscale images of
both fluorescence channels were separately binarized. DCs appeared as dots
that were quantified using the morphometric analysis tool. The ratio of
migrated knockout DCs was calculated as the number of knockout cells
divided by the total number of DCs in the T-cell cortex, with 0.5 as the value
where 50% of knockout cells and 50% WT cells located in the center of the
lymph node, and with 0 as the value where only WT cells located in the
T-cell cortex of the lymph node.
Ex vivo migration assay
Ears of killed C57BL/6 mice were removed and mechanically split into
dorsal and ventral halves. During separation, the dermis detached from the
cartilage layer that remained on one of the halves. LPS-matured, BM-
derived, magnetic-activated cell sorting (MACS)–purified, TAMRA-
labeled DCs were resuspended in culture medium, added on top of the
dermis, and incubated for 120 minutes at 37°C, 5% CO2. For immunofluo-
rescence stainings, ear sheets were then fixed with 1% paraformaldehyde,
incubated with a rabbit polyclonal anti–LYVE-1 antibody (R&D Systems,
Wiesbaden, Germany), washed with PBS, and stained with A488-
conjugated anti–rabbit secondary antibody (Invitrogen). Images were
obtained with a Leica DMIRE2 confocal microscope (objective HCX PL
APO/40/1.25-0.75 oil; Leica, Wetzlar, Germany). Merged z-stacks were
generated with the Leica confocal software. For quantification of DC
numbers within lymphatic vessels, z-stacks were 3D reconstructed, before
the intersection of grayscale images from both fluorescence channels was
determined, leaving only DCs within lymphatic vessels to be quantified by
integrated morphometry analysis with MetaMorph.
In vitro migration assays
Three-dimensional collagen gel chemotaxis assays (Figure 6D) have been
described earlier.7 PureCol (INAMED, Fremont, CA) in 1 minimum
essential medium eagle (Sigma-Aldrich) and 0.4% sodium bicarbonate
(Sigma-Aldrich) was mixed with cells in RPMI (Invitrogen), 10% fetal calf
serum (FCS; Invitrogen) at a 2:1 ratio, resulting in gels with a collagen
concentration of 1.6 mg/mL. Final cell concentrations in the assay were 106
DCs/mL gel. Collagen-cell mixtures were cast in custom-made migration
chambers with a thickness of 0.5 to 1 mm. After 30-minute assembly of the
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collagen fibers at 37°C, the gels were overlayed with 50 L of 0.6 g/mL
CCL19 (R&D Systems) diluted in RPMI/10% FCS.
For 3D collagen gel invasion assays (Figure 6A), 2.5 g/mL CCL19
was added before polymerization of the 1.6 mg/mL collagen gel in a
custom-made migration chamber. DCs (5  105) were placed on top of the
collagen gel, and the chamber was incubated in an upright position for
8 hours at 37°C, 5% CO2, before images were taken with an inverted
Axiovert 40 (Zeiss).
Under-agarose chemotaxis assays (Figure 3A) have been performed as
described elsewhere.29 Briefly, 2.5% UltraPure agarose (Invitrogen) in
distilled water was heated and mixed with 56°C prewarmed RPMI/20%
FCS and 2 Hank buffered salt solution (Sigma-Aldrich) at a 1:2:1 ratio,
resulting in an agarose concentration of 6.25 mg/mL. Two microliters of
warm agarose-medium mixture was cast in 3.5-cm cell-culture dishes (BD
Falcon, Franklin Lakes, NJ) and allowed to polymerize at room tempera-
ture. A responder hole (for DCs) was punched 1 mm from an attractor hole
(for chemokine) into the agarose. After 30 minutes of equilibration at 37°C,
5% CO2, 5  105 DCs were transferred into the responder hole and
1.2 g/mL CCL19 was filled into the attractor hole. Time-lapse videomicros-
copy was initiated when DCs started to migrate between the cell-culture
plastic and the agarose. For under-agarose assays with homogenous
chemokine (Figure 2A), 2.5 g/mL CCL19 was added when the agarose-
medium mixture cooled to 37°C before casting and polymerization. DC
suspension (1 L) was injected beneath the agarose with a fine pipette tip,
and time-lapse videomicroscopy recording started immediately.
Low-magnification bright-field movies of 3D collagen chemotaxis
assays and all agarose assays were recorded at indicated time intervals
using inverted Axiovert 40 (Zeiss) cell-culture microscopes, equipped with
custom-built climate chambers (5% CO2, 37°C, humidified) and PAL
cameras (Prosilica, Burnaby, BC) triggered by custom-made software (SVS
Vistek, Seefeld, Germany). The objectives used were A-Plan 10/0.25 Ph1
and LD A-Plan 20/0.3 Ph1 (both Zeiss). Manual tracking was applied to
3D and under-agarose chemotaxis assays. DCs were tracked over 3 to
4 hours with ImageJ (National Institutes of Health [NIH], Bethesda, MD)
and the Manual Tracking Plugin. Speed and directionality parameters were
calculated and visualized as plots by analyzing the acquired data with the
Chemotaxis and Migration Tool Plugin.
To visualize the 3D morphology of DCs migrating toward CCL19 in a
3D collagen gel (Figure 7A), DCs were labeled with 3.5 M TAMRA
(Invitrogen) and imaged with an inverted Zeiss Observer.Z1 microscope
equipped with a Yokogawa spinning disc confocal scanhead, Coolsnap
HQ2 camera (implemented by Visitron Systems, Pucheim, Germany) and a
Plan-APOCHROMAT 40/0.95 Korr oil objective (Zeiss). Images were
3D reconstructed in MetaMorph and processed with the Surpass Tool of the
Imaris 4.0.6 software (Bitplane, Zu¨rich, Switzerland).
Actin dynamics and total internal reflection microscopy
DCs were transfected with lifeact:GFP between days 8 and 10 of culture
using the primary mouse T-cell kit and the Amaxa nucleoporator (Amaxa,
Cologne, Germany).30 Cells were transfected according to the manufactur-
er’s recommendations, and immediately after transfection LPS was added
for overnight maturation. The actin network of DCs migrating in an
underagarose setting was visualized with an inverted Zeiss Axiovert 200M
microscope equipped with a total internal reflection setup, Coolsnap HQ2
camera (both Visitron Systems) and a Plan-FLUAR 100/1.45 oil objec-
tive (Zeiss). Images were taken every 2 seconds. Image analysis was
performed with MetaMorph: protrusion and retraction of leading edge
regions were presented as time montage after applying the background
flattening tool. Actin dynamics were quantified by kymograph analysis,
whereby the actin polymerization rate was calculated as the sum of the
retrograde actin flow (as observed in some DCs) and the actin forward
protrusion at the leading edge.
Statistics
After data were confirmed to fulfill the criteria, t tests were performed;
otherwise, Mann-Whitney U tests were applied. Analyses were performed
with Sigma Stat 2.03 (Systat, San Jose, CA).
Online supplemental material
Videos S1 through S6 and legends are available on the Blood website (see
the Supplemental Materials link at the top of the online article).
Results
DC differentiation and maturation do not require Cdc42
We conditionally deleted Cdc42 in hematopoietic precursor cells
by crossing mice carrying the conditional alleles with transgenics
for the inducible Mx1 promoter–driven Cre recombinase.26,27 We
generated mature DCs in vitro from BM suspension of mice with
induced knockout and obtained cells that were entirely negative for
Cdc42 protein as tested by Western blotting (Figure 1A). The cells
showed normal DC surface markers including high MHCII and
costimulatory molecules and also normal expression levels of
chemokine receptor CCR7 (Figure 1B). Cdc42-deficient (Cdc42/)
DCs had the typical veiled morphology, but were slightly smaller
than WT DCs as revealed by the altered scatter profile in flow
cytometry (Figure 1B). These findings show that Cdc42 deficiency
does not prevent myelopoiesis and DC generation and maturation
in vitro. Apart from their smaller size, immature Cdc42/ DCs
were severely impaired in the uptake of fluorescent dextran and
also bacterial particles (data not shown), which is in agreement
with previous reports that dominant-negative inhibition of Cdc42
function led to decreased endocytosis and phagocytosis.22,31
Symmetry-breaking in response to homogenous chemokine
exposure
To observe the cells upon exposure to polarizing stimuli, we
established an assay system that allowed us to follow the morpho-
logic response of DCs by time-lapse video microscopy. As mature
DCs are nonadherent,6 we chose a setup where the cells are
squeezed between a layer of agarose and a coverslip29 (Figure 2A).
The spatial constraint in this semi-3D setting caused flattening of
the cells, leading to a “2D projection” that ideally suits to assess
Figure 1. Knockout efficiency and maturation of Cdc42/ dendritic cells. At
day 8 of culture, bone marrow (BM)–derived dendritic cells (DCs) were matured with
200 ng/mL lipopolysaccharide for 24 hours and used for experiments. (A) Cdc42
expression was determined by Western blot analysis of wild-type (WT) and Cdc42/
DC lysates. Actin expression was used as loading control. Cdc42/ DCs with no
detectable Cdc42 stain were chosen for experiments. (B) Size (dot plots) and
maturation (histograms) of WT and Cdc42/ DCs were analyzed by flow cytometric
analysis. Expression of surface maturation markers on DCs (CD11c-positive cells)
was detected with PE-labeled antibodies against MHCII, CD40, CD86, and CCR7
(white open curve) and corresponding isotype controls (gray closed curve). Represen-
tative result of independent DC cultures derived from BM of 4 WT and 4 Cdc42/
mice.
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morphologic changes. When WT DCs were exposed to uniform
concentrations of the CCR7-binding chemokine CCL19 (Figure
2B; Video S1), they underwent radial symmetrical expansion until
after 2 to 3 minutes the disc shape was reached. This expansion was
followed by sudden collapse of radial symmetry and segregation
into a leading and a trailing edge, which was accompanied by
locomotion. Although some WT cells developed multiple leading
edges, the majority polarized along one randomly oriented axis. In
Cdc42/ DCs, expansion and symmetry breaking occurred equally,
demonstrating that CCR7 signaling was intact and that polarization
as such was not impaired. However, leading and trailing edge were
rarely aligned along one axis. Instead, many cells developed
multiple competing leading edges (Figure 2B; Video S1). These
observations were in line with previous work demonstrating that
Cdc42 regulates temporal and spatial stability of actin protrusions
by either reinforcing one existing protrusion or suppressing the
development of new protrusions.32 This phenotype motivated us to
use Cdc42/ DCs as a model system to study the role of actin flow
polarization during locomotion.
Locally intact, but globally dysregulated, actin flow in
Cdc42/ DCs
Cdc42 is an upstream activator of Rac activity and was further
shown to negatively affect RhoA activation in a neutrophil-like cell
line.16 Both effects might affect the protrusive and contractile
aspects of the actin cytoskeleton. To characterize actin dynamics in
Cdc42/ DCs, we transfected the cells with lifeact:GFP, a recently
described actin-binding peptide, that leaves actin dynamics unaf-
fected and allows dynamic visualization of actin flow within the
cells30 (Figure 2C,D; Video S2). As an optical setup to image the
cortical actin flow, we observed the transfected DCs under agarose
with total internal reflection (TIRF) microscopy that excites
exclusively the membrane-proximate 100 to 200 nm of the cell and
allows high spatial and temporal resolution while phototoxic
effects are minimized. In these assays, polarized WT DCs showed a
continuous and expanding sheet of F-actin at the leading edge
(Figure 2C), whereas retrograde flow was observed at the lateral
aspects of the leading edge (data not shown). In line with our
bright-field observations, the morphology of the actin cytoskeleton
of Cdc42/ DCs was altered, as many cells developed 2 and
sometimes multiple competing leading edges (Figure 2D). Despite
this global shape change, local actin flow at the leading edge did
not significantly differ from WT cells: kymograph analysis showed
that, on short timescale, polymerization rate and accordingly
protrusion velocity were unaltered in the absence of Cdc42 (t test,
P  .069; Figure 2E). As the persistence time of each protrusion
was decreased, protrusion was frequently followed by phases of
contraction and retrograde flow (data not shown). These findings
show that locally actin protrusion and contraction can be initialized
in the absence of Cdc42, meaning that a principal failure in Rac and
RhoA activation is unlikely. It rather occurs that spatial and
temporal coordination of actin dynamics is disturbed, leading to
multiple competing, instead of one unifying, protrusions.
Chemotactic movement in Cdc42/ DCs is moderately
impaired in 2D
We next wanted to test whether this failure to coordinate protru-
sions affects chemotactic movement. A graded distribution of
chemoattractant might preferentially trigger protrusion develop-
ment toward the high concentration of attractant and, therefore,
(partially) counteract the development of competing protrusions
that we observed during spontaneous polarization.33
We exposed WT cells in the under-agarose assays to diffusion
gradients of CCL19 (Figure 3A; Video S3), and observed direction-
ally persistent chemotactic movement toward the chemokine
source with single-cell velocities ranging between 5 and 15 m/
minutes and high directional persistence (Figure 3B-D). In Cdc42/
DCs, median velocities were only moderately reduced (U test,
P  .001) and cells still reached 80% of the WT values (Figure
3C). Although Cdc42/ DCs still showed net movement toward
the chemokine, directionality values dropped to 59% of the WT
cells (t test, P  .001; Figure 3B,D). To test whether the decreased
directionality was a consequence of impaired coordination of
protrusions, we tracked the morphology of the chemotaxing DCs.
To exemplify shape changes, we traced the outlines of single cells
and displayed cellular morphology alongside instantaneous migra-
tion velocities (Figure 3E). Although chemotaxing WT DCs
underwent constant shape change, the development of multiple
Figure 2. Actin polymerization and coordination at the leading edge of dendritic
cells. (A) DCs were injected between a glass coverslip and a layer of agarose
containing 2.5 g/mL CCL19. This experimental setup served for studying the
chemokinetic response and actin dynamics of DCs at 37°C, 5% CO2 (in panels B-E).
(B) Initial radial spreading, symmetry breaking, and subsequent polarization of DCs
was recorded by time-lapse videomicroscopy. Morphology outlines of DCs were
obtained by morphometric analysis (MetaMorph). A time sequence of a representa-
tive WT and Cdc42/ DC is shown. Time (minutes:seconds). Scale bar represents
50 m. Objective: LD A-Plan 20/0.30 Ph1 (Zeiss). (C,D) WT (C) and Cdc42/
(D) DCs were transfected with the actin marker lifeact:GFP and actin dynamics
observed by TIRF microscopy over time. (Top panels) A time sequence of a
representative entire cell is shown. Time (minutes:seconds). Scale bar represents
10 m. Objective: Plan-FLUAR 100/1.45 oil (Zeiss). (Bottom panels) Leading edge
regions indicated by the white boxes were analyzed for phases of protrusion and/or
retraction. After background flattening (MetaMorph), a time-lapse montage over
91 seconds (2 seconds/frame) presents the dynamics at the leading edge. (E) Quan-
tification of the actin polymerization rate at the leading edge by kymograph analysis.
Cells were derived from 2 independent BM DC cultures (of both WT and Cdc42/
mice). Single cells (dots) were analyzed (line: mean, t test, P  .069, WT: n  19,
Cdc42/: n  24).
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protrusions was rarely observed. Whenever protrusions branched,
retraction of the deviating protrusion occurred almost instanta-
neously, leading to no significant deceleration of the cell. In
addition, Cdc42/ DCs showed phases of high velocities during
which they resembled WT cells (Figure 3E, gray-shaded track
phases). These phases were frequently interrupted by episodes
where the cells displayed multiple competing leading edges, which
caused either spinning behavior or complete migratory arrest. Occasion-
ally, multipolar cells even underwent self-fragmentation when multiple
protrusions migrated in different directions (data not shown).
Taken together, the graded distribution of chemokine could not
compensate for the coordination defect of Cdc42/ DCs, and the
ability of chemotaxing cells to unify the actin flow in one
protrusion was impaired. Importantly, this defect led only to
slightly diminished migration velocities. Chemotactic migration
was still possible in the vertically confined, but horizontally open,
2D setting of the under-agarose assay, albeit directionality was
decreased due to the development of competing leading edges.
In vivo migration of Cdc42/ DCs is completely abolished
Having defined the coordination defect of Cdc42/ DCs in vitro,
we wanted to test how the phenotype manifests in vivo. Bone
marrow–derived DCs are well suited for this purpose, as injection
into the dermis of mice results in in vivo migration toward the
draining lymph node. In an internally controlled experiment, we
injected Cdc42/ DCs together with differentially labeled WT
DCs into the footpads of mice and monitored their arrival in
draining lymph nodes (Figure 4A). Strikingly, arrival in the T-cell
area was completely abolished in the Cdc42/ cells, and we could
not detect even trace amounts of these cells either in the sinus area
or in the T-cell cortex of the lymph node (Figure 4B,C). This drastic
phenotype was somewhat in contrast with our under-agarose assay
and raised the question at which level migration was blocked. This
could be movement in the dermal interstitium, entry into the
lymphatic vessels, or transport toward the node.
To distinguish between a possible block of interstitial migration
and impaired entry into the lymphatic vessels, we directly observed
the DCs upon entry into the dermal compartment. To this end we
used “crawl-in” assays where labeled BM-derived DCs were
layered on exposed dermis of explanted murine ear sheets (Figure
5A). This technique allowed us to monitor dermal movement and
lymphatic entry of DCs as the lymphatic vessels were visualized
with fluorescent staining against LYVE-1. After 2-hour incubation,
WT DCs localized within the lymphatic vessels, whereas Cdc42/
DCs appeared randomly distributed (Figure 5B,C; Video S4). To
Figure 3. Directed migration of dendritic cells toward a CCL19 gradient in a planar under-agarose assay. (A) Analysis of DC chemotaxis in a planar under-agarose
assay. DCs migrate beneath the agarose toward the 1-mm afar attractor hole containing 1.2 g/mL CCL19. Directed migration at 37°C, 5% CO2 was recorded by time-lapse
videomicroscopy and analyzed with ImageJ software (in panels B-E). (B) Tracks of single DCs migrating toward a CCL19 gradient over 3 hours (n  30 each). WT indicates
wild-type. (C) Comparison of velocity (line: median, U test, P  .001) and (D) directionality (line: mean, t test, P  .001) of chemotaxing DCs. Cells were derived from
3 independent BM DC cultures (of both WT and Cdc42/ mice) and applied to individual experiments. Forty single cells (dots) per experiment were tracked (WT: n  120,
Cdc42/: n  120). ***P  .001. (E) Correlation of morphology and migration tracks of representative single WT and Cdc42/ DCs migrating along a CCL19 gradient. The
top track shows outlines of DC morphology over time (WT: 82 minutes, Cdc42/: 177 minutes). Morphology outlines of DCs were obtained by morphometric analysis
(MetaMorph). The middle track (black line only) represents the migration track, whereas the bottom track indicates migration phases with instantaneous velocities over a
threshold speed of 7 m/minutes (gray shaded). Scale bar represents 50 m. Objective: A-Plan 10/0.25 Ph1 (Zeiss).
Figure 4. Analysis of in vivo dendritic cell migration from the skin via the
lymphatic vessels to the lymph node. (A) Wild-type and Cdc42/ DCs were
labeled with TAMRA (red) or Oregon Green 488 (green), and a 1:1 mixture was
injected subcutaneously into the hind footpads of C57BL/6 mice and arrival in the
popliteal lymph node (LN) was analyzed 48 hours later. (B) Immunofluorescence
microscopy (Axio Imager; Zeiss) of 12-m-thick LN cryosections. Counterstaining
against laminin (Cy5, blue) distinguishes B-cell follicles (B) and T-cell cortex
(T). Scale bar represents 200 m. Objective: EC Plan-NEOFLUAR 10/0.3 (Zeiss).
(C) Quantification of immunofluorescence analysis. Three different layers of the
T-cell cortex of each LN were documented and quantified by morphometric analysis
(MetaMorph). Dotted line at 0.5: 50% of DCs that migrated into the LN are Cdc42/
DCs. Circles indicate single experiments (1 LN).
ACTIN COORDINATION IN 3D DENDRITIC CELL MIGRATION 5707BLOOD, 4 JUNE 2009  VOLUME 113, NUMBER 23
 For personal use only. at Københavns Universitetsbibliotek on June 6, 2009. www.bloodjournal.orgFrom 
narrow down the anatomic site where migration was blocked, we
recorded confocal z-stacks of the dermis. In an internally controlled
experiment, we found that Cdc42/ DCs remained on the surface
of the tissue, whereas WT cells deeply penetrated the dermis where
the lymphatic vessels are buried (Figure 5D). These data demon-
strate the complete incapability of Cdc42/ DCs to infiltrate the
interstitial meshwork despite their principal ability to perform
chemotactic movement.
Configuration, not molecular composition, of the environment
leads to abrogated migration
Our previous data made it unlikely that the incapability to infiltrate
the dermal interstitium was caused by a defect in chemokine
sensing. Furthermore, the finding that DCs can migrate in the
absence of adhesive interactions with the tissue7 argued against
Cdc42/ DCs being unresponsive to other cues of the dermal
interstitium, such as extracellular matrix molecules. Hence, we
explored the option that not the composition but the geometry of
the environment could prevent entry of Cdc42/ DCs.
To simulate a complex fibrillar scaffold in the absence of the
diverse dermal interstitial matrix molecules, we used 3D collagen
gels as migration substrates. We showed previously that collagen
gels are excellent substrates for chemotactic DC movement and
that, like in vivo, the migration in these assays is independent of
adhesion receptors.7 We modified the previously described colla-
gen gel chemotaxis assay to test for the invasive potential of DCs
and layered WT and Cdc42/ DCs on top of collagen gels that
contained CCL19 (Figure 6A). Wild-type cells quickly invaded the
gels, whereas Cdc42/ DCs strictly remained on top of the gel and
invasion was virtually abolished (t test, P  .001; Figure 6B,C).
This indicated that the sheer configuration of the extracellular
environment rendered the mutant cells unable to enter.
We next “forced” the cells into the gels by incorporation into the
collagen scaffold before exposure to a CCL19 gradient (Figure 6D;
Video S5). In line with the invasion assays, WT cells vigorously
Figure 5. Analysis of ex vivo dendritic cell migration in a dermal ear explant.
(A) Ears of C57BL/6 mice were separated into halves and mature DCs placed on top
of the dermis. Two hours after addition of TAMRA-labeled DCs (red dots) and
incubation at 37°C, 5% CO2, entry of DCs into deep lymphatics was analyzed (in
panels B-D). (B top row) Wild-type and (bottom row) Cdc42/ DCs were placed on
dermal ear explants in separate experiments. One percent PFA-fixed ear sheets
were counterstained with anti–LYVE-1 antibody (green) to detect lymphatic vessels in
the dermis. The images represent merged z-stacks (WT: 18 planes, 1.1 m z-steps;
Cdc42/: 24 planes, 1.3 m z-steps) obtained by confocal microscopy (Leica
DMIRE2). Scale bars represent 100 m. Objective: HCX PL APO/40/1.25-0.75 oil
(Leica). (C) Quantification of immunofluorescence analysis. Cells were derived from
2 independent BM DC cultures (of both WT and Cdc42/ mice). Single DC cultures
were applied to 3 C57BL/6 ears, confocal z-stacks 3-dimensional (3D) reconstructed,
and the number of DCs within lymphatics calculated by morphometric analysis
(mean 	 SD; t test, P  .001, WT: n  6, Cdc42/: n  6). ***P  .001. (D) Side
view of the ear dermis (z  50 m) after addition of a 1:1 mixture of WT (red) and
Cdc42/ (green) DCs.
Figure 6. Directed migration of dendritic cells toward a CCL19 gradient in 3D
collagen gels. (A) Three-dimensional in vitro setup to study DC tissue invasion (in
panels B,C). DCs were layered on top of a polymerized 1.6 mg/mL collagen gel
containing 2.5 g/mL CCL19 and incubated at 37°C, 5% CO2. After 8 hours, DC
invasion into the gel was analyzed. (B) Images of WT and Cdc42/ DC invasion
were obtained by bright-field microscopy (inverted Axiovert 40; Zeiss). Scale bar
represents 200 m. Objective: A-Plan 10/0.25 Ph1 (Zeiss). (C) Cells were derived
from 2 independent BM DC cultures (of both WT and Cdc42/ mice). Single DC
cultures were applied on top of 6 collagen gels and the distance of DC migration into
the gel was measured (mean 	 SD, t test, P  .001, WT: n  12, Cdc42/: n  12).
***P  .001. (D) Three-dimensional in vitro setup to study DC interstitial migration.
DCs were added to 1.6 mg/mL collagen, followed by fiber assembly for 30 minutes at
37°C. Polymerized gels were overlaid with 0.6 g/mL CCL19. DC migration at 37°C,
5% CO2 was recorded for 4 hours by time-lapse videomicroscopy and analyzed with
ImageJ software (in panels E,F). (E) Tracks of single DCs migrating toward a CCL19
gradient in 3D (n  40 each). (F) Comparison of velocities (line: median, U test,
P  .001) and directionality (line: mean, t test, P  .001) of DCs chemotaxing in 3D
collagen matrices. Cells were derived from 2 independent BM DC cultures (of both
WT and Cdc42/ mice) and applied to individual experiments. Fifty single cells
(dots) per experiment were tracked (WT: n  100, Cdc42/: n  100). ***P  .001.
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moved along the chemokine gradient, whereas Cdc42/ DCs had
a drastically reduced migration perimeter (Figure 6E). When we
visualized the cells in high resolution within the gels, it became
apparent that in the absence of Cdc42 the ability to move long
distances was completely abolished as the cells simultaneously sent
protrusions in all directions (Figure 7A; Video S6). Such behavior
naturally leads to an entanglement of the cell in the dense
meshwork. Accordingly, median migration velocities of Cdc42/
DCs in collagen gels dropped to 44% compared with WT DCs
(U test, P  .001) and directional persistence was reduced to 25%
(t test, P  .001; Figure 6F).
Taken together, our 3D in vitro results completely resemble the
severe in vivo migration defect and demonstrate that a loss of
Cdc42-mediated coordination of protrusive actin flow leads to DC
trapping in fibrillar networks. We interpret the data as the logical
3D extension of the moderate phenotype in the 2D context of the
under-agarose assay, which permits unrestricted movement in the
horizontal dimension as no physical barriers exist.
Discussion
Our previous findings showed that interstitial leukocyte migration
is nonadhesive and driven mainly by shape changes of the cortical
actin network and protrusive flowing of the leading edge.7 Hence, it
appears especially essential to gain more knowledge how cytoskel-
etal regulation affects locomotion in hematopoietic cells. We show
here that depletion of Cdc42 in DCs results in a defect of global
cytoskeletal coordination, whereas, locally, actin polymerization
and actomyosin contraction remains intact. In cells migrating on
2D surfaces, this defect manifests as tumbling and 41% reduction
of directional persistence, although the cells still reach 80% of the
velocities of their WT counterparts. These findings are in line with
previous in vitro 2D migration studies that show intact chemokinesis,
but impaired chemotaxis in macrophages,17 neutrophil granulocytes,15
and T lymphocytes34 expressing dominant-negative mutants of Cdc42.
The phenotype also resembles the phenotype of Cdc42/ fibroblastoid
cells, which show unimpaired migration speed during wound closure,
while directionality is mildly affected.35
Surprisingly, the mild manifestation of the phenotype we
observed in the 2D assays is qualitatively different in vivo where
migration is almost completely arrested. As DCs migrate in the
absence of adhesive interactions, it is unlikely that the different
phenotypes result from distinct migration substrates in the 2D in
vitro assays versus the interstitium of the dermis. We rather think
that it is entirely due to the spatial configuration of the environ-
ment. This conclusion is supported by our finding that we also
observed arrested migration in 3D collagen gels, which mimic the
geometry of the dermis but not its complex molecular composition.
This raises the question why increasing geometric complexity of
the environment demands more tightly coordinated cytoskeletal
protrusions. DCs and most other quickly migrating leukocytes do
not use path-generating mechanisms such as pericellular proteoly-
sis during migration in 3D environments.36 They rather move along
the path of least resistance and—if at all—they transiently deform
their environment by squeezing contractions of the cell rear.7
Hence, for a leukocyte, the interstitial environment can be de-
scribed as a complex array of fixed pores (scheme, Figure 7B). The
migratory process is a series of decisions to traverse the “most-
promising” pore, which mechanistically means to funnel all actin
flow into one cellular protrusion. In this scenario, indecisiveness
is extremely problematic, as multiple protrusions lead to
entanglement. The geometric complexity of the interstitium
compared with the unrestricted environment of the 2D assay
explains why the decision problem of Cdc42/ DCs shows
different manifestations in vivo and in vitro. In this study, we
did not investigate in detail how Cdc42 regulates the decisive
process of actin flow coordination. However, there is a large
body of literature involving Cdc42 in molecular feedback loops
that promote the stable formation of one leading protrusion
while competing protrusions are suppressed.37
Interestingly, observations similar to our 2D findings were
made in hemocytes of Drosophila embryos after blocking of
Cdc42 activity by dominant-negative inhibition: when the
chemotaxing cells were tracked in vivo, the inhibited cells
reached velocities that were even higher than their WT counter-
parts but the directional persistence was diminished.19 Although
these observations in the 3D environment of a living fly embryo
are contradictory with our 3D data at first sight, they are
explainable, as animals with an exoskeleton lack an interstitial
matrix scaffold.38 Like in the unrestricted 2D assays, entangle-
ment in the nonfibrillar environment appears unlikely, as a
cellular or viscous tissue probably allows deformation by the
cytoskeletal forces of the hemocyte.
So far, in vivo data on the effects of Cdc42 depletion in murine
leukocytes are limited to a study showing that Cdc42/ hematopoi-
etic stem cells are severely impaired in their BM homing and
retention capacity.18 By investigating DC migration in a physi-
ologic context, we show here that tight regulation of polarized actin
is decisive for leukocyte migration in the interstitium. Our findings
underline the importance of considering the extracellular context
when investigating cell migration—even in cells locomoting
independent of the molecular composition of the tissue. We further
think that the cellular polarity module might be a promising target
Figure 7. Morphology of migrating dendritic cells in 3D collagen gels and
concluding scheme. (A) TAMRA-labeled DCs were added to 1.6 mg/mL collagen,
followed by fiber assembly for 30 minutes at 37°C. Polymerized gels were overlaid
with 0.6 g/mL CCL19. After 60 minutes, snapshots of DCs migrating at 37°C,
5% CO2 in the 3D collagen gel toward CCL19 were obtained by spinning disc
confocal microscopy. DC morphologies result from 3D reconstruction of confocal
stacks (MetaMorph) and Surpass processing with Imaris software. Scale bars
represent 5 m. Objective: Plan-APOCHROMAT 40/0.95 Korr oil (Zeiss). (B) Con-
cluding scheme about the decisive role of coordinated actin protrusions for leukocyte
migration in complex 3D environments.
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to influence the interstitial migration of DCs or other types of
leukocytes.
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